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My interest in porphyrin metabolism started in 1951 when, 
as a medical registrar, I presented a patient with acute porphyria 
at a clinical meeting in the Western Infirmary, Glasgow. Later, 
I studied other patients with this disease through the kindness of 
Dr. J.k.W. McCluskie, Mr. E. Gerstenberg, F.R.C.S.E. and Professor 
Sir J.W. MeI ee. 
In 1952 I received a Nuffield research fellowship tenable 
at the department of Chemical. Pathology, University College 
hospital Medical School, London. From 1952 - 1954 much of the 
clinical and experimental work in this thesis was done under the 
guidance of Professor C. Rimington, F.R.S. The experimental work 
was published as each section reached completion and I enclose 
reprints of such work. The clinical section and the histories of 
50 cases have not been published, with the exception of 2 cases 
(Kos. 4 and 25) reported by Goldberg, MacDonald and Rimington in 
1952. 
From September 1954 to January 1956 I held an Eli Lilly 
travelling fellowship in medicine, awarded by the Medical Research 
Council. During this period I worked in Professor Wintrobe's 
department in Salt Lake City, Utah. The major part of my work 
there was a study of haem synthesis, to which I have briefly 
referred in Section 2. 
The subject I had tackled, at first appearance so circum- 
scribed, quickly revealed attachments to many other branches of 
medical science. Throughout this thesis I have tried to make it 
clear to whom I owe gratitude for such specialised knowledge or 
aid. I would particularly like to thank Dr. James B. Gibson who 
was mainly responsible for the joint paper on neuropathology. 
I would also like to thank Professors Cameron, Dent and Rosenheim 
and Drs. H.Harris, Harold Heath and Elizabeth Work for their advice. 
From the beginning of these studies I have been greatly 
influenced by the example and benevolence of Professor Rimington 
and to him I owe much. 
A. Goldberg. 
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HISTORY OF ACUTE INTERMITTENT PORPHYRIA 
31) Scherer, chemisch- physiologische Untersuchungen. 
bei welchem aoslalt der Kochsalzlösung, das Blut mil Wein - 
geist gemischt und 11'asserslolfgas durchgeleitet wurde. 
tim die Capaclliit des Blutserums für Kohlensäure zu 
priifru, wurde folgender Versuch angestellt. In eine mit 
Quecksilber gefüllte graduirle (ilasriihre wurden Iti4 C. C. 
J oblensiiuro geleitet und sodann (30 C. C. Serum voll Och- 
senblut dazngebracht. Nach 24 Stauden war die Kohlen - 
siiure bis auf (i0 C. C. verschwunden, folglich 124 C. C. Koh- 
lensiiure roll dem Blutserum absorbirt worden. Es wurden 
nun 30 C. C. l:nsig,änre zu dem Serum gebracht und die Fliis- 
sigkeit etwas gesrhültelt. lis entwickelten sich darauf wie- 
der áS C. C. Kohlöl iure aus dem Serum. 
Bei einem andern Versuche wurden zu 132 C. C. ,Koh- 
lensäure 1.113 C. C. Illulsernln gebracht. Nach 24 Stunden 
waren noch 21 C. C. Kohlensäure Übrig, also Il l C. C. ab- 
sorbirt worden. Auf Zusatz von 2R C. C. Essigsäure ent- 
wickelten sich wieder 31 C. C. Kohlensäure uud S0 C. C. 
blieben mit dem Serum verbunden. 
Es geht daraus hervor, dafs frisches Blutserum von 
Ochsenblut sein doppeltes Volumen Kohlensäure absorbirt. 
Auch Tiber den Farbstoff des Blutes und namentlich 
Tiber die Frage, oh das Eisen der fiirbende Theil desselben 
sev, habe ich, nach der Angabe des Ilrn. Prof. L i e big, 
einige Versuche angestellt. Insbesondere waren es die Ver- 
suche von Sa nson, welche wiederholt wurden. 
r Trockener Blutkuchen wurde zu einem feinen Pulver 
zerrieben und mit concentrirter Schwefelsäure iu cincos 
Mörser aufs innigste gemischt. Die Masse wurde sodann 
in ein Becherglas mil destillirtem Wasser gebracht und an 
einem kiihlen Orte ruhig stehen gelassen. Nach einigen 
Stunden hatte das Wasser, welches ganz hell und klar blieb, 
eine bedeutende Menge schwefelsaures Eisenoxyd aufgenom- 
men, was aichdurch die gewiihulichcu Ileagentien aufs leich- 
Plate I. Section I. 
Tho first historical allusion to the porphyrin 
pigments of blood was by Scherer (1841). 
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I. HISTORY OF ACUTE INTERLITTENT POI- HYRIA 
The first historical allusion to porphyrins was made by 
Scherer (1841). He added concentrated sulphuric acid to dried 
and powdered blood and washed the precipitate free of iron. The 
iron -free residue was then heated with alcohol which toek on a 
blood -red colour. He thus had shown that the red colour of 
blood was not due to iron (Plate 1). Mulder (1844) carried out 
a similar study and described a "purple -red fluid" devoid of 
iron, which he named "iron -free haematin ". 
This red substance was called cruentine by Thudicurn (1867) 
in a report to the Privy Council of Great Britain. He defined 
its spectrum and noted its remarkable fluorescence by a simple 
method (Plate 2). In 1871 Hoppe -Seyler found that the iron -free 
haematin, described by Mulder, was a mixture of twc substances, 
the main constituent of which he called haematoporphyrin. (Greek, 
porphuros - red -purple). Three years later Schultz (1874) 
published the clinical details of a case of so- called 'Pemphigus 
Leprosus' for his doctorate thesis.. He described the patient as 
a 33 years old weaver who had suffered from skin photosensitivity 
since the age of 3 months. His spleen was enlarged and he 
passed a wine -red urine. The urine of this case was thoroughly 
investigated by Baumstark (1874), who named two pigments derived 
from it - urorubrohaematin and urofuscohaematin. Baumstark 
considered that the spectrum of an acid solution of 
urorubrohaematin resembled that of Hoppe -Seyler's acid 
haematoporphyrin, although he did not regard these two substances 
Mode of testing Fluids with respect to Flaoresence, by means of a Cone of Sunlight 
collected by a system of Quartz Lenses. 
Bands. Measurements. 
1. 142° 18' - 142° 
2. 141° 53' - 141° 
3. 141 °21' -1.11° 
4. 140° 45' - 145° 
Blue cut off at 139° 9'. 
Width. lt,tcusity. liank. 
3' = O. 15' 3 Y 
30' = 0° 25' 1 iì 
= 0° 21' 5 
18' = 0° 27' .5 ß 
Diagram ql' Spectrum ql' ne(av,t /lorc.w ce( ('re,l(ic. 
AaBC D rb F G IiH' 
IN 111 
a ß 
Thu . ttturated chloroform solution was one Or. thick. '('he spectrum 
was measured with the aid of a gaslight only. It fluoresced with n 
splendid blood -red colour in the suti cone. This is the first body which 
is known to Haute,cc witlt homogeneous light, that is to say, the saute 
kind of light or colours which it ttnusntits. The fluorescent cone has 
an intensity of colour'.lual to that of it solution about ten times more 
concentrated. Considering its beauty alone tho phenomenon may be 
placed by the sidoof those exhibited by quinine, chlorophyll, or cud - 
hear. But by its pettlini ity it is perfectly unique. 
Alkaline Four -banded ('rtuntinc.- spectrum 11. plate U., reprosents 
Plate 2. Section I. 
Thudicum (1867) first observed the 
fluorescence of porphyrins (ff cruentinefl ) 
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as identical. It is often written that Baumstark obtained 
haematoporphyrin from a case of leprosy but it is clear that the 
case of Schultz and Baumstark was the first description of what 
we now call congenital porphyria and in fact the first association 
of this pigment in urine with a disease in man. 
In 1850 MacMunn described a dark pigment excreted in the 
urine of a patient with subacute rheumatism, who had been taking 
sodium salicylate. He called this pigment urohaematin but later 
(MacMunn 1885) renamed the pigment urohaematoporphyrin because it 
"bears a very striking resemblance to haematoporphyrin ". 
Le Nobel (1887) confirmed this finding and also listed a number 
of diseases, including lead poisoning, in which he had found the 
pigment. He also found it in normal urine. 
Sulphonal was introduced as a hypnotic in 1888. Shortly 
after this Stokvis (1889) reported that an elderly woman who had 
taken sulphonal excreted a dark red urine and had later died 
(Plate 3). He considered that the pigment in this urine was 
similar to, but not identical with haematoporphyrin. Harley 
(1890) reported a fatal case of an unusual form of nerve 
disturbance, associated with dark red urine in a woman of 27 under 
the care of Dr. John Wyllie, at the Edinburgh Royal Infirmary. 
This woman had been given sulphonal and presented many of the 
neurological features of porphyria. Ranking and Pardington 
(1890) described two women who excreted ' haematoporphyrin' and who 
exhibited the gastro -intestinal and neuro- psychiatric manifestations 
of the disease we now call acute intermittent porphyria. These 
patients were unrelated, though they lived in the same house and 
.1% 13. 28 September. 1889. 
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OVER TWEE ZELDZAME KLEURSTOFFEN IN 
URINE VAN ZIEKEN, 
DOOR 
Prof. B. J. S T O K VI S. 
(Met een Plant.) 
I. LaKMOE8 ( ?) IN URINE NA GEDRUIK VAN ItP.SORCINE. 
In Maart 1.1. ontving ik door bemiddeling van Dr. c. C. DELPRAT een 
urine, die zieh door haar donkerbruine kleur, haar hoog soortelllk gewicht, 
baren rijkdoul tutu ureum en acid. uric., mar bovenal aan indoxyl-zwavelzure 
zouten onderacheidde. De urine bevatte zoúvecl indozyl -zwuvelzuur, dat 
5 C.C., met zoutzuur en ehloorkalk behandold, voldoendo waren, om 30 
-40 C.C. chloroform intensief blauw le klearen. I)e urine wan afkomalig 
van een pntii'ntje, door perityphlitia en peritonitis aangetast, en hoar rijkdom 
aun indozyl- zwuvelzuur was dus zeer vorklaurbaar. Mahr bjj behandeling en 
sell widen met nether, na tocvoeging van eon weinig phosphorzuur, block 
buitendien uit dc urine in den nether een lichtrbao kleuratof over to guan. 
Plate 3. Section I. 
The first case of "sulphonal porphyrie" 
was reported by Stokvis (1889). 
3 
had not taken sulphonal. In the next 20-30 years many other 
cases were recorded of "haematoporphyrinuria" associated with a 
definite pattern of symptoms. G{lnther (1911, 1922) carefully 
listed these individual cases. Sometimes sulphonal or the allied 
drugs, tetronal and trional, were taken for long periods prior to 
the onset of symptoms. Other cases had no obvious relationship 
to drugs and presumably were precipitated by unknown causes. 
Barbiturates were introduced into clinical medicine in 1903 and 3 
years later Dobrschansky (1906) described a case, which we would 
now regard as typical of acute porphyria without paralysis, 
occurring in a patient after prolonged administration of diethyl- 
barbituric acid. 
Hans Gunther was the first to classify the diseases of 
porphyrin metabolism in two comprehensive papers in 1911 and 1922. 
In the first of these he quoted fourteen cases from the literature 
in which acute symptoms of porphyria arose spontaneously 
(haematoporphyria acuta) and fifty -six cases of haematoporphyria 
acuta toxica, in which the symptoms were associated with the 
ingestion of sulphonal, trional or veronal. He also defined and 
named, for the first time, the very rare condition congenital 
porphyria ( haematoporphyria congenita) in which the predominating 
symptoms are due to skin_ photosensitivity. There is in this 
description of congenital porphyria the realization that the disease 
persists throughout life and Garrod (1923), in the second edition 
of his classical monograph, credits Gunther with the first 
recognition that this disease was an "inborn error of metabolism." 
Garrod himself (1892, 1893a, 1893b)and in association with Gowland 
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Hopkins (1896) had made outstanding contributions to the chemical 
detection of porphyrins in urine. 
In Günther's second work in 1922, he elaborated on his 
first thesis, quoting further cases. He noted the possibility 
that acute porphyria might be hereditary and suggested that people 
liable to develop acute or congenital porphyria had a diathesis 
(Porphyrism) with certain notable physical and mental character- 
istics - neurosis, insomnia, dark hair and pigmented skin. In a 
survey of the clinical features of acute porphyria, he introduced 
a triad of symptoms which were commonly present - abdominal pain, 
constipation and vomiting. One of Genther's cases of congenital 
porphyria was a man called Petry. Hans Fischer commenced a study 
of the excreta of this patient and between the years 1915 and 
1945 made monumental contributions to porphyrin chemistry. By 
these researches the naturally- occurring porphyrins of excreta - 
uroporphyrin and coproporphyrin - were found to differ structur- 
ally from haematoporphyrin, which was considered to be a 
chemical artefact. Fischer (1915 a,b), Laidlaw (1904) and 
Schumm (1924) differentiated the naturally- occurring porphyrin of 
haem itself from haematoporphyrin and the name protoporphyrin was 
suggested for this by Fischer. Thus it was that the diseases of 
porphyrin metabolism came to be termed Porphyrias, by Waldenstrem 
(1937), rather than Haematoporphyrias (Gunther, 1911). 
Waldenstrem (1937), in his excellent monograph, made a clinical 
survey of 103 cases of acute porphyria found in Sweden. He 
reviewed some previously published cases of chronic haemato- 
porphyria (anther's classification) in which light sensitivity 
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had occurred some years after birth, at times associated with 
abdominal pains. For these cases he substituted the name 
Porpria Cutanea Tarda. In 1954 Schmid, Schwartz and Watson 
classified the porphyrias on the basis of the porphyrin content 
of the livers and bone marrows of 31 cases. In two cases of 
congenital porphyria they found porphyrins concentrated in the bone 
marrow, particularly in the normoblastic nucleus, an elaboration 
of the original observations of Borst and Kbnigsdorffer (1929). 
This rare group was therefore termed Porphyria Erythropoietica. 
In the remaining 29 cases porphyrins were mainly found in the 
liver and they were therefore called Porphyria Hepatica. This 
included the typical acute intermittent porphyria, a mixed type 
in which photosensitivity and acute symptoms may occur in the 
same patient, and Porphyries Cutanea Tarda, a term reserved for a 
group in which photosensitivity occurs later in life, unassociated 
with acute symptoms (Table 1). 
Waldenstr6m was greatly aided in his studies by the 
presence in acute porphyria urines of a substance which gives a 
red colour with Ehrlich's aldehyde reagent (paradimethylamino- 
benzaldehyde). This substance is now known to be the precursor 
chromogen of the uroporphyrin found in these urines and with 
certain very rare exceptions (Watson, Hawkinson and Bossenmaier, 
1953) its presence in urine is a specific test for acute porphyria. 
As early as 1890 Harley had noted that the urine of a case of sulph- 
onal- induced acute porphyria contained a chromogen which, when oxidised, 
became a red pigment. Paula Sachs (1931) described a substance in the 
urine of a patient with acute porphyria which gave a red colour, 
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insoluble in chloroform, with Ehrlich's aldehyde reagent and 
which was therefore not urobil.inogen. 
Waldenstrthm (1937) showed that this Ehrlich reacting 
substance, which he considered to be a chromogen of a porphyrin, 
was not only excreted in the urine of every case of acute 
porphyria, but that some apparently healthy relatives of these 
patients also excreted it. He thus conceived the idea of a 
latent porphyries and traced examples of acute or latent porphyria 
to second and even third generations. On the basis of his work, 
he suggested that acute porphyria was transmitted as a Mendelian 
dominant characteristic. Later Waldenstr'm and Vahlquist (1939) 
suggested that the Ehrlich- reacting chromogen, which they partly 
purified and named arphobilinogen, was a dipyrrylmethane. 
Prunty (1945) and Gray (1950) found that the liver and kidney of 
fatal cases of acute porphyria contained porphobilinogen. A 
most important step occurred when yJestall (1952) isolated 
crystalline porphobilinogen from the urine of a patient with 
acute porphyria in University College Hospital, London, (Case 
36). Cookson and Rimington (1953) elucidated its structure as 
a monopyrrole. Recently Granick and Schrieck (1955) have 
suggested that á -aminolaevulic acid, a precursor of porpho- 




Classification cf Porphyrias 
I Gunther (1911) 
1. Haematoporphyria acuta 
2. Haematoporphyria acuta toxica 
3. Haematoporphyria chronica 
4. Haematoporphyria congenita 
II Waldenstr'óm (1937) 
1. Porphyria congenita 
2. Porphyria cutanea tarda 
3. Porphyria acuta 
(a) Latent porphyria 
(b) Abdominal form 
(c) Nervous form 
(d) Classical acute porphyria 
(e) Comatose form commencing as (b) 
III Schmid Schwartz and Matson (1954) 
1. Porphyria erythropoietica - congenital photosensitive 
porphyria, usually associated with haemolytic 
anaemia and splenomegaly. 
2. Porphyria hepatica - hepatic disease or functional 
impairment frequent. 
(a) Intermittent acute type - abdominal 
and /or nervous manifestations 
(b) 'Cutanea tarda' type - late appearance 
of photosensitivity without other 
manifestations. 
(c) 'Mixed' type - photosensitivity with 
intermittent abdominal and /or nervous 
manifestations. 
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Tic. 1. Section 2. 
Laemin chloride. 
CH = CH$ 
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2 mois. 8- aminolaevulic acid Porphobilinogen 
Scheme summarizing biosynthetic steps from 
glycine + succinate (from the tricarboxylic acid cycle) to 
porphobilinogen, the simplest pyrrolic substance known to be 
a precursor of haem and porphyries. 
Fig. 2. Section 2. (After Rimington, 1955.) 
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2. PORPHYRIES 
Chemical and Biochemical Background 
The porphyrins are nitrogen -containing compounds whose 
chemical structure consists of 4 pyrrole rings united by means of 
methene bridges. They occur throughout the animal and vegetable 
kingdomsin the free state or as metal complexes. The iron complex 
of protoporphyrin IX or haem (Fig. 1) is of especial importance in 
animals and forms the prosthetic group of haemoglobin, the cyto- 
chromes and catalase. 
The porphyrins have been known for nearly a hundred years 
and yet it has only been in the past decade that the main steps in 
the biosynthesis of haem have been ascertained. This advance has 
been principally due to the introduction of isotopic labelling. 
techniques. From work carried out primarily in the laboratories 
of Shemin, Neuberger and Rimington the following pattern emerges 
(Fig. 2). Active succinate condenses on the 04- carbon atom of 
glycine to give o(.amino -- Ketoadipic acid, which is then decar- 
bcxylated to give rise to S -aminolaevulic acid, 2 molecules of 
which condense to form porphobilinogen. Porphobilinogen is the 
precursor monopyrrole of all the porphyrins and is also the 
characteristic excretion product of acute porphyria. The mechan- 
ism of conversion of the monopyrrole to the tetrapyrrole structure 
is not yet known and the biological sequence of porphyrins in the 
formation of haem from the porphobilinogen stage is not certain. 
There was some controversy as to whether protoporphyrin 
itself was an intermediate in the synthesis of haem (Granick, 
HYPOTHETICAL SCHEME 
COON COOK 
COON CHA COOK CHA 
CH CH CH CHA CH, P CH, P 
A I I I I I f 1 
A P P A CH3 P P CH, 
UROPORPHYRIN III COPROPORPHYRIN III 
CHA ëH2 
CHa CH CH, CH 
I I I I 
CH3 P P 
I-I A E M e 
CH, 
PROTOPORPHYRIN 
Fig. 3. Section 2. 
The probable pathway of haem synthesis. 
It is likely that the reduced forms of 
uroporphyrin. III and coproporphyrin III 
are the true intermediates. The por- 
phyrins are illustrated in abbreviated 
form. They are distinguished by the 
groups attached to the C.atoms of 
each pyrrole. 
A = acetic. P = Propionic. 
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1954; Dresel, 1955; Erikson, 1955; Schwartz and Ikeda, 1955). 
The present author, while working in Professor Wintrobe's 
laboratory in Salt Lake City, U.S.A., described a method for the 
measurement of haem synthesis in a haemolysate of chicken erythro- 
cytes, in which he used raclioiron as a tracer for the rate of 
synthesis. Free protoporphyrin IX, as well as glycine, 
azninolaevulic acid, and porphobilinogen, significantly stimu- 
lated haem synthesis. Furthermore the conversion of protoporphy- 
rin to haem was shown to be enzyme dependent (Goldberg, 1955; 
Goldberg et al. 1956). A particle-free aqueous extract of chicken 
erythrocytes contained this enzyme, the activity of which was 
retained after lyophilisation and storage for at least 4 weeks. 
This iron- incorporating enzyme requires a co- factor, which is re- 
moved by ultrafiltration of the aqueous extract (Goldberg, 1956). 
The work of Neve et al. (1955) suggests that reduced 
uroporphyrin III and coproporphyrin III are also intermediates in 
haem synthesis. It is thus probable that uroporphyrin III is the 
first formed tetrapyrrole from porphobilinogen and that by a 
process of decarboxylation cf its reduced form, coproporphyrin III 
is formed, which is later decarboxylated to protoporphyrin, the 
precursor of haem itself (Fig. 3). 
1 litre of human urine normally contains 10-200 micrograms 
of a mixture of coproporphyrin I and III, only traces of uropor- 
phyrin and no porphobilinogen. In the diseases of porphyrin 
metabolism the pattern of excretion is abnormal (Table 1). There 
are probably abnormalities of porphyrin metabolism in man other 
than the main group of porphyrias. The use of improved chemical 
10 
Disease Main urinary excretion product 
Acute intermittent Porphyria. r'erphobilinogen. 
Ç`amin_o- laevulic acid. 
Porphyria Cutanea Tarda. 
Congenital Porphyria. 
Hereditary Coproporphyria. 
Uroporphyrins I and III. 
Uroporphyrin I. 
Coproporphyrin III. 
trace of uroporphyrin I. 
Table 1 Main urinary excretion products in the diseases of 
porphyrin metabolism. 
methods should help to detect them. Hereditary coproporphyria 
is such a condition, first mentioned by Berger and Goldberg (1955). 
Four cases of coproporphyria were described in a single family - 
a boy aged 10 years, his mother and father (first cousins) and his 
paternal aunt. The symptoms of porphyria were absent. The 
adults excreted moderately high quantities of coproporphyrin III 
in the urine and stool, whereas the boy excreted very large 
quantities of coproporphyrin III in the urine and stool, with a 
trace of uroporphyrin I in the urine. The boy also suffered 
from rickets and riboflavine deficiency, both of which were improved 
by treatment. 
3 
ACUTE INTERMITTENT PORPHYRIA. 




The first observation that acute porphyria occurred in 
members of the same family was made by Barker and Estes (1912). 
Gìnther (1922) noted the hereditary implications of the disease 
but it was Waldenstree (1937) who firmly established its 
hereditary nature. Gates (1946) reviewed Waldenstrdm's data and 
considered that the disease was inherited as an irregular dominant 
character. In the present series of 50 cases at least 19 have 
one or more relatives with the active or latent condition. 
9 latent porphyries were revealed by investigation of relatives. 
It was only possible to study 11 families in detail (see Appendix). 
The family trees were constructed on the basis of whether or not 
porphobilinogen was definitely found in the urine on at least one 
occasion. There is only one exception to this rule. Case 
No. 41 died in 1935 and although the urine was noted to be dark 
in colour it was not tested for porphobilinogen. The clinical 
and family histories of this patient make the diagnosis of acute 
porphyria highly probable. The urines were routinely tested by 
the methods of Watson and Schwartz (1941) and Vahlquist (1939). 
Where a doubtful positive was obtained about 0.5 to 1 litre of 
urine was concentrated and any porphobilinogen present was ident- 
ified by paper chromatography ( Westall, 1952; Cookson and 
Riraington, 1954). Concentrates of normal urine, so treated, 
gE I am indebted to Dr. H. Harris, London Hospital, for his help 
and advice in the writing of this portion on genetics. 
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showed no porphobilinogen. This method. proved very helpful in 
identifying 3 latent porphyrias who excreted small quantities 
of porphobilinogen - family 2, son of propositus; family 3, father 
of propositus; family 9, nephew of propositus. It should be 
noted, however, that out of 18 previously active cases whose urines 
were tested in a state of remission, 5 had ceased to excrete 
porphobilinogen (Cases 15, 31, 37, 46 and 47). Case 10 did not 
excrete porphobilinogen at the age of S years but did do so at 
11 years. Thus the absence of porphobilinogen in the urine of 
a relative does not rule out the possession of the trait and this 
is of particular importance in testing the urine of the child 
relative. 
The findings in this series confirm those of Waldenstrbm 
(1937, 1956). In 4 families (Nos. 1, 2, 3 and 8) the condition 
was found in more than 1 generation, apparently transmitted 
directly from a parent to one or more of the offspring. In 
another family (No. 7) where it was not possible to test the 
parents, 2 half -sibs with unrelated fathers were found to be 
affected. Thus a single gene would seem necessary for the man- 
ifestation of the disease. There was no evidence of increased 
parental consanguinity. This familial distribution is consistent 
with the hypothesis that the condition is inherited as a Mendelian 
dominant character, i.e. the individuals are heterozygous for 
an abnormal gene. In 2 instances, however, (families 1 and 
10), where more than one of a group of sibs were affected, it was 
not possible to detect porphobilinogen in the urines of either 
of the parents. It must, therefore, be assumed that there is 
13 
considerable variation in the degree of the expression of the 
character and that one can get all grades from the acute case, the 
latent porphyria, to the apparently normal individual who excretes 
no porphobilinogen. It is possible that some of the latter 
group might begin to excrete porphobilinogen, if suitably provoked. 
In only 2 families (Nos. 1 and 8) is there the association of a 
parent and a child who have both had the active disease. This 
is not altogether surprising, because if a gene produces a severe 
and lethal illness variable in its manifestations, then those with 
the milder form of the affection are more likely to survive to 
adult life. 
The apparent sporadic occurrence of the disease (families 
5 and ll) might perhaps be attributed to mutation, that is the 
sudden change from the normal gene to its abnormal counterpart in 
the germ tract of one or other of the parents. Although the 
occurrence of a mutation in these families cannot be excluded, it 
is probable that in the majority of instances where an affected 
child has been derived from normal parents, one or other of the 
parents is in fact heterozygous for the gene. 
From a study of these families, it has been possible to 
calculate that approximately 25o of the sibs of a case may be 
expected to have porphobilinogen in the urine. A high proportion 
of these are liable to have an acute attack. Furthermore, about 
1 in 4 of the children of individuals who excrete porphobilinogen 
may be expected to become similarly affected. If it is true 
that affected individuals are heterozygous for an abnormal gene, 
then 2 out of 4 children of parents, only one of whom is affected, 
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should carry the abnormal gene. Thus half of those carrying the 
gene may not excrete porphobilinogen. 
AGE OF ONSET 
The most frequent age of onset (Fig. 1) in this series 
occurred in the third decade for females and in the fourth decade 
for males. The high incidence of the third decade in females is 
confirmatory of Waldenstrbm (1937). The youngest case was a girl 
of 11 years (No. 10). Rothman (1926) and Bauer (1943) have 
described acute porphyria in children of 3 years 10 months and 
2-i years respectively. 2 of the 5 cases which started after the 
age of 40 years commenced after prolonged administration of bar- 
biturates. It is possible that a relationship exists in the ages 
of onset of siblings. Thus Cases No. 17 and 18, brothers, both 
commenced symptoms at the age of 30 years. Cases No. 21 and 22, 
brother and sister, started with symptoms at 35 and 36 years, 
respectively. Cases No. 37 and 38, sisters, started to have 
symptoms at 23 years of age. Cases No. 40 and 41, brothers, had 
the commencement of symptoms at 29 and 31 years respectively. 
ENDOCRINE FACTORS 
(a) Sex incidence Priestley (1894) first drew attention to the 
preponderance cf females with porphyria and Garrod and Hopkins 
(1896) found that the majority of cases of "Sulphonal Haemato- 
p orphyria" were women. Subsequent studies (e.g. Waldenstrbm, 
1937) have confirmed this incidence. The present series shows 
that the 50 cases consist of 31 females and 19 males, i.e. 62% 
and 38% respectively. It is questionable whether this sex 
incidence is genetically ordained or whether secondary precipitat- 
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ing causes, e.g. pregnancy, barbiturate intoxication, predispose 
to the sex difference. The disease may be no less severe in the 
male and out of 12 deaths, 33i, were male. 
(b) Menstruation Waldenstrbm noted the apparent relation of 
clinical symptoms to menstruation. In the present series the 
onset of an attack was closely associated with a menstrual period 
in 7 women (Cases No. 5, 12, 20, 25, 34, 37 and 38). In these, 
the periods were generally delayed but not suppressed. Case 34 
had repeated attacks associated with the onset of her menstrual 
period. She was put on testosterone and the doctor believed 
that the testosterone therapy was related to an improvement in her 
condition. In 6 additional women there was amenorrhoea (Cases 
No. 6, 9, 26, 30, 32 and 36). Amenorrhoea is not an infrequent 
accompaniment of a debilitating disease and in Case No. 6 there 
was also the association of tuberculous endometritis. The 
incidence of the disease in males, in pre -pubertal girls (Cases 
10 and 48) and in post -menopausal women (Cases No. 2 and 15) 
suggests that, if there is any association between menstruation 
and clinical symptoms, it is not a primary one. 
(c) Pregnancy This is a matter not only of academic interest but 
of clinical importance since a preponderance of the female cases 
occurs in the child -bearing period. This point concerned 
Waldenström (1937) in whose series 2 cases died during pregnancy. 
He writes, The question of the importance of pregnancy is more 
difficult to answer. Among a large number of mature women, some 
will be pregnant. It is also possible that it is not pregnancy 
itself which precipitates an attack, but the hypnotic and other 
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medical drugs given during this time. It would seem important 
that the doctor realises the possibility of a deterioration in 
the condition if pregnancy occurs." (He then refers to his Cases 
No. 65 and 100, both of whom died during pregnancy). 
"Another question is of importance in this respect. When 
the doctor is asked by a woman patient whether she can have 
children, in spite of her illness, he must also remember the 
dominant nature of the disease and the danger to the child. He 
must not underestimate the danger to the mother and child." 
(Translation) . 
In the present series several cases show an association 
with pregnancy. Cases 1, 22 and 39 commenced an attack 5 days, 
14 days and 1.4 days, respectively, after the birth of a child. 
Cases 3, 30 and 35 started to have symptoms in the very early weeks 
of pregnancy. Both Cases 3 and 30 died shortly after termination 
of pregnancy and in the latter case the child also died shortly 
after birth. Case 20 had a normal pregnancy but had an 
exacerbation of pain immediately after delivery. Watson (1952) 
has stressed that an attack might occur after a confinement. On 
the other hand, there are several examples of normal pregnancies 
occurring in acute porphyria cases (Cases No. 5 and 26) and some 
observers have even reported marked improvement in their cases 
during pregnancy (Rawlings 1950; Freedman et al. 1952). 
Thus no dogmatic statement can be made on the relationship 
between pregnancy and porphyria. In some casos pregnancy may be 
completed with impunity but in others the impression is gained 




In Case No. 7 exacerbations of the disease were associated 
with bouts of alcoholism, although prior to the last attack he 
had also taken barbiturates as well as alcohol. Martin and Heck 
(1956) found that alcohol was a precipitating factor in 23 of 
their 80 acute and photosensitive cases. They did not specify 
what number of the 23 cases were acute porphyria. 
1. oTION SICKNESS 
In Case No. 45 attacks of severe vomiting were associated 
with travel. In the last attack, which started during a sea voyage, 
the urinary porphobilinogen level rose markedly and then fell with 
improvement in the general condition. 
INFECTION 
In the present survey there are many examples of the role 
of infection in precipitating or aggravating an attack of acute 
porphyria. This is not surprising, since in other metabolic 
diseases infection may play a similar role. It is well recognised 
that infection may precipitate a diabetic into diabetic coma, or 
a patient with Addison's disease into a crisis. 
(a) Acute tonsillitis Examples of acute tonsillitis precipitating 
an attack have been given by iialdenstrk5m (1937) and Denny -Brown 
and Sciarra (1945). This has been confirmed in 5 cases of this 
series (Nos. 17, 22, 37, 48 and 49). In Case 37 the effect of 
the throat infection and tonsillectomy on porphobilinogen 
excretion was recorded (Fig. 2). 
(b) Urinary infection Discombe and D'Silva (1945) and Abrahams, 
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CASE 37 ACUTE PORPHYRIA K.M. 2 23yrs. 
Influence of Infection on Porphobilinogen excretion 
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Fig. 2. Section 3. 
Gavey and Maclagan (1947) noted the association of a urinary 
infection in acute porphyria and this has also been recorded in 
Case 36. 
(c) Skin infection This appeared to be a precipitating factor 
in Cases 4 and 14. In Case 25 erysipelas, which followed inject- 
ions of L.C.T.H., greatly aggravated an attack already in progress. 
Skin infection has been noted by Discombe and D'Silva (1945) as 
such a precipitating factor. 
(d) Herpes zoster This occurred in Case 29 just prior to an 
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attack. Vannotti (1954) has described herpes zoster on the 
distribution of the ileo- inguinal nerve, occurring with each 
attack of a case of acute porphyria. 
(e) Tuberculous endometritis was associated with an attack in 
Case 6. 
(f) Pulmonary infection This is usually a complication of a 
severe attack, particularly with immobilisation and respiratory 
paralysis. Thus an aspiration pneumcnia occurred in Case 29 
and lobar pneumonia aggravated an attack in Case 4. In Cases 1, 
3, 6 and 43 pulmonary infection was a fatal complication in 
respiratory paralysis. 
B.RBITUr TES 
Since the introduction of the barbiturates to clinical 
medicine in 1903, there have been conflicting reports on their 
possible relation to human acute porphyria. Drobrschansky (1906) 
described a typical case of acute porphyria, without paralysis, 
occurring in a patient after prolonged administration of 
diethylbarbituric acid. Haxthausen (1927) reported the develop- 
ment of skin photosensitivity and the presence of excessive 
amounts of porphyrins in the urine of an epileptic who had been 
taking ethylphenylbarbiturate for some time. Eliaser and Kondo 
(1942), Denny-Brown and Sciarra (1945), Prunty (1946), Jorgensen 
and With (1947), Macleod and Grant (1953), and Whittaker and 
Whitehead (1956) have described deterioration in the clinical 
state of acute porphyria patients with the development of severe 
or even fatal paralysis, after the administration of certain bar- 
biturates, among which were ethylphenylbarbituric acid and 
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ethyl(1- methyl- butyl) barbituric acid. Waldenstrbm (1939, 1940) 
was convinced that barbiturates may precipitate attacks in cases 
of latent porphyria and that they seriously affect the prognosis 
of the disease. On the other hand, Gunther (1922), Turner (1938) 
and Discorobe and D'Silva (1945) failed to note any relation 
between barbiturates and acute porphyria. 
Information on the relation of barbiturates to normal human 
porphyrin metabolism has been obtained from observations on the 
urinary porphyrin excretion in cases of barbiturate poisoning. 
Rosendorff (1910), Sowden (1910) and MacLean (1912) found no 
abnormal porphyrinuria in patients who had ingested single large 
doses of diethylbarbituric acid, while Rommel (1912) observed 
dark -red urine in a patient who had taken 25 g. of the same drug. 
A study of the cases in the present series suggests 2 
types of relationship between barbiturates and acute porphyria. 
(1) If barbiturates are given over a prolonged period they 
precipitate an attack. 
(2) If barbiturates are given during the course of an attack 
they may accelerate the onset of paralysis. 
The evidence for the first hypothesis is based on Cases 15, 16 
and 50. In these cases barbiturates, mainly phenobarbitone, 
were given for 12 -2 years. Among the presenting symptoms were 
drowsiness and memory loss (Case No. 15), incoherence and 
repetitiousness of speech, convulsions (Case No. 16), hysteria - 
like behavious and depression (Case No. 50). These symptoms 
recall the description by Fraser et al. (1954) of chronic barbit- 













Fig. 3. Section 3. 
The relationship between barbiturates and the onset of 
paralysis in 48 patients with acute porphyria. In 2 
cases it was not certain whether barbiturates were given 
or not, and these were not included in this analysis. 
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cases the main symptoms and signs departed after the cessation of 
this drug and there has been no recurrence for several years. 
On the other hand, there has been evidence that the genetic ab- 
normality exists in this type of case. Thus Case 16 still passed 
porphobilinogen 3 years after the cessation of barbiturates and 
the son of Case 15 is a latent case. It is also noteworthy that 
Cases 15 and 16 were 56 and 59 years of age, respectively, and 
had suffered no previous symptoms until then. This information 
suggests that prolonged ingestion of barbiturates may precipitate 
an attack of acute porphyria where the latent trait exists and in 
these cases the clinical manifestations bear some resemblance to 
those of chronic barbiturate intoxication. 
The evidence for the second hypothesis - namely that bar- 
biturates may cause neurological manifestations if given during 
an attack - is summarized in Fig. 3. Thus 77h (24 out of 31) of 
cases with paralysis or paresis had been given barbiturates, while 
35 (6 out of 17) of those without paralysis or paresis had taken 
barbiturates. This difference is highly significant 
((.2 = 7.8 ld.f. p.01). Of the 7 cases with paralysis who had 
not been given barbiturates, 5 (Cases 12, 13, 34, 35, 44) had 
only mild neurological involvement but Case No. 43 died with 
general paresis and bronchopneumonia after a prolonged smouldering 
course and Case No. 47 had quite severe nerve involvement includ- 
ing pyramidal tract signs. Within the group, who had paralysis 
and barbiturates, are the most severely afflicted patients, e.g. 
Cases 2, 23, 24, 32 and 33, who had explosive and fatal courses 
after repeated administration of barbiturates. 
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In Section 5 the barbiturates are classified according to 
their effect in disturbing the porphyrin metabolism of rabbits. 
Those barbiturates with ally' groups, e.g. seconal, were particularly 
effective. In accordance with this classification an analysis has 
been made (Table 1) of those barbiturates which were used in 
patients who had paralysis and those who did not have paralysis. 
This study reveals one difference in the two groups of cases. In 
each case in which seconal was given (Cases 2, 7, 21, 24) paralysis 
of a very severe degree (in two cases fatal) was found. There 
are an insufficient number of barbiturates used in the group without 
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4 19 13 36 
NOT 
PARA- 0 4 3 7 
LYSED 
(b) 
Table 1. Analysis of barbiturates used in patients (a) who had 
paralysis and (b) who did not have paralysis, according 
to the classification of barbiturates in Section 5 with 
respect to their effectiveness in disturbing the por- 
phyrin metabolism of rabbits. The numbers refer to 
the number of patients given one of a barbiturate group. 
Thus 4 patients, who later became paralysed, received 
seconal. Some patients received more than one 
barbiturate. 
Seconal = sodium allyl(1- methylbutyl)barbiturate 
Phenobarbitone = sodium ethylphenylbarbiturate 
Nembutal = sodium ethyl(1- methylbutyl)barbiturate 
Luminal = sodium diethylbarbiturate 
Soneryl = sodium butylethylbarbiturate 
Amytal = sodium isoamylethylbarbiturate 
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ABDOMINAL PAIN 
ABDOMINAL PAIN + CONSTIPATION 
ABDOMINAL PAIN + VOMITING 
ABDOMINAL PAIN + SENSORY DISORDERS 
ABDOMINAL PAIN + DIARRHOEA 
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The main presenting symptoms at the onset of the disease 
are summarised in Fig. 4. These affect 2 systems - gastro- 
intestinal and neuropsychiatrie. Abdominal pain, either alone or 
associated with constipation, vomiting or more rarely diarrhoea, 
is the most common complaint. However, in 22% of cases neuro- 
psychiatric manifestations were predominant and in the majority of 
these (9 out of 11 cases) there was no complaint of abdominal pain. 
In a few cases (8%) there was a combination of abdominal pain and 
disorders of sensation e.g. paraesthesiae or pains of limbs. The 
6% of cases which presented with epileptic fits are worthy of note. 
The danger in the administration of barbiturates to these cases 
is clear. Many cases had psychological symptoms on admission but 
only 1 case had such symptoms (mental depression and hysteria in 
Case 50) as the main presentation. 
The incidence of symptoms and signs throughout the course 
of the disease is shown in Figs. 5 and 6. 
GASTRO -INTESTINAL FEATURES 
Abdominal pain is predominantly colicky in nature with 
intermissions when it is constantly present. It may be present 
in any part of the abdomen but mainly in the epigastrium and (R) 
iliac fossa or may, in fact, be generalised over the whole abdomen. 
It is characteristically very severe, boring "deep down" and 
usually causes great distress to the patient. 
All of the patients who complained of abdominal pain and 
who were examined by the author, did have some abdominal tenderness. 
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Fig. 5. Section 3. 
Incidence of symptoms in 
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Fig. 6. Section 3. 
Incidence of clinical signs in 
50 cases of acute porphyria 
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This was usually much less in degree than the severity of the pain 
would suggest, but there was no muscular rigidity of the abdomen, 
with two exceptions. In Case 4 the abdomen became rigid like a 
case of perforated duodenal ulcer. In Case 21 there was some 
localised rigidity in the (R) iliac fossa. 
Rectal examination was negative in most cases in which it 
was carried out. In Case 11 there was some rectal tenderness. 
A large number had vomiting and /or constipation, associated with 
the abdominal pain. In 1 case (No. 45) vomiting occurred without 
abdominal pain. Abdominal pain usually preceded the vomiting. 
6 cases (Nos. 1, 18, 21, 42, 44 and 50) had diarrhoea and vomiting. 
It is of diagnostic interest that Case 44 was initially sent to a 
fever hospital with a diagnosis of gastro-enteritis. In all cases 
of some severity there was loss of weight during the attack. 
NEUROLOGICAL FEATURES 
Non -Abdominal pain In 26 cases (52 ) pain was felt in 
the limbs, particularly the legs, in the head and neck, in the 
large joints, e.g. shoulder and knee, in the lumbar region or in 
the anterior chest region. In all except 2 cases (Nos. 24 and 
27) the pain in these regions was accompanied by abdominal pain. 
Case 24 had pain predominantly in the large joints. Case 27 had 
lumbar pain which passed anteriorly and downwards to both groins. 
:viOTTOR DISTURBANCE 
Paralysis or Paresis of limb muscles occurred in 34 (68(M 
of cases. The extent of this varied from weakness of a pair of 
limbs to complete quadriparalysis. There was paresis of upper 
limbs only in 1 case (No. 35), paresis of lower limbs only in 5 
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cases and quadriparalysis or quadriparesis in 2$ casos. In the 
great majority of cases the paralysis was of the lower motor 
neurone type, although in 5 cases (Nos. 23, 32, 33, 44 and 47) 
definite extensor_p_lantar responses were obtained and in 1 case 
(No. 47) there was muscular rigidity of the lower limbs, ankle 
clonus and increased limb reflexes. In 27 of the 34 cases with 
paralysis or paresis there were diminished or absent tendon 
reflexes and in many cases there was marked muscular wasting (Plates 
3a and b Appendix). There was a predilection for extensor muscles 
of wrists and fingers in Cases 5, 14, 25, 41 and 47 (Plate 6b 
Appendix), but there was no definite pattern of paralysis such as 
the Landry type which has been suggested in the past. All cases 
were bilaterally involved but usually unequsTly so. In very severe 
cases the muscles of the trunk were also affected. In Case 35 
the muscles of the back and upper limbs were particularly weak. 
Half of the 28 cases with paresis or paralysis of all 4 limbs had 





























Table 2. Cranial Nerve Involvement. 
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The relationship of paralysis or paresis to barbiturates is 
illustrated in Fig. 3. Incontinence of urine occurred in 6 
cases (Nos. 1, 3, 24, 31, 32 and 33) and urinary retention in 
1 case (No. 38). In Case 1, incontinence of faeces also 
occurred. 5 Cases (Nos. 2, 30, 32, 33 and 48) had respiratory 
paralysis with involvement of the diaphragm and /or intercostal 
muscles. 
SENSORY DISTURBANCE 
19 cases (38%) had involvement of sensation (Table 3). 
Of these all but 2 cases (Nos. 9 and 20) had muscular paralysis 
or paresis, which came on prior to the sensory loss. 15 cases 
had muscular paralysis or paresis but no sensory disorder. In 
2 cases there was paralysis but the sensory examination was not 
recorded. 
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Type of Sensory Disorder Site Case No. 
Analgesia 
(Pin- Prick Loss) 
Trunk and proximal areas 
of limbs 13 
Cervical dernatomes 5 & 6 21 
Upper and lower limbs 14 
Lower limbs 11 
Shins 33 
Generalised 2 & 36 
Hypo- Algesia 
Hyperaesthesia 
Lower limbs 15 
Bathing trunks region 5 & 24 
Lower limbs 9 & 44 
Complete Sensory Loss Lower limbs 17 





Forearms and hands 1 & 7 
Lower limbs 7 & 34 
Waist downwards 50 
Genitalia 23 & 24 
Feet and calf 9 & 20 
Joint and vibration 
sense loss Lower limbs to knees 17 
Table 3. Summary of Sensory Disorders 
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VISUAL DISTURBANCE 
There was a partial and temporary loss of vision in 3 cases 
(Nos. 16, 22 and 48) lasting no longer than 2 days. 
EPILEPSY 
8 cases (Nos. 3, 8, 16, 17, 28, 33, 48 and 50) had epilep- 
tic fits. These were generalised in 7 cases. In Case 16 they 
commenced in the (L) arm, passed to (L) leg and then became 
generalised. Hypertension was present in 6 of the cases but this 
was only of a severe degree in 3 cases. In Case 33 there was a 
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B.P. of 150, papilloedema and fits. A prior history of barbitur- 
ate ingestion was obtained only in 3 cases (Nos. 16, 28 and 50). 
Barbiturates were given to control the fits in Cases 17, 28 and 33. 
In Cases 17 and 33 this was followed by deterioration in the 
condition and in Case 28 the fits continued until the barbiturates 
were stopped. Electroencephalograms were performed on 4 of the 
cases with fits, at the National Hospital, Queen Square, London, 
at the Maudsley Hospital, London, and at the Central Middlesex 
Hospital, London. Cases 17 and 50 had normal electroencephalo - 
grams. That of Case 33 was abnormal but its pattern was 
consistent with the stuporose condition of the patient. Case 28 
had a mildly abnormal E.E.G. The report is as follows: "A low 
to medium alpha rhythm is dominant but tends to be unstable in 
frequency and very mild dysrhythmia is seen at times. There is 
no significant asymmetry nor focal abnormality, nor disturbance on 
overbreathing. The record is non -specific and only just outside 
normal limits, but compatible with the epileptic diathesis ". 
An electroencephalogram was done at the National Hospital, 
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Queen Square, London, on Case 29, although she did not have fits. 
The report of this was as follows: "Slightly abnormal. Confused, 
choppy type with alpha waves and fast rhythm and enough 5 -7 cis 
waves to make it abnormal ". 
MENTAL SYMPTONS 
29 cases (58iß) had mental symptoms associated with their 
illness. These have been arbitrarily classified into 3 grades: 
(i) Depressed, nervous, hysterical lacrymose or "peculiar ". 
Case 1, 2, 3, 8, 12, 23, 24, 28, 30, 31, 39, 41, 49, 50. 
i.e. 14 cases. In Case 50 mental depression was the 
presenting symptom and she was initially treated as an 
out -patient in a hospital for mental diseases. 
(ii) Confused, hallucinated, disorientated or with personality 
change. Cases 4, 5, 7, 21, 22, 25, 40, 43, 46. 
i.e. 9 cases. 
(iii) Mentally certified and /or placed in mental institutions. 
Cases 8, 9, 11, 29, 32, 36. i.e. 6 cases. 
The remaining cases were mentally normal. Their 
reaction to what was, at times, very severe pain, was not excessive. 
CEREBRO- SPINAL FLUID 
A normal cerebro- spinal fluid, in respect to protein 
sugar, chloride and cell content, was obtained in 11 cases (Nos. 
1, 16, 17, 21, 22, 26, 32, 33, 39, 41 and 48). In Case 31 the 
chloride content was 670 mg.% (normal 700 -750 mg.%). In Case 32 
the C.S.F. was tested for porphobilinogen and found to be negative. 
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CARDIOVASCULAR FINDINGS 
Pulse rate 32 cases (64;;) had tachycardia (i.e. P.R. over 100/ 
minute) during the acute phase of the disease. In these the P.R. 
was a good indication of the activity of the condition. In most 
of these cases the P.R. was 110 -120 /minute but in a few it rose to 
150- 160 /minute. 
Blood pressure 28 cases (56 %) had hypertension (i.e. a systolic 
pressure of 150 mmHg. or more and a diastolic pressure of 95 mm. 
Hg. or more. In some cases (Nos. 3, 4, 7 and 33) there was a 
marked hypertension. In Case 7 there was a Grade II retinopathy 
associated with a blood pressure of u, but the fundus returned 
to normal when the B.P. became normal. Case 33 had papilloedema 
and fits associated with the hypertension. Case 2 presented as 
a case of "Essential Hypertension" and a seconal sedation test was 
given on 2 occasions, following which the patient's condition 
rapidly deteriorated and she died. It is of interest that Case 3 
developed hypertension in the final attack but not in the previous 
ones. Case 25 developed hypotension (R) in 1 phase of her 
condition. 
Electrocardiography Electrocardiograms were reported in 9 
cases. Four of these (Nos. 4, 21, 33 and 34) were normal and in 
Case 43 the E.C.G. showed left axis deviation only; the blood 
pressure at this time was 100. In the remaining 4 cases I am 
indebted to Dr. A. Hollinan, University College Hospital, London, 
for help in the interpretation of the E.C.G's. 
In these 4 cases the following features were found. 
P2 was sharply pointed and there were prominent atrial T waves (Ta), 
Plate I. Section 3. 
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Plate I. Section 3. 
Case No. 25. E.C.G. (16/2/52) 
shows tachycardia, low voltage 
T waves, pointed P waves in 
Lead 2, PQ depression in Leads 
II and CR4. 
. '4 
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giving P.Q. and S.T. depression in 2 cases (Nos. 25 and 47). These 
findings suggest atrial damage or atrial strain and /or hypertrophy, 
possibly related to respiratory embarrassment. On the other hand, 
Case 32, in whom (R) atrial dilation and pulmonary collapse was 
detected post -mortem, did not show these findings. 
Low voltage T waves were found in 3 cases (Nos. 25, 32 and 
47) which suggests generalised myocardial damage. The serum 
potassium in these cases was never low enough to account for these 
changes. There was some cardiac rotation in each of these 4 
cases - clockwise in Cases 32 and 36, anti -clockwise in Cases 25 
and 47. This was possibly related to (R) heart strain and hyper- 
tension respectively. 
An example of such an abnormal E.C.G. (Case No. 25) is 
given in Plate 1. 
Ophthalmoscopic Examination Retinal artery spasm was seen in 4 
cases (Nos. 30, 36, 37 and 47) (Plate 7 Appendix). As noted 
above, Cases 7 and 33 had a Grade II retinopathy and papilloedema 
respectively. 
DERMATOLOGICAL FINDINGS 
No case had frank photosensitivity of skin, with the 
exception of Case 47 who had a slight vesicular eruption on her 
cheeks and bridge of nose at the beginning of her illness. This 
healed and her facial skin later became pigmented (Plate6a Appendix). 
Cases 11, 12, 20, 21, 24, 29, 32 and 36 showed a darkening of the 
exposed areas of their skin and this returned to a normal colour 
if the patient recovered. 
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TEMPERATURE 
7 cases had an intermittent low grade pyrexia (99- 100.6° F) 
without obvious infection. These were Cases 11, 19, 20, 25, 31, 
43 and 46. 
HAEMATOLOGICAL FINDINGS 
Haemoglobin determinations were recorded in 27 cases and 
showed a mean of 14.7 G;- (Range 11.8 - 17.3). 
The volumes of pack red cells in Cases 32 and 47 were 
elevated to 55 and 51% respectively. Both these female patients 
were dehydrated and after adequate hydration the haematocrit of 
Case 47 became normal. Case 32 died. 
The erythrocyte sedimentation rate was recorded in 16 
cases by the Westergren or Wintrobe methods. In 11 cases normal 
values were obtained. In Cases 12, 29, 38, 39 and 49 there were 
slightly elevated readings by the Westergren method, i.e. 16, 19, 
20, 17 and 17 mm. /hour respectively. 
LEUCOCYTE COUNTS 
In 28 cases the leucocyte counts during the active phase 
were between 4- 10,000 /cmm. In 11 cases there was an elevated 
leucocyte count (Table 4), the elevation being due to an increase 
in polymorphonuclear leucocytes. From Table 4 it can be seen 
that any substantial leucocytosis was associated with infection 




Infection if any 
or other possible cause 
1 24,000 Bronchopneumonia 
5 13- 45,300 Pulmonary Infection 
o 11,600 None 
9 12,600 None 
16 11,000 None 
17 21,000 Post -Epileptic 
24 12,000 None 
25 29,000 Erysipelas 
26 12,000 None 
32 12,600 None 
39 11,600 None 
Table 4. Analysis of leucocyte counts 
above 10,000 /cram in 11 cases 
of acute porphyria. 
RENAL FINDINGS 
Traces of protein were found in the urines of 12 cases, 
of which 4 also had granular casts. The blood urea was raised in 
3 cases (Nos. 2, 11 and 31) but this was probably, in each case, 
an "extrarenal" type of uraemia due to excessive vomiting. 
Urinary infections were responsible for aggravations in the 
condition of Case 36. 
PYRUVATE TOLERANCE TEST 
Dr. J.N. Cumings, National Hospital, Queen Square, London, 
carried out pyruvate tolerance tests in Cases 17 and 33 (Table 5). 
Case 17 showed a slightly abnormal result, while that of Case 33 
was frankly abnormal. 
TABLE 5 
Pyruvate Tolerance Test 
Case No. Fasting 
Results expressed as mg pyruvate /100m1 blood 
After 60 mins. After 90 mins. 
Normal 
upper limits 1.12 1.26 1.34 
Case 17 1.02 1.08 1.46 
(30 -4 -51) 
Case 33 0.88 - 2.2 
(26 -8-53) 
(31-8-53) 1.0 1.68 2.08 
m Joiner, McArdle, and Thompson (1950). 
SERUM rJ N,CTROLYTES 
These are recorded in 8 cases (Table 1 Appendix). In 6 
of these abnormalities were found. There were diminished sodium 
and chloride levels in Cases 1 and 47. In Cases 25, 32 and 38 
the chlorides were somewhat diminished, while in Case 3 there was 
a hypochloraemia associated with a hypokalaemia and alkalosis. 
In each of these cases excessive vomiting had taken place and the 
results may thus be explained. 
EMPIÍ ICAL LIV.:;ñ FUNCTION TESTS 
Some Liver Function tests from 18 cases are recorded in 
Table 2 (Appendix). It should be emphasised that these were done 
in different laboratories by different workers. Nevertheless the 
study of the results bringsforth the following conclusions. In 
the majority of cases no abnormality was detected. The total 
protein content of plasma is low in Cases 21 and 34. It is 
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difficult to know the significance of the abnormality in the 
Albumen- Globulin ratio in Case 21. The alkaline phosphatase 
levels in Cases 3 and 33 were raised. It is of interest that in 
both these cases this test was performed during a very severe 
phase of a fatal attack. The thymol turbidity was increased in 
Case 27 and possibly so in Case 30, in which the thymol floccula- 
tion was grossly abnormal. The cephalin flocculation was 
repeatedly abnormal in Case 7, who is an alcoholic. The hippuric 
acid synthesis test was diminished in Case 4. 
Creatinuria Creatine (50 - 700 mg /24 hours) was consistently 
present in the urine of Case No. 21 in the acute phase of the dis- 
ease. 
CHEMICAL PATHOLOGY OF POST- MORTEM TISSUS 
The porphyrin and porphobilinogen analysis of post -mortem 
tissues in 7 cases of acute porphyria and 2 control patients who 
did not have porphyria is summarised in Table 3 (Appendix). The 
liver and kidney contained porphobilinogen in the acute porphyria 
patients and the liver contained some uroporphyrin whore this was 
tested, in contrast to the control tissues which contained neither 
porphobilinogen nor uroporphyrin. The livers, bone -marrows and 
spleens of porphyria patients did not have significantly higher 
concentrations of coproporphyrin and protoporphyrin than the tissues 
of control patients The kidney of 1 case, which was tested, had 
elevated concentrations of coproporphyrin and protoporphyrin. 
The presence of porphobilinogen in the liver and kidney 
of cases of acute porphyria corroborates the findings of Prunty 
(1945), Gray (1950) and Schmid et al. (1954). 
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PATFHOLOGICAL FINDINGS 
Post- mortems were carried out on Cases 1, 2, 3, 24, 32 and 
43 (see case records). Terminal respiratory infection was found 
in Cases 1, 3 and 43. Pulmonary oedema and (L) ventricular 
cardiac failure occurred in Case 2. In Case 32 there were small 
intrapulmonary haemorrhages and areas of collapse, secondary to 
respiratory paralysis. There was also a small pericardial effusion 
of about 15 cc. of slightly cicudy fluid, but no pericarditis; 
the right auricle was dilated; on microscopic examination there 
was fine patchy atheroma of the coronary arteries and little 
oedema of the left ventricular myocardium. In Case 24 there was 
fatty degeneration of the liver and gastric petechial haemorrhages. 
Gibson and Goldberg (1956) reported on the neuropathology of acute 
porphyria in 5 Cases, 4 of which belong to the present series 
(Cases 2, 24, 32 and 43). Concurrently with this, Dr. R.A.B. 
Drury investigated a biopsy of a dorsal interosseus nerve of the 
foot of Case 36 (Drury 1956). These neuropathological findings 
are summarised in Table 4 (Appendix). 
COURSE AND PROGNOSIS 
The course of acute porphyria in these 50 cases is 
variable. In a few cases, e.g. 10 and 46, there was merely some 
intermittent and occasional abdominal pain; in others, e.g. Cases 
2, 23, 24, 32 and 33, there was an explosive fatal attack which 
lasted from 10 days to 10 weeks. The courses in the majority of 
cases in the present series lie between these 2 extremes. In 
these, attacks recurred for months or years. A "step ladder" 
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pattern of increasing severity is seen in Cases 1 and 5. In 
both of these cases 3 attacks occurred over a period of months, 
each attack more severe than the last, until the final fatal and 
paralytic attack took place. In Cases 3 and 30 the patients' 
condition worsened throughout pregnancy, until death occurred 
shortly after the birth of the child. The mortality rate in 
relation to age groups is recorded in Table 6. The overall 
mortality rate is 24 per cent. These 12 fatal cases are further 
analysed in Table 7. It can be seen that the majority died from 
paralyses with or without a terminal respiratory infection. In 
Case 3 there was also a profound electrolyte disturbance. The most 
dangerous decade for the patient with acute porphyria is the second 
in which there was a mortality of 63 per cent. 
The duration of the activity of the disease, i.e. the 
period from the first to the end of the last attack, is some 
measure of the tendency to relapse. In Table 8 the mean of those 
periods in the non -fatal cases has been calculated for each 10 year 
age group. This suggests that after the 4th decade, patients are 
less liable to relapse, and in fact the 4 patients above the age 
of 40 who survived their first attack have had no further attacks 
for several years. The impression is also gained that if a 
patient in any age group survives a profound and crippling attack, 





No. of Cases No. of Fatal Per cent 
Cases Mortality 
10 - 19 8 5 63% 
20- 29 24 4 17% 
30 - 39 13 2 15% 
40 - 49 1 0 0 
50 - 59 4 1 25% 
Total 50 12 24% 
Table 6. Relation of mortality rate to age of onset of 
disease. 
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Table 7. Analysis of Deaths 
Case Age at Duration Precipitating Barbiturates 
No. onset 
(years) 
of illness cause of death given during 
attack 
1 23 1 year General Paralysis Sodium amytal 
Bronchopneumonia. Phenobarbitone 
2 52 4 weeks General Paralysis Seconal 
Pulmonary oedema. 
3 29 19 months End of pregnancy No barbiturates 














24 33 16 days General Paralysis Seconal 
30 19 6 months General paresis. 
Collapse after 












41 31 2 years Respiratory 
paralysis 
Medinal 2 doses 
43 18 2 years Bronchopneumonia No barbiturates 
General paresis. 
48 15 16 months Respiratory 
paralysis 
Phenobarbitone 
Age No. of 
Group non -fatal 
(years) Cases 
Mean duration 
of activity (years) 
10 - 19 3 1.5 (0.5 to 3 yrs). 
20 - 29 20 1.9 (10 days - 14 yrs). 
30 - 39 11 1.5 (2 weeks - 8 yrs). 
40 - 49 1 0.1 
50 - 59 3 0.9 (3 weeks - 2 yrs). 
Total 38 1.6 (10 days to 14 yrs). 
Table 8 Relation of duration of activity of disease 




A definitive diagnosis rests simply on the presence of 
porphobilinogen in the urine, but the critical point is the recog- 
nition that this comparatively rare disease may present with 
symptoms suggestive of an acute abdominal condition, a psychosis 
or psychoneurosis, a peripheral neuritis, an epilepsy of unknown 
causation etc. 'In this series 6 
because of their symptoms - Cases 
Case 19 a gastric ulcer was found 
gastrectomy was performed. Thus 
cases had abdominal operations 
11, 19, 21, 26, 40 and 47. In 
on another occasion and a partial 
the co- existence of a second 
condition, unrelated to porphobilinogenuria, may complicate the 
diagnosis. Case 38 developed abdominal symptoms 4 months after 
the birth of her child and a diagnosis of post- partum salpingitis 
was made. Case 26 was diagnosed as a case of poliomyelitis. The 
articular pain described by Case 24 suggested a diagnosis of acute 
rheumatism. Case 29 was diagnosed as a "post -herpetic 
encephalitis ". Acute porphyria has been well named "the little 
simulator" (Waldenstrbm 1939). 
TREILTIT,TT 
Prophylaxis 
In this disease, where definitive treatment awaits a 
deeper understanding of the biochemical abnormalities, the pre- 
vention of an acute attack is important. Whenever an active case 
is discovered it becomes a duty to test the urines of relatives 
for the presence of porphobilinogen. The family doctor is thus 
able to mark the latent porphyria case and if an attack arises, 
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avoid the dangers of a delayed diagnosis. On the other hand, there 
is no guarantee that a relative without porphobilinogenuria does 
not have the genetic defect. It has been observed that individuals 
heterozygous for the abnormal gene may not excrete porphobilinogen 
in the urine. Furthermore 5 out of 18 cases did not have porpho- 
bilinogen in the urine in states of remission. For these reasons, 
it is suggested that no member of a family in which there is a 
known case should be given barbiturates. This is no great thera- 
peutic denial, since there are several excellent non -barbiturate 
hypnotics. 
In dealing with the established case in remission, care 
should be taken to avoid the several precipitating factors which 
have been enunciated. Infections should be treated swiftly. 
Tonsillectomy was a valuable preventive measure in Case 37. 
Advice on pregnancy will be asked, but no dogmatic 
answer can be given. The dangers must be explained and if 
pregnancy ensues the obstetrician should be alerted. If any 
surgical procedure becomes necessary, a barbiturate must not be 
used as an adjuvant to anaesthesia. Careful surveillance through- 
out the puerperium is necessary since this period, especially the 
early part of it, is a treacherous one. 
Treatment of an acute attack 
Usually the patient is a difficult one to treat and nurse. 
It may be advisable to place her in a side ward rather than in a 
general ward when gross psychological disturbance and severe 
abdominal pain are present. If there are signs of paralysis, an 
artificial respirator should be held in readiness. The relief of 
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pain can be tried with morphia, pethidine (meperidine), or codeine. 
Aspirin is not contra -indicated. 
The re- establishment and maintenance of salt and water 
balance is important if excessive vomiting has occurred. The 
experience should be remembered of Case 47 who was improved by 
A.C.T.H. administration after enteral and parenteral saline had 
been given without success. Infection should be sought and 
treated. Substantial elevations of temperature (more than 101°F), 
leucocyte count (more than 12,000 /c.n. in the absence of convul- 
sions) or sedimentation rate (more than 20 mm /hour) should give 
rise to the suspicion that such an infection exists. This aspect 
of the treatment of the acute porphyria attack resembles the 
search for a focus of infection in a diabetic colaa. The value 
of this measure is seen in Cases 25, 36 and 37. 
Specific Drug Treatment 
The efficiency of any treatment is difficult to assess 
in acute porphyria, in which spontaneous remission and rapid 
improvement are often encountered. In spite of this, it is of 
value to attempt an objective judgment of the various kinds of 
specific drug therapy used in these 50 cases. 
A.C.T.H. It is of interest to note that Urquart (1898) 
suggested that suprarenal extract should be tried in cases of 
porphyria, since disease of the suprarenals had been recorded in 
this condition. Campbell (1898) gave "suprarenal tabloids" to a 
porphyria patient without effect. On the other hand, Prunty 
(1949) found evidence of adrenal cortical hyperplasia in his case. 
A.C.T.H. was given in 5 cases in this series. In 3 of these (Nos. 
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3, 12 and 43) there was no obvious effect, but in cases 25 and 47 
there was some improvement of the clinical condition associated 
with the administration of the drug. In the latter case (No. 47) 
the hypochloraemia did not respond to enteral or parenteral salt 
therapy, until A.C.T.H. was given. This may be compared with the 
severe post -operative hyponatraemia and hypochloraemia, persisting 
despite adequate intake of sodium, potassium, and chloride, which 
is quickly corrected by cortisone (Graber et al. 1956). A.C.T.H. 
is worth trying in those cases in which there is generalised 
weakness and /or salt and water loss (Goldberg, Macdonald and 
Rimington, 1952). Watson (1954) has stressed that A.C.T.H. should 
be given as early as possible in the course of the disease. 
(Figs. 1 and 3 Appendix). 
Cortisone In 3 cases (13, 36,43) cortisone had no effect, 
while in Cases 5 and 13, there was some improvement associated with 
its administration. 
Neostigmine (Prostigminql is a parasympathomimetic drug, 
which stimulates postganglionic cholinergic nerve endings by means 
of its anti -cholinesterase activity. Besides this action it 
exerts a component of direct action on voluntary muscle fibres 
(Goodman and Gilman, 1955). In many cases of acute porphyria 
there is an apparent depression of parasympathetic activity (hyper- 
tension, tachycardia, constipation, although diarrhoea has less 
frequently been observed). A myasthenia -gravis -like picture has 
also been described (Denny -Brown and Sciarra, 1945). It is not 
surprising, therefore, that neostigmine has been used in the 
treatment of this condition - in some cases with good effect 
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(Waldenstrbm, 1944; Berg, 1945; Gordin, 1948; Veflingstad, 1949; 
Oigard and Roos, 1953; Gillhespy and Smith, 1954) and in other 
instances without benefit (bshby and Bulmer, 1950; Fawcett, 1954). 
Berg (1945) and Berlin and Cotton (1950) observed by kymograph and 
X-ray examination, respectively, an improvement in the peristaltic 
activity of the stomach and small intestine of acute porphyria 
cases, after the injection of prostigmine. In the present series 
neostigmine had no effect on the paralysis or pain in Cases 5, 6, 
9, 11 and 30 but did relieve constipation and retention of urine 
in Case 30. In Case 36 there was a marked improvement of the 
mental state associated with administration of neostigmine, but this 
was probably fortuitous. It is possible that some cases of acute 
porphyria might be symptomatically helped by this drug, particular- 
ly where there is a diminished action of smooth muscle. 
Hexamethonium may diminish hypertension (Case 23, 36, 30). 
It does not alter the course of the disease; it may not relieve 
pain pari passu with the depression of hypertension (Case 30). 
In Case 33 this drug was only effective as a hypotensive agent for 
short periods after its injection. Wehrmacher (1952) has described 
the variable effects of tetraethyl ammonium chloride and 
tubocurarine chloride on pain in a case of acute porphyria. 
Other Drugs The following drugs were used without 
apparent benefit - calcium gluconate I.V. (Cases 4 and 25), 
benadryl (Case 25), priscol (Case 25), probanthine (Case 39), 
eucortone (Cases 4 and 47). Vitamin B therapy (aneurin and 
riboflavin) was given enterally or parenterally in several cases 
(7, 9, 17, 33, 46). With the possible exception of Case 7, an 
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alcoholic, it had no benefit. 
Psychological Attitude In many patients a definite 
diagnosis is delayed for some time. The patient may begin to 
accept the statement that the very real pain she is suffering is 
due to "nervousness" or even "imagination's and in some cases this 
situation may in itself aggravate the mental state of the patient. 
Case 29 said she felt greatly relieved when she realized that her 
doctors had found a cause for her pain, even though her symptoms 
were not immediately relieved. For this reason it is a kindness 
to explain that the symptoms have been brought about by a definite 
disease. In family 10, a brother of Cases 43 and 44, developed 
an hysterical equivalent of the disease, but had no porphobilino- 
genuria. The fear of the disease which may be present in healthy 
relatives should be noted. 
Physiotherapy Where paralysis or paresis has occurred 
the limbs should be correctly maintained in positions of function 
and active physiotherapy should be started as soon as possible 
and continued until complete recovery has been attained (see below). 
Treatmgnt after a severe attack 
The patient may recover quickly and completely. On the 
other hand, she may be left severely crippled or even insane after 
the acute attack. It is important to realize that complete 
restitution of physical and mental function is the rule in these 
patients, but this may take 4 or 5 years. Thus Cases 36 and 40 
were mentally ill for several years, but both eventually returned 
to a normal state. Cases 14, 17, 21, 26 and 36 had marked wasting 
and weakness of musculature, but showed remarkable recoveries. 
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That the pathological changes of the nervous tissue in this 
disease are so completely reversible should be of great encourage- 
ment to the medical attendant and patient. 
DISCUSSION OF CLINICAL FILATURES 
Gunther (1922) suggested that 3 symptoms commonly occurred 
in acute porphyria - abdominal pain, vomiting and constipation. 
This is in agreement with the incidence of symptoms in this survey 
(Fig. 5). Attacks may, however, occur entirely without abdominal 
pain. The pain may be felt in the limbs, chest, head, neck or 
the joints. This point has been repeatedly made since Ranking 
and Pardington (1890) and Harley (1890) referred to non -abdominal 
pain in the disease. Diarrhoea has also been noted (Garrod and 
Hopkins, 1896; Gunther, 1922; Van den Bergh et al. 1937). 
Waldenstr6m (1937) described 3 cases with mucous colitis, a 
condition present in Case No. 42 of the present series. Hyper- 
tension in acute porphyria was first described by Melkersson (1926), 
and Waldenstrema (1937) noted the significance of the hypertension 
and tachycardia, but Bostroem (1920) recorded a B.P. of 95/30 in 
one case. This may be compared to Case 25, who developed hypo- 
tension in one of her attacks. Essential hypertension may occur 
simultaneously as in Case 2 and in Saint et al. (1954). 
Some of the electrocardiographic findings are substantiated 
by those of other workers. Thus Berlin and Cotton (1950) noted 
P.Q. depression in one case. Eliaser and Tondo (1942) found 
marked elevation of the S-T segment, which they attributed to 
coronary arterial spasm. Degenerative changes of the mycocardium 
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have been described by van den Bergh et al. (1934) and Saint et al. 
(1954). 
The type of neurological involvement - patchy, predominantly 
motor and this mainly lower motor neurone - is the same as that 
found by Waldenstrbm (1937). The evidence for pyramidal tract 
involvement in 5 cases of the present series corroborates similar 
findings by Melkersson (1926) and Waldenstriim (1937) . Waldenström 
also found that 60 per cent of his cases had neuropsychiatrie 
manifestations. Five of these were mentally certified. These 
figures are in agreement with the present series. The association 
of epileptiform seizures with acute porphyria was noted early in 
the history of the disease (Campbell, 1898; Brown and Williams, 
1909). 
Abnormal E.E.G. patterns were obtained in Cases 28, 29 
and 33. Berlin and Cotton (1950) and Perrault et al. (1953) 
also reported definite abnormalities. The former workers noted 
low voltage waves of 5 -7 cycles /sec present throughout the tracing, 
suggestive of diffuse cortical damage (cf. Case 29 in this series). 
The latter found signs of paroxysmal activity likely to be basal 
in origin; this activity disappeared between attacks. 
The finding of skin pigmentation in several of the cases 
in this series corroborates Waldenstrtm (1937) and Vannotti (1954). 
The latter also described "mild cutaneous lesions of a vesicular 
nature ", which may occur in acute porphyria and this description 
recalls Case No. 47, in whom such a vesicular eruption occurred on 
the face at the very onset of the condition. It may be argued that 
Case 47 should be classified as a porphyria cutanea tarda in view 
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of this skin manifestation and also because of the raised faecal 
porphyrin obtained in remission (MacGregor, Nicholas and Rimington, 
1952). On the other hand, the skin manifestations were mild and 
fleeting, while the acute attack was the predominant clinical 
manifestation. 
Proteinuria was present in about 25 per cent of cases. 
Such a finding has been noted by many observers, e.g. Garrod and 
Hopkins (1896), G$nther (1911, 1922), Grund (1919) and Melkersson 
(1926). Hymens Van den Bergh et al. (1937) and Harbitz (1924) 
also described the association of subacute and chronic nephritis 
respectively, while Stern (1894), Denny -Brown and Sciarra (1945) 
and Prunty (1949) obtained renal tubular necrosis at the post- 
mortems of their cases. 
Excessive vomiting was suggested as a cause of the serum 
electrolyte changes. Similar changes have been explained on this 
basis ( Vannotti, 1954), but Prunty (1949) suggested that the 
pathological lesions he found in the renal tubules might be the 
cause of the diminished plasma sodium and chloride levels of his 
patient. The empirical liver function tests show only slight or 
moderate changes in a few cases. Vannotti (1954) found the 
galactose tolerance test positive in 30 per cent of his cases. 
The diminished hippuric acid synthesis in Case 4 may be related to 
a diminished glycine pool in the liver. 
In experimentally induced porphyria in the rabbit, where 
much porphyrin was formed, there was a diminished urinary glycine 
excretion, revealed by paper chromatography (Section 6). In 
cases of human acute porphyria no such change was found, but the 
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hippuric acid synthesis test may be a more sensitive index of 
available glycine. The mild diabetic curve in Case 11 and the 
abnormal pyruvate tolerance test in Case 33 suggest that abnormal- 
ities in carbohydrate metabolism, particularly in the brain, may 
exist in this disease and might repay further study. 
The marked creatinuria in Case 36 emphasises the muscle 
wasting in this condition. Vannotti (1954) recorded creatinuria 
in a rare form of acute porphyria, which he called "Myoporphyria ", 
and in which muscular atrophy and decolorisation were present. 
The presence of a raised blood cholesterol in Case 8 is 
of interest. Vannotti (1954) recorded that a lowered level was 
more commonly found. 
In Cases 45 and 46 large amounts of coproporphyrin as 
well as porphobilinogen were found in the urines. The significance 
of this finding is not known. 
4 
PHARMACOLOGY OF THE PORPHYRINS AND PORPHOBILINOGEN 
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4. PHARMACOLOGY OF Ttih POñPHYRIdS AND rOR:f'HOBILIIdOGLïú 
The work described in this section attempts to define the 
relationship between the abnormal substances excreted in acute 
porphyria and the clinical manifestations of this disorder of 
porphyrin metabolism. During an attack of acute porphyria, 
patients usually excrete large quantities of porphobilinogen 
either alone or with certain porphyrins. The excretion of the 
porphyrins and porphobilinogen is usually in direct proportion to 
the severity of the symptoms, suggesting a causal relation, 
although Waldenstrem (1939) has reported an authenticated case 
in which the patient did not pass uroporphyrin or porphobilinogen 
in the urine or bile during the attack, but did so on other 
occasions. Several authors have claimed that porphyrins may 
influence the intestine or uterus (Supniewski, 1927; Gilnther, 
1922; Reitlinger and Klee, 1928; Vannotti, 1937; and Siruici, 
1938). Critical appraisal of these reports has led to the 
repetition of this work using porphyrins of the kind known to be 
excreted in porphyria, which were obtained by improved methods 
of purification. The isolation of porphobilinogen in crystalline 
form ( Westall, 1952) has for the first time allowed pharmacological 
testing of the pure substance, although Waldenstr6m and Wendt 
(1939) and Prunty (1945) had injected partially purified porpho- 
bilinogen into rabbits. 
METHODS 
Anilual Experimente Observations were made on the blood pressure 
(recorded with a cannula in the carotid artery) and on the 
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respiration of 13 cats and 3 rabbits (anaesthetized with chloralose 
(50mg. /kg) after induction with ether) and of 1 pithed cat, 1 
pithed and eviscerate cat, and 1 decerebrate cat. Injections were 
made into the right femoral vein or the splenic vein. 
Stimulation of the distal end of the vague, separated and 
cut in the neck, was with supramaxiinal 0.5 msec. shocks at 10 c. /s. 
Isolated Organs Experiments were also made on isolated strips 
of guinea -pig ileum, non -pregnant rabbit uterus, rabbit jejuu m 
and ileum, or cat ileum, set up in Tyrode's solution at 34 °C. 
Contractions were recorded on smoked paper by a frontal writing 
lever. Experiments with light irradiation were done with an 
electric bulb of 300 w. at 25 cm. from the tissue in the organ bath. 
Drugs The porphyrins, with the exception of haematoporphyrin, 
had beenisolated from biological material as the methyl esters. 
Before use the esters were hydrolysed with 7 N HC1 for 36 hours, 
at room temperature, the excess of HC1 being then removed in a 
vacuum desiccator over KOH. Haematoporphyrin was prepared and 
used as the dihydrochloride. Pure crystalline porphobilinogen 
(Westaîl, 1952) was used; the porphobilin was obtained by 
Mr. R. G. Westall as a by- product in the preparation of porpho- 
bilinogen. 
Porphobilinogen was dissolved in a minimum volume of 0.1 N 
NH4.0H and then made up to the required volume with 0.9% saline. 
For the porphyrins and porphobilin M/7 sodium bicarbonate was 




Anaesthetized Cats and Rabbits Recordings were made of the 
direct effect of porphobilinogen - and, in one experiment, of 
uroporphyrin I - on the blood pressure, respiration and vascular 
responses of the treated animals to acetylcholine, histamine, 
nicotine, adrenaline, noradrenaline, and vagal stimulation. 
The amount of porphobilinogen injected (up to 100,c4g /kg.) was 
limited by the amount available; but from the known rate of 
excretion in patients (40 -160 mg. /day), and from the fact that 
tests for plasma porphobilinogen concentrations at the height of 
an attack were not greater than 1.5 µg/ml. (see Section 713), it 
is likely that the blood levels obtained in our experiments were 
comparable to or even greater than those obtaining in acute 
porphyria. The only effect observed was an apparent potentiation 
by porphobilinogen of the response to adrenaline and noradrenaline 
in a few of the early experiments (Fig. 1) . This apparent 
potentiation of adrenaline and noradrenaline could not, however, 
be repeated and its interpretation is complicated by the fact that 
considerable spontaneous fluctuations in sensitivity to these drugs 
may occur. 
m The work on anaesthetised cats and rabbits was performed by 
Drs. W.D.M. Paton and J.T. Thompson. The remainder of the 
work on isolated tissues and unanaesthetised animals was 







I 00 - 
3µg. 3µg. 3µg. 3µg. 
Ad. NA. NA. T NA. 
1 1 1 Porphobilinogen 
minutes 100µg. 
Flo. 1. -Cat.; chloralose; blood pressure recording; intravenous 
injections. Responses to 3 pg. adrenaline and noradrenaline 
before and after 100 pg. porphobilinogen. 
3µg. 
Ad. 
Isolated Organs After obtaining records of spontaneous activity 
and tone, and of consistent responses to acetylcholine, histamine, 
adrenaline, and 5- hydroxytryptamine, the effect of adding 
porphyrins, porphobilinogen, and porphobilin to the preparation 
was investigated. With uroporphyrin I the effect of light 
irradiation was also determined. A summary of these results is 
given in Table I. 
TABLE I 












Drug concn. .. .. 1/40,000 1 /10,000 1/40,000 1/40,000 1/40,000 
Effect on spontaneous acti- 
vity and tone .. .. 0 0 0 0 0 
Effect on response to adren- 




Drug concn. .. .. 1/40,000 1 /10,000 1!10,000 
Effect on spontaneous acti- 
vity and tone .. .. 0 0 0 
Effect of combining with 
light irradiation .. .. 0 
Effect on response to hist- 
amine, acetylcholine, 




Drug concn. .. .. 1/20,000 1/40-10,000 1/10,000 1; 20,000 1/20,000 1 8,000 1/20,000 
1 
Effect on spontaneous acti- 
1 vity and tone .. .. 0 
Slight + 
twice only 0 
+ twice 
only 0 - + (histamine contaminant ?) 
1 
Effect on response to acetyl - 
choline .. .. .. 0 . 
Effect on response to 5 -OH 
tryptamine 0 0 0 0 
Effect on response to hist- 
amine .. .. .. 
+ (50%) 
once only - 
0 = No effect: + = increase; -= decrease. 
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The only significant responses were those to haemato- 
porphyrin (1/8,000) and to porphobilin. The former produced a 
distinct waning contraction of guinea -pig ileum, followed by 
inactivity of the intestine and a refractoriness - which became 
complete - to histamine and acetylcholine. Rabbit intestine 
was unaffected. Porphobilin produced a histamine -like 
contraction, sensitive to mepyramine, but less so to atropine 
(Fig. 2); it was considered likely that the effect was due to 
contamination (c. 0.4 mg. /g) with histamine itself. 
(a) (b) 
!mg. 0.3Yg.0.25I,g. 0.3Ng.0.25Ng.lmg. 





H PBN ACh. 
C ) 
Mepyramine 
1.5 x I.0-9 10-9 
FIG. 2.- Isolated guinea -pig ileum. Response to 1 mg. porphobilin, 
0.3 pg. histamine and 0.25 pg. acetylcholine (a) normally, (b) in 
presence of 1.5 x 10 -9 atropine, (c) in presence of 10 -9 mepyr- 
amine. 
Test of Porphobilinogen on Unanaesthetized Rabbit 
10 mg. porphobilinogen was injected intravenously into a 
rabbit (2.2 kg.) with an external biliary fistula. The animal 
showed no abnormal symptoms in the 3 days following the injection. 
There was a slight rise in the level of bile protoporphyrin during 
this period and a trace of uroporphyrin was noted in the urine 
several hours after the injection. No porphobilinogen was found 
in the urine. 
Test of Whole Urine from Patients with Acute rorphyria 
As a final test, to cover the possibility that in 
porphyria some unidentified pharmacologically active substance 
is excreted, a sterile specimen of urine from a patient suffering 
a moderately severe attack of acute porphyria (with hypertension 
and abdominal pain) was infused into an anaesthetized cat at a 
rate of approximately 4 ml. /min. for 15 min. This by itself 
produced no effect on blood pressure or respiration; and its 
effect on the responses to adrenaline, noradrenaline, histamine, 
acetylcholine, and nicotine was indistinguishable from that of a 
specimen of normal urine. 
DISCUSSION 
Despite a great deal of research on acute porphyria the 
mechanism of the production of symptoms remains obscure. Recent 
work has tended to minimize the possible direct influence of the 
porphyries (Wald.enstrbm, 1939) and to emphasize the importance of 
the pathological features of patchy myelin change observed in the 
peripheral and autonomic nerves (Denny-Brown and Sciarra, 1945). 
These authors considered that the changes might be caused by an 
intermittent ischaemia, probably due to a circulating vaso- 
constrictor substance. Following this, Wehrmacher (1952) 
reported clinical improvement in acute porphyria with the use of 
ganglion -blocking agents. A search for some such vasoconstrictor 
substance, which might be present only in active cases of acute 
porphyria, would be a reasonable approach to the problem. 




excretion products was clearly necessary. It would be unlikely 
that uroporphyrin and coproporphyrin could fulfil this role, 
since these are excreted in increased amounts in both congenital 
porphyria (as the series I isomers), and in porphyria cutanea 
tarda (as the series I and III isomers) where skin photo- 
sensitivity may be the only symptom. . Porphobilinogen, however, 
is always excreted in the urine in attacks of acute porphyria and 
in those phases of porphyria cutanea tarda where acute symptoms 
are superimposed on the cutaneous syndrome. For this reason, 
porphobilinogen or some closely related substance has been strongly 
suspected of being the materia peccans of acute porphyria (Lowry 
et al., 1950). 
These experiments have failed to show that either the 
porphyrins or porphobilinogen have any significant pharmacological 
action. The initial animal experiments, in which porphobilinogen 
appeared to potentiate the blood pressure responses of the cat 
to adrenaline and noradrenaline, could not be repeated. These 
interesting results cannot be explained, although it is just 
possible that there may be an individu»l tissue and animal sen- 
sitivity to such drugs. Their inactivity is at variance with the 
results of some previous investigators. The difficulty of 
isolating porphyrins from biological materials, such as urine, in 
a state of purity that will guarantee freedom from possible 
histamine contamination, is very great. It is suggested that 
the contradictory results obtained by previous workers may 
possibly have been due to histamine contamination. 
The results of intravenous injection of porphobilinogen 
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into a rabbit confirm Prunty's (1945) findings, but contradict 
those of Waldenstr`óm and Wendt (1939), who found porphobilinogen 
in the urine of a rabbit into which they had previously injected 
the partially purified substance (amount used unknown). 
Experiments on the excretion of porphobilinogen after enteral and 
parentera1 administration to rats have shown that this substance 
is removed by glomerular filtration without significant tubular 
re- absorption (Section 7A). The reason for the present results 
in the rabbit is probably due to the loss of porphobilinogen 
through the external bile fistula. 
Further work has tended to substantiate the absence of 
pharmacological activity of the porphyrins and porphobilincgen. 
An "experimental porphyries" or disturbance of porphyrin metabolism 
has been produced in rabbits by the non -hypnotic substance allyl 
isopropyl acetamide (Goldberg, 1953); very large quantities of 
uroporphyrin and porphobilinogen were excreted - in one animal 
for as long as three weeks - without obvious pharmacological 
effect. Apart from constipation, there is no evidence that the 
state of these rabbits compared with the clinical state of human 
acute porphyria, although the animals excreted proportionately 
greater quantities of the substances. Falk, Dresel, and Ri.min_gton 
(1953) have shown that porphobilinogen is a porphyrin precursor 
in a tissue system. This emphasizes that in perphobilinogen we 
are probably dealing with a physiological substance. While 
these experiments therefore do not rule out the possibility that 
an unidentified vasoconstrictor substance may be produced in 
acute porphyria, or that the known excretion products may exert 
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a pressor action by a mechanism at present unknown, they render 
these suggestions unlikely. 
SUIVARY 
1. The porphobilinogen and the porphyrins usually excreted in 
acute porphyria, as well as haematoporphyrin and porphobilin, 
have been tested pharmacologically. 
2. Apart from slight and variable action of uroporphyrin T, 
coproporphyrin I, and porphobilin, these substances show no 
pharmacological action. 
3. The significance of the results in relation to the symptoms 
of acute porphyria is discussed. 
5 
THE EFFECT OF CERTAIN BARBITURATES 
ON TIIE PORPHYRIN METABOLISM OF RABBITS 
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5. TIE i:;n'LCT OF CLRTAIL`T B1ll-tBITUIATLS ON TEE 
_a0i+d I?vRIIú IviLTABOLISM OF RABBITS 
Introduction 
In Section 3, evidence was put forward that the barbit- 
urates may precipitate an attack of acute porphyria or may be 
associated with the paralytic phase of the disease. Lehmann and 
Zinn (1910) first carried out an experiment with diethyl 
barbituric acid, which had caused a porphyrinu i a in one of their 
patients. They gave this drug in prolonged dosage to one rabbit 
without the production of similar pigments. Animal experiments 
were also carried out by Laubender and Monden (193e), who investi- 
gated the effects of diethyl, broriailylisopropyl and ethyl - 
cyclohexenyl-barbituric acids on the urinary porphyrins of 
rabbits. They failed to find any such effect in all these 
experiments with the exception of one animal treated with 
diethylbarbituric acid, which showed a slight rise of urinary 
porphyrins. 
The barbiturates comprise a group of chemically related 
drugs, while acute porphyria is a rare disease. Moreover, it 
is usually impossible to tell from published records whether the 
barbiturates had precipitated the overt disease in a case of 
latent porphyria or had in fact provoked acute porphyria in a 
formerly healthy subject. To overcome this difficulty and the 
uncertainty in assessment of these clinical impressions, the 
effects of different barbiturates on the porphyrin metabolism of 
rabbits were studied. Out of nine barbiturates so tested, six 
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had a significant effect on the urinary porphyrin excretion; 
those containing one or more allyl groups were particularly 
effective. 
METIIODS 
Seventeen rabbits (average wt. 2.8 kg.) were housed in 
individual metabolism cages allowing the separation of urine and 
faeces. A preliminary base -line period of 4 -7 days before drug 
administration was allowed during which the total daily urinary 
coproporphyrin and sometimes also faecal porphyrins were deter- 
mined. If the animal died during an experiment, tissue porphyrins 
and porphobilinogen were also determined. The average duration 
of each course of barbiturate was 12 days. The types of 
barbiturates and their route of administration are recorded in 
Table 1. If the rabbit survived this course, analyses were 
continued during a recovery period of 4 -7 days. After such an 
interval, some rabbits were started on a different barbiturate as 
indicated in Table 1. The maximum sub -lethal dose of each drug 
was employed. 
Quantitative analyses 
Urinary porphyrins. These were determined by the method 
of Rimington and Sveinsson (195G) with the following modifications. 
Ether -soluble porphyrins were extracted by ether: acetic acid 
(10:1 by vol.) and after the ether had been washed three times 
with water, were transferred directly into 1.4N -C1 for 
spectrophotometric determination (Beckman, model DU) . One part 
of urine containing porphobilinogen, was diluted with 4 parts 
21I sodium acetate buffer pH 4.22, and placed in boiling water for 
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Table 1. Effect of barbiturates on the urinary excretion of coproporphyrin in rabbits 
The sodium barbiturates were given in equally divided dosage twice daily. A letter after a rabbit number signifies that 
the rabbit obtained the corresponding barbiturate on a primary course a, or on subsequent courses b, c, etc. Doses were 





Rabbit Average level 
Drug no. (mg. /kg. /day) 
- 
Duration level 
(days) (µg. /day) 
5:5- Diallylbarbituric acid 2 a 113* 15 19.7 +193.7 
lb 103* 35 7.5 +169.5' 
3 100 17 5.2 +119.2 
4a 128* 12 8.7 +88.3 
5 101.6 7 8 +86 
6 125 9 5.3 +84 
7 114 7 2 +51 
8 148 7 3.3 +47 
Sodium 5- allyl- 5- (1- methylbutyl)- 9 172 7 3.7 +42.6 
barbiturate 10 115 12 3.8 +22.9 
11 b 100 12 9.8 +20.2 
2d 82.8 12 19.7 +17.3 
5- Allyl- 5- isopropylbarbituric acid 2b 67.8t 12 19.7 +81.6 
12 76t 13 7 +40 
13 74t 12 7 +27 
Sodium 5:5- diethylbarbiturate 14b 171 13 5 + 9.7 
13d 140 12 7 + 9.6 
15 169 13 1.8 -+ 8.7 
16 144 12 2.4 + 5.6 
Sodium 5- ethyl- 5- (1- methylbutyl)- 11 98.5 12 9.8 +15.2 
barbiturate 2c 110.5 12 19.7 + 7.3 
4b 128 14 8.7 + 2.3 
Sodium 5- ethyl -5- phenylbarbiturate 14a 71 9 5 +14.7 
la 67 20 7.5 +13.5 
13e 81 12 7 +11.7 
16b 82 12 2.4 + 6.8 
Sodium 5- isoamyl- 5- ethylbarbiturate 13b 90 12 7 - 2 
2e 83 12 19-7 - 5.2 
Sodium 5- butyl -5- ethylbarbiturate 17e 109.5 12 11.5 + 5.5 
16a 98 12 2.4 + 2.3 
Sodium 5- ethyl- 5- (1- methylbutyl) -2- 17b 218 12 11.5 + 5.2 
thiobarbiturate 2f 164 12 19.7 - 1.7 
* Some doses given by gastric intubation. t Given by gastric intubation. 
20 min. Appropriate dilution for spectrophotornetric deter- 
mination of the total uroporphyrin was made with HCl so that 
the final concentration of acid was 0.5N. 
Faecal coproporphyrin and tissue copro- and proto- 
pórphyrin. Faeces and tissues were ground thoroughly in a 
mortar. Liver tissue was in addition comminuted in a Waring 
Blender. The ether -soluble porphyrins from weighed portions 
of faeces and tissue were extracted by repeated shaking with 
ether :acetic acid (10:1, v /v) until the supernatant after 
centrifuging showed no porphyrin fluorescence. The porphyrins 
were then analysed as in the case of urine. 
Porphobilinogen. Porphobilinogen in urine was deter- 
mined by the method of Vahlquist (1939). Tissue dispersions 
were treated with about an equal volume of 20% (w /v) 
trichloroacetic acid, the mixture was centrifuged and the super- 
natant analysed as in the case of urine. 
Blood examination. Haemoglobin was determined by the 
method of Rimington (1942). Erythrocyte counts and reticulocyte 
counts were carried out using standard techniques. 
Urinary amino acids. These were examined by methods of 
Datta, Dent and Harris (1950). 
Identification of porphyrins 
The urines from rabbits treated with sodium ally (1- 
methylbutyl) barbiturate or allylisopropylbarbituric acid 
contained increased amounts of porphyrins, all of which were ether 
soluble. These urines were preserved with toluene and stored at 
3 °. The porphyrins were extracted with ether:acetic acid and, 
after the ether had been washed 3 times with water, were trans- 
ferred into a minimal volume of 2.8N -HC1 and then precipitated 
at the isoelectric point (pH3.1). The precipitate was 
centrifuged, dried, and esterified by contact with methanolic 
ECl for 24 hr. The porphyrin esters were transferred into 
CH013 by the addition of saturated sodium acetate, the CH01.; 
layer washed once with. water, once with dilute ammonia, and twice 
with water, in that order. Them band (absorption band at 
longest wavelength) of the porphyrin ester at this stage was noted 
on the Hartridge Reversion Spectroscope. A portion of the ester 
was dried, hydrolysed t, *ith 7N -HC1 for 36 hr. and chromatographed 
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on paper (Nicholas and Rimingtcn, 1951) . The remainder was 
crystallized from CHC13 : methanol (1:5, v/v.). Melting points, 
which were not corrected, were determined on an electrically 
heated micro apparatus U.. Gallenkamp and Co. Ltd.) . Isomer 
analysis was done by the method of Chu, Green and Chu (1951). 
Urines from some rabbits treated with diallylbarbituric 
acid contained uroporphyrin and porphobilinogen as well as an 
increase in ether -- soluble porphyrins. These combined urines 
were brought to pH3 -4 with glacial acetic acid and sufficient 
talc was added to adsorb all porphyrins. The talc was filtered, 
dried, and repeatedly eluted with 2N ammonia until no porphyrin 
fluorescence appeared in the supernatant. The total alkaline 
eluates were then brought to the isoelectric point and the por- 
phyrins thus precipitated were dried, esterified and taken into 
CHC13 as described above. The porphyrin esters were fractionated 
by chromatography on columns of aluminium oxide Grade IV and 
magnesium oxide Grade III (Nicholas, 1951). The fractions were 
defined byd band estimations and, after hydrolysis, by paper 
chromatography (Nicholas and Rimington, 1951). Isomer analysis 
of octacarboxylic porphyrin esters was performed by the method of 
Falk and Benson (1953), while that on tetra and penta- carboxylic 
porphyrins was done by the method of Chu et al. (1951). The 
uroporphyrin ester was crystallized from chlorofcrm:methanol. 
RESULTS 
Those barbiturates which produced the greatest increase 
cf urinary porphyrins also caused the most prolonged hypnosis. 
Diallybarbituric acid was the most effective drug, while 
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ailylisopropylbarbituri c acid and sodium all y? (1- rethylbutyl) 
barbiturate, caused a higher excretion of urinary coproporphyrin 
and a more prolonged hypnosis than the remaining barbiturates. 
In each of three rabbits treated with diallylbarbituric acid, the 
drug was given sometimes by gastric intubation and sometimes by 
intramuscular injection. No significant quantitative difference 
of urinary porphyrin excretion was obtained by thus changing the 
route. 
Urinary coproporphyrin Table 1 records the average daily 
excretion of coproporphyrin in the urine during the pre -dosage 
period and the average deviation from this figure during admin- 
istration of the drug. Coefficients of variation are not included 
since in almost every instance the results were quite obviously 
significant. Where an effective barbiturate was used, the urine 
coproporphyrin excretion showed a prompt increase after the 1st 
or 2nd day, rose to a maximum level on about the 6 -7th day, remained 
at about that level during the subsequent administration of the 
drug and fell to normal within 2 -3 days of its cessation. 
Urinary uroporphyrin and porphobilinogen In three rabbits 
(lb, 2a and 3) treated with diallylbarbituric acid, uroporphyrin 
and porphobilinogen appeared in the urine on the 7th, 7th and 8th 
days, respectively, and generally continued to be excreted for as 
long as the drug was given (Table 2 and Fig. 1). 
Faecal coproporphyrin In rabbit lb the faecal coproporphyrin 
was determined before and during administration of diallylbarbit- 
uric acid. This showed that the faecal coproporphyrin rose at 
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25 730 
Fig. 1. Effects of diallylbarbituric acid on the 
urinary uroporphyrin, coproporphyrin and porpho- 
bilinogen and faecal coproporphyrin excretion 
of rabbit lb. 
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Rabbit No. Average Maximum Average Maximum 
lb 1720 4750 456 1607 
2a 360 800 78 161 
3 250 340 78 109 
* Vahlquist (1939) 
Table 2. Daily urinary uroporphyrin and porphobilinogen 
excretion in rabbits receiving diallylbarbituric acid. 
daily average of 38µg. /day to a daily average of 1495 /. g. /day. 
Tissue porphyrins Table 3 summarizes the tissue analyses for 
porphyrin of four normal rabbits, and five rabbits which had died 
from barbiturate intoxication at a stage when they were excreting 
increased urinary coproporphyrin. There was an increase of 
copra- and proto- porphyrin concentrations in the bile and liver 
in intoxicated rabbits, but the levels in the bone marrow showed 
no abnormality. The liver of rabbit 10 gave a faint but 
definitely positive reaction for porphobilinogen. Uroporphyrin 
was never found in any tissue. 
Blood examination Haemoglobin determinations, erythrocyte counts 






























































































































































































































































































































































































































































































































































after administration of the drug to three rabbits treated with 
diallylbarbituric acid and one treated with allylisopropyl 
barbituric acid. No significant change was observed in any of 
the erythrocyte counts or reticulocyte counts. In two of these 
rabbits (2b and 3), a slight fall (about 2 g.`ío) in the haemo- 
globin level was observed, while two rabbits (lb and 7) showed no 
significant change. 
Urinary amino acids In seven rabbits, in which a rise of urinary 
coproporphyrin was obtained, the urinary amino acid pattern was 
no different before and at the end of barbiturate administration. 
Identification of porphyrins The ether -soluble porphyrins 
obtained from the urines of rabbits treated with allylisopropyl- 
barbituric acid or sodium allyl(1- methylbutyl)barbiturate 
consisted entirely of coproporphyrin III. The ester m.p. »s 
and the results of paper chromatograms are shown in Table 4.. 
Table 4. Identification of urinary porphyrine. Summary of results 
Free porphyrin Porphyrin ester 
Paper Paper chromatography 
chromatography (a) (b) M.p. of 
(Nicholas & Chu et al. Falk & crystals 
Rimington, 1951) a Band 1951 Benson, 1953 ( °) Summary 
Diallylbarbituric acid 8 COOH 625.1 Mainly 
series III 
274 Uroporphyrin III 
6 COON 623.6 Hexacarboxylic 
porphyrin 
5 COOH 622.5 Series III Pentacarboxylic 
porphyrin III 
4 COOH 621.1 Series III Coproporphyrin III 
Sodium allyl(1- methyl- 
- butyl)barbiturate 













The porphyrin esters obtained from the urine of rabbits 
treated with diallylbarbituric acid were fractionated on a 
magnesium oxide column. This separated first an octacarboxylic 
porphyrin with an et band 625.0 m fc. ; then two intermediate 
fractions with bands 623.0 and 621.6 m,.. , respectively; and 
finally a tetracarboxylic porphyrin with d band 621.1 mtc. The 
first fraction was rechromatographed on a magnesium oxide column 
and yielded a single porphyrin zone. The appearance of the 
crystals obtained from this zone was suggestive of uroporphyrin 
III. The m.p. (274 °) and paper chromatography (Falk and Benson, 
1953) showed the series III isomer to be that mainly present 
(see Table 4). The two intermediate fractions were further 
chromatographed on an aluminium oxide column. This allowed the 
separation of a main portion with d band 622.5 mfn. and a lesser 
portion with dC band 623.5 m,.., which behaved as pentacarboxylic 
and hexacarboxylic porphyrins, respectively, when examined by 
paper chromatography (Nicholas and Rimington, 1951) . On a paper 
chromatogram (Chu et al. 1951), the pentacarboxylic porphyrin 
had about the same mobility as coproporphyrin III. The final 
fraction was identified as coproporphyrin III by melting point 
and paper chromatography (see Table 4). 
DISCUSSION 
This work has shown that of the nine different barbiturates 
examined, six were capable of producing some effect on the por- 
phyrin metabolism of rabbits. Of seventeen rabbits used, eight 
were given more than one barbiturate in separate courses. This 
was considered as a possible factor influencing results. However, 
another barbiturate was never started until the urinary copropor- 
phyrin level had returned to its normal from the previous course, 
and the results in Table 1 show that the same drug, used on 
different animals, whether it was their first or subsequent bar- 
biturate, generally gave corresponding results in porphyrin 
excretion. For the more effective barbiturates, sufficient 
numbers of rabbits were used, on a primary or subsequent barbit- 
urate course, to demonstrate the unimportance of previous 
intoxication. Difference in effect upon porphyrin excretion 
must depend, among other things, upon the chemical constitution 
of the drug, the daily dosage employed and its duration, and also, 
possibly, upon the normal level of porphyrin excretion of the 
individual animal. 
The results in Table 1 show that the barbiturates used 
may be classified in four groups according to their effectiveness 
(Fig. 2) 

















ALURATE BARBITONE PENTOTHAL 
SECONAL NEMBUTAL AMYTAL 
PHENOBARBITONE BUTOBARBITONE 
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Fig. 2. Each vertical segment 
represents the average daily 
coproporphyrin output in a 
single rabbit during barbi- 
turate administration in 
excess of (or less than) the 
normal average daily copro- 
porphyrin excretion. I, 
diallylbarbituric acid; II, 
allylisopropylbarbituric acid 
and sodium allyl(1- methylbutyl) 
barbiturate. III, sodium 
diethylbarbiturate, sodium 
ethyl (1 -methylbutyl)barbiturate, 
and sodium ethylphenylbarbiturate. 
IV, sodium ethyl(1- methylbutyl) 
thiobarbiturate, sodium isoamyl- 
ethylbarbiturate, and sodium 
butylethylbarbiturate. 
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(I) Diallylbarbituric acid, which caused a considerable 
rise of urinary coproporphyrin in each of eight rabbits and, in 
three of these, the excretion also of uroporphyrin and porpho- 
bilinogen. o
(2) iìilylisopropylbarbitu_ric acid and sodium ally(1- 
methylbutyl)barbiturate, which caused a moderate rise of urinary 
coproporphyrin. 
(3) Sodium diethyibarbiturate, sodium ethyl(1- methyl- 
butyl)barbiturate, and sodium ethylphenylbarbiturate, which caused 
only a slight increase of coproporphyrin in the urine. 
(4) Sodium ethyl( 1- methylbutyl)ti:iobarbiturate, sodium 
is oaamylethylbarbiturate, and sodium butylethylbarbiturate, which 
did not alter significantly the urinary coproporphyrin excretion. 
The possession of the allyl group thus appeared to make 
the barbiturate more effective in producing a rise of porphyrin 
in the urine. These drugs also caused deeper and more prolonged 
hypnosis in rabbits. Drugs possessing an allyl group have been 
known to give rise to pathological and metabolic changes in 
humans and in experimental animals. Popper (1936) and J&rgens 
(1951) have shown that n11ylformate and N- (diallyiacetyl)urea, 
respectively give rise to hepatic cellular degeneration in 
experimental animals. N- (Allylisopropylacetyl)urea may cause 
thrombocytopenic purpura in humans (..ckroyd, 1949), may influence 
the course of human acute porphyria (Duesberg, 1932), and gives 
rise to the hepatic type of experimental porphyria in rabbits 
with the excretion of large amounts of uroporphyrin and porpho- 
bilinogen (Schmid and Schwartz, 1952). Diallylbarbituric acid 
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has for some time been known to be one of the most toxic of the 
barbiturates and for this reason has generally been abandoned as 
an hypnotic in humans. 
The finding in post- mortem tissue analysis that the liver 
and not the bone marrow contained excessive copro- and proto- 
porphyrin (and in one instance porphobilinogen) recalls the finding 
in the liver of porphobilinogen (Prunty, 1945) and uroporphyrin 
(Watson, Schwartz and Hawkinson, 1945) in human acute porphyria 
and of these two substances in experimental porphyria in rabbits 
(Schmid and Schwartz, 1952). It also may be related to the known 
hepatotoxic effect of other allyl derivatives in experimental 
animals. It is of interest, too, that the coproporphyrin and uro- 
porphyrin produced in excess were the series III isomers. Rimington 
(1952) has proposed a scheme of possible enzymic derangements, 
occurring in the porphyries and the toxic porphyrinurias. It is 
not possible from the present results to interpret the precise 
mechanism occurring in the barbiturate porphyrinurias, but a reason- 
able inference from them might be that some of the barbiturates, 
especially those containing the allyl group, may interfere with the 
enzymes which decarboxylate uroporphyrin III to coproporphyrin III 
and protoporphyrin and, perhaps, with those responsible for the 
transformation of protoporphyrin to haem. Diallylbarbituric acid 
may also block the formation of tetrapyrroles from porphobilinogen. 
The main site of this interference may possibly be the liver. 
The present findings raise the questions of the bearing 
of these animal experiments upon barbiturate medication in human 
beings and of the relation, if any, which exists between human 
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acute porphyria and the disturbances of pigment metabolism caused 
by barbiturates in rabbits. The doses of barbiturates used in 
the animal experiments were proportionately (weight for weight) 
greatly in excess of those normally taken by humans. The 
rabbits, however, generally tolerated these daily doses well and 
were mostly able to survive the period of drug administration. 
Humans if given a proportionate amount of barbiturate almost 
certainly could not survive. A weight- for -weight comparison of 
the effect of the barbiturates on human and rabbit porphyrin 
metabolism would therefore be misleading. From these experiments, 
we may possibly infer that barbiturates in proportionately 
smaller dosage may effect the abnormally sensitive porphyrin 
metabolism in human acute porphyrias; the clinical impression 
that this does in fact take place may receive some substantiation 
from these results (Section 3). The differing degree of 
effectiveness of the barbiturates in the experimental animal may 
also explain the divergence of opinion on this clinical impression, 
which was based on the observation of different barbiturates. 
It is of great interest that diallylbarbituric acid administered 
to a normal animal causes the excretion of porphobilinogen and 
uroporphyrin. 
A further point of inference may be important. Barbit- 
urates have been shown to inhibit some of the oxidative processes 
of brain tissue (Quastel and Wheatley, 1933), the degree of 
inhibition being directly proportional to the hypnotic activity 
of the drugs. These authors also emphasized the importance of 
the allyl group in this connexion. Changes in nerve and brain 
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tissue occurring in acute porphyria (Tíason, Courviïle and Ziskind, 
1933; Denny- Brown and Sciarra, 1945; Gibson and Goldberg, 1956) 
may be the most important lesions responsible for the clinical 
results of this disease. It is possible that barbiturates 
might aggravate this upset in brain and nerve metabolism, as 
distinct from their effect on porphyrin metabolism. This might 
explain why some barbiturates, producing no marked effect on the 
porphyrin metabolism of rabbits, have been among those suspected 
of adversely affecting the course of acute porphyria. (see Section 8). 
STJMAßY 
1. Barbiturates have been suspected of adversely affecting the 
clinical course of acute porphyria. To assess this clinical 
impression objectively, the effect of nine barbiturates on 
the porphyrin metabolism of rabbits has been observed. 
2. These barbiturates may be classified into four groups. 
(i) Diallylbarbituric acid, which caused a considerable rise 
of urinary coproporphyrin_ III in each of eight experimental 
rabbits and in three of these the excretion also of uropor- 
phyrin III and porphobilinogen. (ii) Allylisopropylbarbit- 
uric acid and sodium allyl (1- methylbutyl)barbiturate, which 
caused a moderate rise of urinary copropoiphyrin III. 
(iii) Sodium diethylbarbiturate, sodium ethyl(1-methylbutyl)- 
barbiturate and sodium ethylphenylbarbiturate, which caused 
only a slight coproporphyrir_ increase in the urine. 
(iv) Sodium ethyl (1- methylbutyl)thiobarbiturate, sodium iso- 
amylethylbarbitur ate and sodium butylethylbarbiturate, which 
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did not alter significantly the urinary coproporphyrin 
excretion. 
3. The effect of the presence of an allyl group in the barbitur- 
ate is discussed. 
4. The significance of these results in animals is considered 
in relation to human acute porphyria. 
6 
EXPERIMENTALLY PRODUCED PORPHYRIA IN ANIMALS 
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6. EXPERIMENTALLY PRODUCED POCrHYRIx Iì`' ANIMALS 
Introduction 
Stokvis, who made the first observation on the "sulphonal 
haematoporphyrinuria" in man, also produced the first experimental 
copr oporphyrinuria, by the administration of sulphon_al to rabbits 
and dogs (Stokvis, 1895). These experiments were later confirmed 
by other workers . In 1939 Waldenstrbm and Wendt attempted un- 
successfully to produce an experimental porphyrinuria by the non - 
hypnotic derivative of suîphcn'1 dimethyl sulphone dimethyl methane. 
Rimington and Hemmings (1935) found that sulphonilamide caused a 
high excretion of coproporphyrin in rats, while Dent and Rimington 
(1947) observed a marked coproporphyrinuria in rats fed on a diet 
including oxidised casein. The pattern of porphyrin excretion 
in the urine of rabbits given lead was investigated by Weatherall 
and Comfort in 1952. Schwartz, keprios, and Schmid (1952) 
caused the excretion of uroporphyrin, increased ccproporphyrin and 
porphobilinogen in the urine of rabbits treated with phenyl- 
hydrazine,  lead and exposure to unfiltered light from a mercury 
arc lamp. Schmid and Schwartz (1952) described an experimental 
porphyria in rabbits induced by sedoriaid (allyl-isopropyl- 
acetylurea) in which they noted the urinary excretion of large 
amounts of uroporphyrin and porphobilinogen and in many of their 
animals the development of 'transient paralysis of the hind legs 
and bladder and functional gastrointestinal disturbances', 
reminiscent cf human acute porphyria. The chemical findings cf 
these authors were confirmed, but the difficulty in making a 
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clinical assessment cf rabbits treated with sedormid, which is a 
profound hypnotic, led me to investigate related drugs, one of 
which might produce the same chemical features, but yet be non - 
hypnotic. Such a drug is ally.- isopropylacetamide (Goldberg, 
1953) (henceforward called A.I.A.). This drug has given a 
clearer view of what happens to rabbits affected by a pigment 
dyscrasia, apparently the same as in human acute porphyria. 
Comparison of the effects of these related drugs on the 
porphyrin metabolism of rabbits, together with the similar study 
of certain barbiturates (Section 5), has also allowed the 
definition of a chemical structure which may interfere with normal 
porphyrin formation. Some rabbits receiving sedormid or A.I.A. 
excreted large amounts of porphobilinogen and uroporphyrin, while 
others excreted only small amounts of these materials. A study 
of this difference in individual animals and its relation to 
corresponding differences in the pathological histology of the 
liver and urinary amino -acid excretion has confirmed the import- 
ance of the liver in porphyrin metabolism (Prunty 1945; Watson, 
Schwartz and Hawkinson 1945). 
The occasionally beneficial effect of splenectomy in 
congenital porphyria (Aldrich, Hawkinson, Grinstein and Watson 
1951) suggested a trial of the effect on a rabbit of splenectomy 
between two separate courses of sedormid. 
The type of cells in which porphyrins are normally 
fabricated is unknccm, but the liver is probably of great :import - 
face. An attempt has been made to investigate the role of the 
reticulo- endothelial cells of the liver in the porphyrin metabolism 
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of experimental porphyria by means of the R.E. blockading substance 
thorium dioxide (Gottlieb 1934), although it is doubtful if a 
complete blockade can be achieved. 
For some time the barbiturates have been considered to 
have an adverse effect on patients with acute porphyria. 
Waldenstr'bm (1939) considered that they might precipitate neuro- 
logical manifestations in patients who might otherwise suffer 
only the abdominal symptoms of this disease. For this reason the 
effect was observed of a barbiturate given to an A.I.A.- intoxi- 
cated rabbit already excreting large quantities of porphobilinogen 
and porphyrins. Further to explore any possible relationship 
between experimental porphyria, paralysis and barbiturates, an 
experimental porphyria, with and without the addition of a 
barbiturate, was induced in fowls, animals known to be susceptible 
to metabolic derangement of their nervous system. An experi- 
mental porphyria has also been induced in rats by means of A.I.A. 
METHODS AND MATERIALS 
Rabbits (2 to 4 kg. body weight) were kept in metabolism 
cages, allowing the separate collection of urine and faeces. In 
general, porphyrin and porphobili.nogen determinations were carried 
out on 24 hr collections of urines; in a few cases, 48 hr collect- 
ions were used. Where faecal porphyrins were determined, 2 -, 3- 
or 4 -day specimens were pooled, having been collected daily and 
stored at 2 °G. In most cases, a 4- to 7 -day base -line period was 
allowed before the drug was given. Oral drugs were administered 
once daily by gastric intubation. 
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Urinary, faecal and tissue porphyrin and porphobilinogen 
determinations were C, one as in Section 5. Uroporphyrin in 
tissues was determined, after extraction of ether- soluble por- 
phyrins, by shaking repeatedly with N- ammonium hydroxide until 
extracts no longer exhibited red fluorescence when brought to 
0.5N in HCl. The dissolved uroporphym_in was determined spectro- 
photometrically as in the case of urine. Identification of 
porphyrins by chromatographic methods, melting -point and spectro- 
photometric determinations and haematological measurements were 
carried out as in Section 5. Platelet counts were done by the 
direct method using Rees -Ecker solution (Tvantrobe 1951). 
The isolation of crystalline porphobilinogen and its 
identification by paper chromatography were carried out by the 
methods described by Uestall (1952) or Cookson and Rimington (1954). 
Blood pressure in the rabbits was determined by the method 
of Grant and Rothschild (1934). Four consecutive readings were 
taken under their recommended conditions at the same time each 
morning for several days before the d rug was given and then 
similarly during the course of its administration. 
All rabbits' urines were examined initially, and at the 
end of the drug course for amino -acids by the method of Datta, 
Dent and Harris (1950) . Urines found to contain many amino - 
acids were then further examined by the method of Dent (1948). 
The thorium dioxide used was in a 25. colloidal 




Urine Table 1 summarizes the urinary uroporphyrin 
and porphobilinogen excretion of twenty -three rabbits, intox- 
icated with allyl- isopropyl- acetanide (A.I.A.) (nine rabbits), 
sedormid (six rabbits), propyl- isopropyl- acetamide (three 
rabbits) and allyl-isopropyl-acetic acid (five rabbits). For 
comparison; the results of a similar series, using diallyl 
barbituric acid (Section 5), have been added to the present group. 
A.I.A. and sedormid caused en immediate increase above normal in 
the level of urinary coproporphyrin, mounting rapidly stepwise 
with continued administration of the drug until the 4th to 7th 
day, when porphobilinogen and uroporphyrin were noted in the urine 
(see figures 1 and 2). From this point, the urinary copropor- 
phyrin excretion remained approximately constant, but the porpho- 
bilinogen and uroporphyrin mounted to reach maximum levels 2 to 
3 days later. These drugs were continued in every case except 
two (Nos. 5 and 12) until the rabbit died. In rabbits 5 and 12, 
withdrawal of the drug led to a rapid (within 48 hr.) cessation 
x Urines were heated with 2N acetate buffer pH 4.2 for 20 min. 
at 100CC to convert porphobilinogen present into uroporphyrin 
and the total uroporphyrin then determined spectrophotemetric- 
ally (see Methods). The term 'urinary uroporphyrin' is used 
throughout this paper to indicate the total uroporphyrin so 
measured. 
TABLE 1. EFFECTS OF DRUGS ON URINARY PORPHYRIN AND PORPHOBILINOGEN 
EXCRETION OF RABBITS 
copro- 
uroporphyrin porphobilinogen porphyrin 
(mg /day) (mg /day) (aug /day) 
rabbit dose duration additional 
no. route* (mg /kg /day) (days) mean max. mean max. to normal 
A.I.A. 
1 I.G. 187 14 1.52 2.62 5.3 11.2 289 
2 I.G. 226 11 0.43 1.48 2.7 11.0 264 
3 I.G. 217 8 1.47 3.87 6.3 20.1 272 
4 I.G. 170 13 10.21 18.33 53.7 101.8 292 
5 I.G. 182 23 6.32 15.85 36.8 70.4 342 
6 I.G. 176 8 7.37 12.52 19.8 34.5 203 
7 I.G. 181 12 10.26 17.7 63.6 116.2 188 
8 I.G. 183 5 2.46 7.66 18.81 62.4 217 
9 I.G. 204 13 3.85 13.44 9.05 24.4 125 
sedormid 
10 I.G. 257 9 1.53 5.5 5.4 11.5 120 
11 I.G. 230 9 6.6 19.0 7.4 18.2 182 
12 I.G. 217 11 11.29 27.0 38.0 64.5 94 
13 I.G. 187 8 8.8 15.2 not done 279 
14 I.G. 212 14 1.78 3.8 3.7 9.0 104 
15 I.G. 187 7 2.5 3.2 not done 126 
P.I.A. 
16 I.G. 236 6 - - - nil 
17 I.G. 256 12 - - 5 
18 I.G. 143 7 - - nil 
A.I.Ac. acid 
19 I.G. 372 5 - - - - 5 
20 I.G. . 154 12 - 16 
21 I.M. 193 6 - 10 
22 I.M. 267 9 - 9 
23 I.G. 128 9 - 2 
dial 
24 I.M. or I.G. 113 15 0.36 0.80 0.6 1.24 194 
25 I.M. or I.G. 103 35 1.72 4.75 3.6 12.4 169 
26 I.M. 100 17 025 0.34 0.6 0.84 119 
27 I.M. or I.G. 128 12 - - - - 88 
28 I.M. 102 7 - - 86 
29 I.M. 125 9 - - 84 
30 I.M. 114 7 - - - 51 
31 I.M. 148 7 - - 47 
* I.G. = intragastric; I.M. = intramuscular; A.I.A. = allyl- isopropyl -acetamide; P.I.A. =.n- propyl- 














COPROPORPHYRIN 1,000- - pq /day 
300 - - 
URINARY 
COPROPORPHYRIN 200 - - 
Aq /day 
100 - - 
5 10 15 20 25 30 
DAYS 
Figure 1. affect of sedormid in a rabbit on its excretion of 
urinary porphobilinogen and coproporphyrin and 
faecal coproporphyrin. 130 units of porphobilinogen 
equal 1 mg. of porphobilinogen ( Westall 1952). 
of urinary porphyrin and porphobilinogen excretion and a more 
gradual lessening of coproporphyrin excretion until the former 
normal levels were regained in 4 days' time. No significant 
difference was noted when comparing the pattern of porphyrin and 
porphobilinogen excretion of the sedormid rabbits with that of 
theA.I.A. rabbits, except that one A.I.A.- intoxicated rabbit 
(No. 5) continued to excrete large amounts of these materials for 
3 weeks, a duration not found possible with sedormid rabbits. 
Some rabbits (Nos. 4, 5, 6, 7, 11 and 12) excreted large amounts 
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BLOOD PRESSURE 80 
mm.Hg. 
60 
a-0 Hb. G. 
%a 10 o-o R.B.C. mill. /cmm. - RETIC'S Count % 
BRONCHOPNEUMONIA 
. ........... .. 
......... . 
5 10 15 20 
DAYS 
Figure 2. Effect of allyl- isopropyl- .acetamide in a rabbit on its 
excretion of urinary porphobilinogen and on its body 
weight, systolic blood pressure and haematological 
values. 130 units of porphobilinogen equal 1 mg. of 
porphobilinogen (Westall 1952) . 
of porphobilinogen and uroporphyrin and continued to do so for as 
long as the drug was given (Nos. 5 and 12), or until some inter - 
current cause cf death intervened, e.g. bronchopneumonia in rabbits 
7 and 12 or uraemia in rabbit 4. Other rabbits (Dios. 1, 2, 3 
and 10) reached maximum excretions of uroporphyrin and porphobil- 
inogen at much lower levels and ceased excreting these substances, 
although still maintaining a coproporphyrinuria, 1 or 2 days 
before death from severe hepatic damage. 
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The chemical identification of urinary porphyrins is 
summarized in Table 2. 
n- Propyl -isopropyl- acetamide showed no effect on the 
porphyrin excretion of rabbits, while allyl -isopropyl- acetic acid 
caused slight increases in coproporphyrin excretion above normal 
(more than 5 ,4g /day) in three out of five rabbits tested. 
Faeces Faecal coproporphyrin was determined in six 
rabbits (Nos. 5, 11, 12, 13, 14 and 15) whose daily excretion 
rose from normal (pre -drug) levels of 254, 44, 70, 64, 6 and 
61µg to levels of 495, 315, 942, 473, 1060 and 221 /4g respect- 
ively. In the two animals which survived (Nos. 5 and 12) , 
faecal coproporphyrin levels were determined after the cessation 
of the drug. In No. 5 the average daily coproporphyrin 
excretion for . the first 8 days of this period was 3659/.4g. This 
animal was severely constipated during the drug course, but 
excreted a normal quantity of faeces as soon as the drug was with- 
drawn. The large rise from 495 to 3659 /4g /day was thus probably 
TABLE 2. IDENTIFICATION OF PORPHYRINS. SUMMARY OF RESULTS 
drug material 
free porphyrin a band 
no. of carb- in CHC13 
oxyl groups (nap) 
porphyrin methyl 
ester isomeric 




( °C) summary 
sedormid urine 8 625.3 mainly III 254 -258 uroporphyrin III 
5 622.4 
4 621.2 III - coproporphyrin 
III 
A.I.A. urine 8 625.6 mainly III 247 -261 uroporphyrin III 
plasma* 8 625.0 I and III - uroporphyrin 
III and I 
bile 8 III uroporphyrin III 
4 III coproporphyrin 
III 
2 630.2 protoporphyrin 
* Ether -insoluble fraction only. 
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due to rapid evacuation of the overloaded bowel. In rabbit 
No. 12 constipation was less marked, and the faecal coproporphyrin 
fell from a mean of 602 "g /day on the last 3 days of the drug 
course to 202,ccg /day on the 3 days following the cessation of 
dosage. 
In the course of these determinations it became evident 
that the faecal protoporphyrin was considerably raised. The 
quantitative extraction of this porphyrin was rendered unsatis- 
factory by the presence of large amounts of chlorophyll -type 
pigments in the stool. 
Bile Increased coproporphyrin and protoporphyrin levels 
were found in the bile of all rabbits showing an increased urinary 
coproporphyrin excretion (see Table 3). In six rabbits 
intoxicated with either A.I.A. or sedormid, an ether -insoluble 
porphyrin was obtained. On spectrophotometric examination in 
0.5 N -N01 this porphyrin had a maximal absorption at 405 mfc . 
It was further investigated by chromatographic methods and shown 
to be uroporphyrin III. The coproporphyrin was identified by 
paper chromatographic methods as of the series III type (see 
Table 2) . 
Plasma In three rabbits (Nos. 4, 7 and g) the plasma or 
serum at post -mortem showed red fluorescence. In one of these 
(No. 4) this was found, by further investigation, to be due to 
coproporphyrin and uroporphyrin III with some uroporphyrin I 
(see Table 2). 
Tissues (see Table 3) The coproporphyrin and proto- 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































proportional to tho degree of porphyrin increase in the urine. 
In A.I.A.- and sedormid- intoxicated rabbits, the spleen, marrow 
and kidney coproporphyrin and protoporphyrin were slightly raised 
above normal, but not to the same degree as in liver and bile. 
In rabbit 4, portions of skeletal muscle tissue showed marked 
porphyrin fluorescence. Two upper incisor teeth which had 
accidentally been broken at the beginning of the experiment grew 
to their previous length in 1 week. At post -mortem examination, 
the roots of these teeth had porphyrin fluorescence. Rabbit 16 
(n- propyl- isopropyl- acetamide) had no porphyrin increase in any 
tissue. Rabbits 19, 21 and 22 (ally' -isopropyl- acetic acid) had 
small increases in liver and bile coproporphyrin and protoporphyrin, 
while marrow coproporphyrin and protcporÑhyrin were also slightly 
raised in rabbit 22. 
Porphobil.inogen 
Urine Porphobilinogen was isolated from rabbit urine by 
the method of Triestall (1952) or that of Cookson and Rimingtcn 
(1954) and found to be identical in all respects with porpho- 
bilinogen from acute porphyries urine. 
Plasma In four rabbits (Nos. 1, 4, 7 and 8) the blood 
plasma tested qualitatively for porphobilinogen (Vahiquist 1939) 
at the height of the induced attack, or at post -mortem, gave a 
positive result. In the case of rabbit 8, a spectrophotometric 
extinction curve was also obtained showing maxima at 527 and 
556 mtu., characteristic of the product of porphobilinogen and 
Ehrlich's aldehyde reagent. The concentration of plasma porpho- 
bilinogen in rabbit 4 post -mortem was 105/xg /ml. (for quantitative 
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determination of porphobilinogen see Westall (1952)) . 
Tissues In five rabbits there was a positive porpho- 
bilinogen reaction in the liver; in three of these it was also 
positive in the kidney. Faeces, brain, bile, spleen and marrow 
were negative for porphobilinogen, with the exception that in 
rabbit 8 traces of porphobilinogen were present in spleen and 
marrow. In this animal the plasma porphobilinogen was strongly 
positive, and . these trace reactions could have been derived from 
the blood which its spleen and marrow contained. 
Urinary amino -acids 
These were identified in ten rabbits (A.I.A.- or sedormid- 
intoxi cated) by moans of paper chromatography. Normal rabbit 
urine (10 to 15 /41. in method of Datta et al. (1950) and 15 to 
25/1. in method of Dent (1948)) shows only a glycine spot. In 
rabbit 14 no abnormality was detected at the end of the drug course. 
In five rabbits, all high excretors of uroporphyrin and porpho- 
bilinogen (Nos. Z -, 5, 6, 7 and. 12) , the glycine spot at the end 
of the course was markedly reduced in intensity from that before 
the drug was given. In rabbits 4 and 6, this diminution was 
established by an approximately quantitative experiment. Volumes 
of urine, from before and at the end of the drug course, correspond- 
ing to the same fraction of the total daily urine output, were 
placed on to the same paper chromatogram and developed by either 
phenol or butanol acetic acid respectively, in a one -dimensional 
run. The dilution of the stronger urine necessary to match the 
weaker was assessed and confirmed experimentally by further 
chromatographic runs. This experiment showed administration of 
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FIGURE 3. Urinary amino -acids of rabbit 1 on last day of experiment. 













FIGURE 4. Urinary amino- acids of rabbit 10 on last day of experiment. 
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the drug in both animals to have caused at least fourfold 
reduction in urinary excretion of glycine. Rabbits 1, 10 and 
12 (all poor excretors of uroporphyrin and porphobilinogen) voided 
many amino-acids at the end cf the drug course, the day before 
death, viz: - 
Rabbit 1 excreted taurine, alanine, glutamic acid, 
glutamine, ethanolamine phosphate and glycine (see figure 3). 
Rabbit 10 excreted glutamic acid, glycine, 04-amino 
butyric acid, lysine, threonine, taurine, small amounts of 
histidine, methyl histidine, arginine, serine and a trace of 
leucine (see figure 4). 
Rabbit 12 excreted glutamic acid, glycine, alanine, 
taurine, threonine, .alanine, histidine, trace valine, trace 
tyrosine, leucine and some aspartic acid. 
CLINICAL FINDINGS OF A.I.A.- AND S;DORUID- INTOXICATED RABBITS 
Neurological 
Rabbits intoxicated with sedormid differed from those 
treated with A.I.A. Sedormid proved to be a profound hypnotic, 
the animals remaining unconscious for about 10 hours after each 
dose of the drug. Those treated with A.I.A. never lost con- 
sciousness, but a few appeared slightly dazed for about 1 to 
1.5 hours after the administration of the drug. It was thus very 
difficult to evaluate the claim of Schmid and Schwartz (1952) 
that sedormid- treated rabbits exhibited paralysis or paresis. 
Using A.I.A. alone, limb paralyses or pareses never occurred, and 
these rabbits remained normally mobile and active even though 
excreting amounts of uroporphyrin as high as 7 mg/day or more for 
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many days; rabbit No. 5 maintained an excretion near this level 
during an entire 3 weeks' course of the drug. 
Gastro -intestinal 
appetite and weight Both groups quickly developed a 
relative anorexia; they left most of their pellet (M.R.C. No. 18, 
Bruce and Parkes 1946) diet, but usually ate cabbage and drank 
sufficient water to maintain their normal urinary volume. The 
rabbits lost weight steadily; mean daily losses for those on 
A.I.A. being 52 g (six rabbits tested), and for those on sedormid 
36 g (five rabbits tested). In the case of rabbit 5, normal 
appetite returned the day following cessation of the drug (A.I.A.), 
and the body weight gradually rose to its previous level. 
Faeces Rabbits .of both groups became quickly constipated. 
Thus average daily faecal weights were recorded of 87 g before and 
17 g during the administration of A.I.A., and of 60 g before and 
25 g during the administration of sedormid. In most rabbits this 
drop took place the day following the first dose of the drug. 
The stool weight of rabbit 5 rose from an average level of 4 g /day 
during the period of drug administration to 89 g /day on the second 
day after withdrawal of the drug. 
Straight X -ray of the abdomen was done on two rabbits 
before and at weekly intervals during A.I.A. administration. In 
one (No. 1) no difference was observed, while in the other (No. 5), 
a progressively increasing gaseous distention of loops of bowel 
was revealed. This appearance gradually returned to normal on 
withdrawal of the drug. 
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Bl od 2 ensure 
Table 4 summarizes the results of systolic blood -pressure 
readings of four rabbits intoxicated with 11.I.1.. It is difficult 
to presume any significant change of blood pressure consequent on 
drug administration. The systolic blood pressure of rabbit 10 
maintained a steady level, averaging 73 mm.Hg in the first 6 days 
of its sedormid course, during which there was a mounting excret- 
ion of coproporphyrin and later of uroporphyrin and porphobilino- 
gen. On the 7th, 8th, 9th and 10th days, the blood pressure fell 
to 38, 42, 40 and 14 mm.Hg respectively, during which time there 
was a fall of porphobi l inogen and uroporphyrin excretion, although 
the drug was maintained at the same dose. The rabbit died on 
the 10th day; post -mortem examination revealed hepatic necrosis. 
TABLE 4. SYSTOLIC BLOOD PRESSURE OF RABBITS WITH EXPERIMENTAL 
PORPHYRIA 
mean mean daily B.P. 
uroporphyrin (systolic) (mm Hg) 
excretion 
rabbit no. (mg /day) before drug during drug 
1 1.62 '78 85 
3 1.47 64 69 
5 6.32 81 74 
7 10.26 83 78 
Haematological 
The results of serial haematological determinations in 
five rabbits are summarized in Table 5, together with total loss 
of porphyrin in the urine during the course of the experiment. 
One animal (No. 5) provided data for porphyrin loss in both urine 
and faeces. The determinations of Hb., R.B.C. and reticulocytes 
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TABLE 5. COMPARISON OF HAEMATOLOGICAL RESULTS AND TOTAL PORPHYRIN 
EXCRETIONS ADDITIONAL TO NORMAL, OF 5 RABBITS TREATED WITH ALLYL- 
ISO-PROPYL-ACETAMIDE NOS. 1, 4, 5 AND 7) AND SEDORMID (NO. 10) 
total faecal 
copro- copro- 
total porphyrin porphyrin 
uro- loss loss 
duration reticu- porphyrin additional additional 
rabbit of drug Hb. R.B.C. locytes loss to normal to normal 
no. (days) (g %) (108 /mm3) ( %) (mg) (mg) (mg) 
1 14 before 10.64 4.10 2.5 21.24 4.05 - 
after 11-77 4.25 1 
4 13 before 13.61 4.90 1 122.5 3.66 - 
after 14.28 4.77 1 
5 23 before 13.31 5.77 2.5 139 7.87 28.65 
after 13.77 5.05 1 
7 12 before 10.88 4.55 1 92.2 2.58 - 
after 11.42 4.71 1 
10 9 before 13.2 5.29 0.75 10-71 1.36 - 
after 13.2 5.19 1 
showed no significant variation. Determinations of blood plate- 
lets and clot retraction on two rabbits before and during sedormid 
administration also showed no significant change. 
Dermatological 
The rabbits showed no evidence of photosensitivity although 
in a normally bright room. The sedormid skin patch test of 
Ackroyd (1949) was applied for 48 hours to the shaved skin of 
the inferior dorsal area of rabbit 11, during its course of sedor- 
mid. There was no skin reaction to this test. 
Effect of barbiturate 
The effect was observed of a small dose of a barbiturate 
on a rabbit (No. 4; 3.3 kg) already excreting high levels of 
uroporphyrin and porphobilinogen under the influence of 
intoxication. 100 mg of sodium allyl -(1- methyl butyl)- barbit- 
urate was injected intramuscularly on the 14th day of the drug 
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course. The rabbit remained unconscious for the next 24 hours. 
In normal rabbits the same dose relative to body weight of this 
barbiturate caused only slight transient sedation. By the next 
day the rabbit had recovered and seemed alert, but the day 
following it lapsed into a weak paretic state, described more 
fully below. 
Mode of death 
Histooatholoçy of tissues In rabbits 1, 3, 10 and 13, 
post -mortem examination of tissues was normal apart from hepatic 
necrosis. Rabbit 2 at post-mortem had mid -zone degenerative 
changes, such as vacuolation and haemorrhage, in the liver. 
These five rabbits had become obviously weaker in the 2 days 
before death, and in rabbit 10 this was accompanied by a fall in 
systolic blood pressure. Rabbits 2 and 3 were found dead in 
their cages, but rabbits 1, 10 and 13 showed a similar mode of 
exitus. They all had tremor of limbs and violent convulsions, 
and in rabbit 13 there was marked opisthotonos lasting 15 to 30 
min. before death. 
Rabbits 7 and 12 became weak and dyspnoeic and developed 
a purulent nasal discharge the day before death. At post -mortem 
examination, bronchopneumonia was noted and confirmed micro- 
scopically. y Rabbit S was apparently normal until the day of 
death, when it became weak, with drooping head, and with a mucoid 
discharge from eyes and nose. This rabbit died during intubation. 
At post -mortem the liver and kidneys were pale, and histological 
examination revealed vacuolation of the peripheral cells of the 
liver lobules and of the convoluted tubular epithelium of the 
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kidneys. The lungs showed a patchy bronchitis with foci of 
collapse and pulmonary oedema. The clinical diagnosis of rabbit 
'snuffles' (Pasteurella septica) was not confirmed bacteriologic- 
ally. 
Rabbit 4, which had been given an injection of barbiturate 
(see above), became very we with paresis of neck and limb 
muscles 2 days following this injection, after having recovered 
from its hypnotic effect. The urinary volume had decreased, but 
the urine contained no protein and merely an occasional erythro- 
cyte on microscopic examination. There was absence of pain 
sensation in the right hind leg, but electromyography of the limb 
muscles by Dr. O. Lippold, University College, failed to reveal 
any abnormality. The rabbit's condition deteriorated and 2 days 
after the onset of this state it was sacrificed, bled and 
immediately perfused with 10% formol saline to allow investigation 
of the nervous system. Dr. J.C.B. Fenton, Dept. of Pathology, 
University College Hospital, examined these tissues. Myelin 
changes were observed in the peripheral nerves of this animal, 
but they were considered to be atypical of true myelin degener- 
ation and could be attributed to causes other than the action of 
the drug, e.g. fasting and dehydration. The blood plasma was 
markedly opalescent. Table 6 shows the results of blood and plasma 
examinations, for which I am indebted to Dr. F.V. Flynn, 
Department of Clinical Pathology, University College Hospital. 
A lower nephron nephrosis (with consequent uraemia) was indicated 
by the microscopic finding of tubular distension with flattened 
epithelium and fatty vacuolation of some of the convoluted tubules 
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of the kidneys. The liver showed minor periportal fatty changes 
without evidence of necrosis. 
TABLE 6. BLOOD ANALYSES OF RABBIT 4 (A.I.A. + BARBITURATE) COMPARED 
WITH NORMAL LEVELS 
plasma cholestrol (mg %) 
blood urea (mg %) 
plasma potassium (m.eq /1.) 









4.5 -5.5 (20) 
140 (20) 
Of the remaining five rabbits, nos. 6, 11 and 15 died 
within half an hour after intubation, and post -mortem examination 
failed to show any histological abnormality. Rabbit 9 became 
weak, with deep, laboured respiration on the day before its death. 
Histology of its tissues was normal. Rabbit 14 did not recover 
from the hypnotic effect of its dose of sedormid. Again, post- 
mortem histological examination was normal. 
SP ENLCTOMY 
In rabbit 12, a period of 3 weeks rest was allowed after 
a course of sedormid lasting 11 days. A splenectomy was then 
performed, and the following day the rabbit was started on a second 
course of sedormid with the same dose as in the initial course. 
Porphobilinogen and uroporphyrin were noted, in addition to 
increased coproporphyrin, on the 2nd day of drug administration 
and rose gradually until a daily level of 9.5 and 2.2 mg. of 
Porphobilinogen and uroporphyrin, respectively, were obtained 
after 1 week. The rabbit then died and was found at autopsy to 
have bronchopneumonia. 
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EFFECT OF RETIOULO-EDDOThILIAL BLOCKADE 
Table 7 summarizes the results of sedormid intoxication 
in the rabbits (Nos. 32, 33 and 34) which had a simultaneous 
reticulo- endothelial blockade by thorium dioxide. In two of 
these rabbits a splenectomy had been performed before the block- 
ade, in order to increase the concentration of thorium dioxide 
in the liver. 
Rabbit 32 showed no change in blood haemoglobin concen- 
tration, erythrocyte, reticulocyte and platelet counts, but did 
develop a leucocytosis, from 3000 /mm3 to 13,400/mm3, and a 
diminished clot retraction at the end of the experiment. This 
rabbit also developed an abnormal urinary amino -acid pattern, from 
a solitary glycine spot before the experiment to an excretion of 
glutamic acid, glycine, taurine, glutamine and histidine before 
death. At post -mortem examination there was marked hepatic 
necrosis. Rabbit 33 survived the full course of the experiment, 
but 20 days later, when the same dose of sedormid was repeated, 
the rabbit g=ent into profound coma from which it did not recover. 
The liver parenchyma at post -mortem examination appeared healthy. 
Rabbit 34 was found dead in its cage; there had been some 
infection of the splenectomy wound. Microscopic examination of 
the livers of rabbits 32 and 33 showed the presence of thorium 
dioxide mainly in the Kupffer cells, but also in small amounts 
throughout the hepatic cells. 
A further experiment was carried out on a normal rabbit 
in which an external bile fistula had been performed. Adminis- 


























































































































































































































































































































































































































































































































































































































































































































































experiment did not cause any fall in the levels of bile porphyrins 
and urinary porphyrins. 
£P,REENTS ON FOWLS 
A.I.A. in gelatin capsules Was administered to two Rhode 
Island Red chickens, each weighing 2 kg. No. 1 received the 
drug for 18 days and No. 2 for 17 days. Chicken 2 was also given 
injections of sodium allyl- (1- methylbutyl)- barbiturate (seconal) 
in a mean daily dosage of 37 mg. during the final 7 days of its 
drug course. 
Porp d hyrrin an porphobilino, en excretion In both animals 
there was an immediate rise in the coproporphyrin and protopor- 
phyrin content of the excreta. Porphobilinogen and uroporphyrin 
were noted on the 4th and 7th day respectively (see Table 8). 
Chicken 1 excreted greater amounts of porphobilinogen and uro- 
porphyrin than chicken 2. The porphobilinogen was identified by 
means of paper chromatography ( Westall 1952) as being identical 
with that isolated from the urine of a case cf acute porphyria. 
Among the porphyrins contained in the excreta, uroporphyrin III 
and coproporphyrin III were identified by means of paper chroma- 
tography (see Methods). 
Clinical and pathological results Both chickens were 
active throughout the course of this experiment, although they 
lost an average of 30 g. weight daily. The weight of their 
excreta progressively diminished. Their Hb. and R.B.C. levels 
did not alter throughout the experiment. Towards the end of the 
experiment, both chickens became weak and lethargic, although 
frank paralysis was not seen. They were sacrificed by means of 
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nembutal intravenously, bled and infused through the aorta with 
10` formol saline. The examination of their nervous system by 
Dr. J.C.B.Fenton did not show myelin degeneration. Iistological 
examination of the kidneys of both these fowls showed subnuclear 
vacuolation in the convoluted tubules. The liver of chicken 
No. 1 was normal and contained porphobilinogen, but that of No. 2 
showed cellular necrosis and contained no porphobilinogen. 
E^ `E ?If°ii i','i S OH RATS 
Nine Wistar strain albino rats (175 to 204 g) were placed 
in metabolism cages, allowing the separate collection of urine and 
faeces. After a preliminary baseline period of 3 days, they 
were given A.I.A. by means cf gastric intubation through a blunted 
metal needle (size: internal diameter 18 s.w.g. (0.048 in.)) 
external diameter 15 s.w.g. (0.072 in.)) attached to a glass 
syringe. The A.I.A. powder had previously been thoroughly ground 
up in a mortar and suspended in ' cellophas' (I.C.I.) (1 part) 
and Crater (4 parts). A useful concentration of the drug was 
100 mg; ml. of suspension. It was found that the appropriate 
dose in these rats was about 100 mg /day (400 to 500 mg /kg.). 
Porphyri.n and porphobilinogen excretion (see Table 9) . 
The nine rats showed an immediate rise in urinary coproporphyrin. 
In rat 6 faecal porphyrins were also determined. The increase 
in ether -soluble porphyrins in the faeces greatly exceeded that 
in the urine, e.g. rat 6 had a mean daily increase of urinary 
coproporphyrin of 54 f[g, the rises in daily stool coproporphyrin 
and protoporphyrin being 115 and 436kg respectively. Seven rats 








































































































































































































































































































































































































































































































































































































































































5), 6th (rat 6) or 11th (rat g) day of drug administration. The 
mean level of porphobilinogen excretion was about 2 mg /day, but 
rat 2 had persistently high levels reaching a maximum of 15.2 
mg /day. Freshly voided urine, containing porphobilinogen, was 
normally coloured and had no porphyrin fluorescence. Spectro- 
photometric examination of this fresh urine showed no evidence of 
any pref orr ed uroporphyrin. It darkened on standing and became 
fluorescent, although these changes were not so marked as in the 
rabbit urines. Small quantities of porphobilinogen were found 
in the rat's stools. 
Two rats (Nos. 7 and 9) excreted no porphobilinogen, 
although there was a rise in urinary coproporphyrin. Throughout 
the experiment they became progressively weaker, and by the 6th 
and 8th day, respectively, were on the point of death, when they 
were sacrificed (see below). 
The porphyrin excreted in the urine was defined as copro- 
porphyrin series III by means of paper chromatography (see 
Methods). Porphobilinogen was isolated from the urine as 
characteristic crystals using the method of Cookson and Rimington 
(1954). 
Clinical and pathological results All rats showed some 
loss of weight (mean loss 2.5 g /day) and diminished appetite, 
although not as severely as did rabbits. They did not have the 
profound constipation noted in most rabbits, although in some 
rats there was a diminution in stool weight from a normal mean 
5 g /day to a mean of 3.1 g /day. They appeared to be more dazed 
than the rabbits for several hours after A.I.A. administration. 
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There was no clinical evidence of paralysis. During the course 
of the experiment, rats 1 and 2 were each exposed to a carbon arc 
lamp at 1 ft. distance on two separate occasions, lasting 15 and 
30 min. respectively. Neither rat showed any sign of photo- 
sensitivity. The clinical course of rats 7 and 9 has been 
described. The other seven rats remained mobile and alert. They 
were sacrificed at the end of the experiment. Chemical analysis 
of tissues is summarized in Table 10. Those rats excreting por- 
phobilinogen in the urine had porphobilinogen in the liver, while 
rats 7 and 9 had porphobilinogen neither in their urines nor livers. 
Histology of the livers in those rats excreting porpho- 
bilinogen was normal. The liver of rat 7 showed fatty degener- 
ation, but that of No. 9 was histologically normal. Amino-acid 
chromatograms of the urines, before and at the end of the experi- 
ment, were done in rats 1, 2, 3, 4, 5, 7 and 10. No change in 
the amino-acid pattern was noted. Histological examination of 
the nervous system of rats 1, 2, 3 and 4 by Dr. J.C.B. Fenton 
did not show myelin degeneration. 
DISCUSSION 
A question, important to our understanding of human acute 
porphyria, is whether or not the known porphyrins or their 
precursors, or unknown substances, released by the pigment 
dyscrasia, cause the clinical symptoms of this disease. The 
work on the pharmacological action of carefully purified porphyrins 
and porphobilinogen (Section 4) afforded no evidence for any 
direct action of these substances, and the finding that porpho- 
bilinogen is probably a normal precursor of porphyrins and haem 
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(Falk, Dresel and ï- .imington 1953) renders less likely the former 
assumption that the symptomatic disturbances in acute porphyria 
were due to porphobilinogen. The work of Schmid and Schwartz 
(1952) suggested a direct association between the chemical dis- 
turbance induced by sedormid and the gastro -intestinal and 
neurological symptoms which they observed in rabbits. In the 
present observations, however, the hypnotic action of sedormid 
obscured the clinical features of the rabbit porphyria. A11y1- 
isopropyl- acetamide allows an experimental porphyria without 
hypnosis. The separation of these two properties, excess porphy- 
rin and porphobilinogen production and hypnosis, is in itself 
noteworthy, since some of the most potent drugs disturbing porphy- 
rin metabolism, e.g. sulphonal, trional, sedormid and certain 
barbiturates, are hypnotics. 
Using either sedormid or h.I.1s., I have confirmed the 
association of the chemical and gastro-intestinal features of 
experimental porphyria, but have failed to observe any paralyses, 
with one exception (rabbit 4) where a barbiturate was given in 
addition to A.I.A. The clinical and histo-pathological pictures 
were here complicated by uraemia. In order to study this point 
more fully, experiments were carried out on fowls, animals 
particularly susceptible to metabolic derangement of the nervous 
system. Fowl 2 was given a barbiturate in addition to A.I.A. 
In these animals there was no evidence, clinical or histopatholog- 
ical, cf any selective damage to nervous tissues. The experiments 
in which rats were intoxicated with Â.I.A. showed that, in spite 
of high levels of porphobilinogen and porphyrin excretion in the 
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urine, the animals remained normally mobile and alert, and histo- 
pathological examination of the nervous system revealed no lesion. 
Another point of dissimilarity between rabbit experimental 
porphyria and human acute porphyria is the absence of hypertension, 
although this is a common finding in acute porphyria. The 
question may be asked, how relevant to the human disease are the 
results of the experimentally produced porphyria in animals': It 
can be argued that if an animal is exposed to a chemical porphyria 
for little more than 3 weeks, this may not be sufficient time to 
produce the clinical manifestations of the human disease, since 
in man the metabolic abnormality may be of long standing before 
the onset of symptoms. Sulphonal, however, may precipitate an 
acute porphyria in man within 5 - 20 days (Header, 1896; 
Erbslbh, 1903; Pförtner, 1914) . 
The haematological data agree with the normal blood levels 
obtained in active phases of human acute porphyria. It must be 
emphasized that these figures are concentration levels, and blood 
volumes, which might alter in the progressive wasting states of 
these rabbits, were not measured. Courtice and Gunton (1949) 
have noted an increase in the plasm, volume of rabbits in which 
cabbage was added to the normal diet. On the other hand, 
Henschel, nekelson, Taylor and Keys (1947) have shown that the 
absolute plasma volume increased slightly in a group of thirty= 
two men undergoing a period of semi -starvation in which about one - 
quarter of the body weight was lost, approximately the same 
proportion as lost by the rabbits studied. If the latter findings 
are applicable to the present experiments, they would suggest that 
106 
the undiminished haemoglobin concentration levels in the rabbits, 
implied, at least, maintenance of the total amount of haemoglobin 
throughout a period during which large quantities of porphyrins 
were excreted. Table 11 attempts to estimate the ratio of daily 
porphyrin loss to normal daily protoporphyrin formation in three 
of these rabbits (Nos. 4, 5 and 7). This ratio is about 1 to 2. 
It is suggested that if the porphyrin excretion represented a 
deviation of porphyrin from normal haem production, this would 
have resulted in a recognizable anaemia. Drabkin (1951) has 
suggested that the porphyrins excreted in the human porphyries 
might be the result of an 'under -utilization' owing to diminished 
globin supply, rather than of an 'overproduction' of these pig- 
ments. The findings in this rabbit porphyria would point to an 
'overproduction' rather than an 'under -utilization'. Another 
factor strengthening this view is the diminished urinary glycine 
excretion noted by paper chromatography in those rabbits (Nos. 4, 
5, 6, 7 and 12) with the high total porphyrin output of 126, 147, 
38, 95 and 88 mg, respectively, during the periods under consider- 
ation. 
TABLE 11. ESTIMATED RATIO (EXPRESSED AS A PERCENTAGE) OF DAILY PORPHYRIN 
EXCRETION TO NORMAL DAILY PROTOPORPHYRIN FORMATION IN 3 RABBITS 
TREATED WITH A.I.A. 
The normal daily protoporphyrin formed was calculated from the following data: (a) blood 
volume in the normal rabbit is 70 ml /kg (6) and (b) average life span of the rabbit erythro- 
cyte is about 68 days (22). (c) haemoglobin level as determined at commencement of 




body probable porphyrin porphyrin porphyrin loss ° 
rabbit weight blood formed loss normal porphyrin (fO) 
no. (kg) volume (mg /day) (mg /day) formation 
4 4.12 288 19.6 9.8 50.0 
5 3.69 258 17.7 7.65 43.3 
7 3.14 220 15.0 7.9 52.7 
Such a diminution of glycine excretion was not observed 
in other rabbits treated with the same drugs, nor in rabbits 
treated with certain barbiturates (Section 5) where the total 
porphyrin excretion was much less. This suggests that in the 
high porphyrin excretors there was some encroachment on the glycine 
pool; but there is, however, still the possibility (in rabbit 4) 
that the diminished glycine excretion is due to renal failure, 
for it is known that in the human, amino -acid excretion in the 
urine decreases in renal failure (Dent 1954). Glycine is known 
to be a precursor of porphyrin (Shemin and Rittenberg 1946). 
Amino -acid chromatography was carried out on the urines of 2 
patients in the active phase of acute porphyria. No abnormality 
was detected. It is of interest that one patient (Case io. 4) 
had a diminished hippuric acid synthesis. It is possible that 
this was causedbyalowered level of the glycine pool. 
Table 12 groups together and compares six 'good porphyrin 
excretors' (above 6 mg uroporphyrin /day) and four 'poor 
porphyrin excretors' (below 2 mg uroporphyrin /day) . These ten 
animals, out of a series cf fifteen treated with A.I.A. or 
sedormid, clearly fell into two groups. The comparison of these 
groups emphasizes the role cf the liver in the production of 
porphobilinogen. All poor excretors had pathological evidence 
of severe hepatic damage and porphobilinogen was not present in 
the livers. The pronounced amino- aciduria might be an expression 
of this hepatic damage. On the other hand, the livers of good 
excretors showed either normal parenchymatous tissue or minor 
changes, with porphobilinogen present in four out of five examined. 
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4 10.21 glycine 
diminished 
+ + + minor periportal fatty 
change 
5 6.32 glycine 
diminished 
animal still on drug after 23 days 
6 11.62 glycine 
diminished 
some fatty change, no 
necrosis 
7 10.26 glycine 
diminished 
0* parenchyma normal 
11 6.6 not determined + ++ parenchyma normal 
12 11.29 glycine 
diminished 
+ ++ parenchyma normal 
1 1.52 many present 0 cellular necrosis 
2 0-43 not determined 0 mid -zone degenerative 
changes 
3 1.47 many present 0 cellular necrosis 
10 1.53 many present 0 cellular necrosis 
* No drug given during last 2 days of life. Died from bronchopneumonia. 
The significance of the diminished urinary glycine spot in tl,.e$e 
good excretors has been discussed. The importance of the liver 
in porphyrin metabolism has been emphasized previously (Prunty 
1945; Watson et al. 1945). The marked fall in the urinary 
excretion of porphobilinogen and porphyrin 1 to 2 days before 
death of the 'poor excretory' suggests a failure of synthetic 
activity in the liver due to progressive intoxication. These 
findings also suggest that the difference between good and poor 
excretors lies in the inherent ability of the liver of an individ- 
ual rabbit to deal effectively with the drug or sedormid). 
One might speculate upon the possibility of this difference 
being genetically determined, and draw a comparison with human 
acute porphyria in which a genetically determined aberration of 
metabolism (probably affecting the liver) is known to exist. 
Of the remaining five rabbits, three could. not be classed 
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as 'goods or spoor' excretory owing to lack of adequate data 
(Nos. 9, 14 and 15); one (o. S) died from an infection before 
maximum porphyrin levels were reached, and the remaining rabbit 
(No. 13) would have been classified as a good excretor (8.8 mg 
uroporphyrin/day) had it not died with hepatic necrosis 6 days 
after the cessation cf sedormid administration. 
In attempting a comparison between human acute porphyria 
and experimental porphyria in the rabbit, emphasis has so far 
been laid on the difference between these two states. There are, 
however, certain similarities, viz. the chemical similarity of 
the porphyries and porphobil.inogen excreted, the relatively 
undisturbed blood picture and the constipation, the gaseous 
distension seen radiologically (Mason, Courville and Ziskind 
1933), although it cannot be excluded that the gastro- intestinal 
symptoms in the rabbit might be a direct result of the drug 
employed. The histological changes in the liver, where any such 
have occurred, are more severe than those usually described for 
human acute porphyria. On the other hand, several rabbit livers 
were histologically normal, just as in many cases of human acute 
porphyria. Certain drugs containing allyl groups are known to 
be hepatoxic (Popper 1936; Section 5), and this must be 
considered in relation to the pathological changes seen in some 
of the rabbits. The histological changes in the renal tubules 
of rabbits 4 and 8 are reminiscent of the lower nephron nephrosis 
described by Prunty (1946) in a human case of acute porphyria. 
Bronchopneumonia, common as a final cause of death in acute 
porphyria, occurred in two rabbits. 
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TABLE 13 Chemical Structure and Effect of Certain Drugs on The 
Porphyrin Metabolism of Rabbits 
i- 













































Very marked effect (much coproporphyrin, porphobilinogen 
and uroporphyrin). 
Marked effect (much coproporphyrin, some porphobilinogen 
and uroporphyrin in three out of eight rabbits). 
Moderate effect (coproporphyrin only) . 
Slight coproporphyrin rise only. 
No effect. 
Table 13 presents the chemical structures of the drugs used 
and their effects on the porphyrin metabolism of rabbits. Froni 
this summary it may be concluded that at least one allyl group, 
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together with an acid amide, ureide or a cyclic ureide, as in the 
barbiturate series, is the constant chemical structure in the 
compounds found to be effective. 
The results of the experiments using reticulo- endothelial 
blockade by means of thorium dioxide agree with the work of 
Vannotti (1937), who found that a preliminary reticulo- endothelial 
blockade did not diminish porphyrin excretion in normal rabbits, 
but decreased porphyrin formation in lead -intoxicated rabbits. 
The three rabbits in the present experiment behaved as 'poor 
excretors'. This might be due to the effect of thorium dioxide 
on the Kupffer cells or the hepatic cells. It is possible, how- 
ever, that all three of these rabbits would have been 'poor 
excretors' even without thorium dioxide. 
The results of splenectomy in rabbit 12 indicate that 
p orphobilinogen, uroporphyrin and coproporphyrin can be formed in 
the absence of the spleen. 
The porphyria induced by A.I.A. in rats showed a certain 
similarity to that in the rabbits, although points of difference 
were also noted. The distinction between 'good excretors' and 
'poor excretors' was more clearly evident in rats than in 
rabbits. The rats tolerated a relatively higher dose of A.I.A., 
were much less constipated than the rabbits and showed no change 
in their urinary amino -acid patterns. Both the rat and rabbit 
illustrate that, as in the normal animal, the main route of 
excretion of the ether -soluble porphyrins is in the faeces. The 
main route of excretion of porphobilinogen appears to be the 
urine, although small amounts are excreted in the stool. 
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All the drugs used in this investigation (with the 
exception of the barbiturates) were most generously provided by 
the Hofmann La Roche Go., Basie. 
SUMMARY 
The chemical findings of Schmid and Schwartz (1952) in 
experimental porphyria of rabbits induced by sedormid have been 
confirmed. 
Since sedormid is hypnotic, a group of related drugs 
has been tested to find one which might produce the chemical 
picture in animals without hypnosis. Such a drug is allyl- 
isopropyl- acetamide (A.I.A.). In this investigation, the 
constant chemical structure affecting porphyrin metabolism was 
found to be 0112= 0H- CH2- CHR- CO-NH- . Some rabbits excrete large 
amounts of porphobilinogen and uroporphyrin when given either 
sedormid or A.T.A., others produce little. It is suggested 
that the cause of this difference is related to a variability 
of the individual rabbit liver to deal effectively with these 
drugs. 
Rabbits, intoxicated with either drug, became constipated, 
had poor appetite and lost weight. They did not become 
paralyzed, nor show any change in systolic blood pressure or in 
their haematological values. Two fowls, one also given a 
barbiturate, and nine rats were intoxicated with allyl-isopropyl- 
acetamide. Although these animals excreted relatively high 
levels of porphobilinogen and porphyrins, they did not develop 
paralysis. 
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The experimentally induced porphyria in animals is 
compared with human acute porphyria. The effects are described 
of reticulo- endothelial blockade, spienectomy and barbiturate 
administration on porphyria induced experimentally in rabbits. 
Experimental porphyria appears to be due to an over- 
production of porphyrins, rather than to an under- utilization of 
porphyrin pigments. 
7 
THE RENAL EXCRETION OF 
PORPHOBILINOGEN IN MAN AND ANIMALS 
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7. THE RENAL EXCRETION OF PORPHOBILINOG ;N IN MAN AND ANIMALS 
Introduction 
Porphobilinogen is excreted in the urine in large 
quantities in acute porphyria and is always found in the livers 
of fatal cases of this disease. In experimental porphyria in 
animals induced by sedormid (allylisopropylacetylurea) or allyl- 
isopropylacetamide, porphobilinogen is likewise found in the urine 
and liver. 
Westall (1952) isolated porphobilinogen in crystalline 
form, an achievement which allowed an adequate experimental study 
of this substance. The fate of porphobilinogen administered to 
the rat was recorded, and this led to observations on the renal 
clearance of endogenous porphobilinogen in patients with acute 
and latent porphyria. These studies suggested that in both 
experimental porphyria and in acute porphyria, the liver is the 
site of formation of the porphobilinogen excreted in the urine. 
7A. FATE OF PORPHOBILIRTOGEN, ADMINISTERED ENTERALLY OR 
PARENTERALLY, IN THE RAT 
Previous reports on the behaviour of porphobilinogen when 
administered to experimental animals are conflicting, probably 
because the porphobilinogen used was only partially purified or 
was available in amounts too small for adequate investigation. 
Thus LJaldenstrIk and Wendt (1939) injected partially purified 
porphobilinogen into rabbits and found it to be excreted in the 
urine, while Prunty (1945) failed to find any in the urine under 
similar conditions. 
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The following experiments with porphobilinogen were done 
in order to clarify its mode of excretion in an experimental 
animal. It was found that porphobilinogen, when administered 
parenterally to the rat, is excreted into the urine mainly by 
glomerular filtration. If it is given enterally or parenterally, 
it is not found in the livers of rats subsequently killed, at a 
time when the plasma still contains porphobilinogen. These find- 
ings suggest that the porphobilinogen, found in the livers of 
rats with experimental porphyria, has been formed there and has 
not been transported to the liver from an extrahepatic site. 
Falk, Dresel and Rimington (1953) showed that porphobilin- 
ogen behaved as a precursor of certain porphyrins in a haemolysed 
chicken- erythrocyte system. In the present work, a small but 
significant conversion of porphobilinogen into coproporphyrin III 
and uroporphyrin III has been detected in the rat. 
METHODS 
General 
The Wistar- strain rats used weighed between 150 and 
214 g. with the exception of rat No. 7 which weighed 112 g. 
Rats Nos. 9 and 13 were female. They were placed in metabolism 
cages. In studies lasting 2 weeks, separate daily urinary and 
faecal specimens were analysed every second day for porphyrins, 
the specimens not determined on the day of excretion being stored 
at 2 °. In experiments where urine was collected at frequent 
intervals, e.g. half -hourly or hourly, micturition was induced by 
a 'tail- pulling' procedure similar to that described by 
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Hutschenreuter (1933). In collecting urine from metabolism 
cages, the cage was washed with water, until the washings were 
free from porphobilinogen (see below). In the experiment on rat 
No. 9, where hourly urine specimens were taken for 20 hours, the 
interior of the metabolism cage was washed 4 times at the end of 
each hour with a total vol. (each hour) of 200 ml. water. 
The porphobilinogen used had been isolated in the 
crystalline form (Giestall, 1952; Cookson and Rimington, 1954) and 
was administered as the hydrochloride in 0.9% (w /v) NaC1, using 
0.5 m1. for parenteral injection and 1 ml. for enteral administra- 
tion. Intravenous injections were given into a tail vein, 
subcutaneous into the dorsal area of the rat. All enteral 
administration was carried out by gastric intubation. 
Haematological values were determined as described in 
Section 5. 
Isolation and determination of porphyrins 
Urine Coproporphyrin was extracted by the method of 
Schwartz, Zieve and Watson (1951). Uroporphyrin from the same 
specimen of urine was obtained by combining the aqueous and sodium 
acetate washings from the coproporphyrin extraction, and bringing 
these to pH3.0 -3.2. The washings were then shaken with ethyl 
acetate, the aqueous layer was discarded and uroporphyrin extracted 
with 0.6N -HC1. 
Faeces Coproporphyrin and protoporphyrin were extracted 
by the method of Schwartz and Wikoff (1952) with the following 
modifications. The ethyl acetate was shaken with 20 -30 ml. 
0.005% aqueous I2 immediately after extraction of porphyrins with 
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3N -HC1. The aqueous layer was discarded and a further extraction 
with 3N -HC1 carried out, in order to obtain any porphyrin 
precursor. This was not found in any specimen. The final 
coproporphyrin extraction in 0.1N -HC1 was not shaken with 0H013. 
Uroporphyrin was obtained from the sodium acetate washings of the 
ethyl acetate layer during the above procedure. These acetate 
washings were dealt with in the same way as described for urinary 
urop orphyrin . 
The porphyrins, so extracted from urine and faeces, were 
determined by the method of h,imington and Sveinsson (1950) using 
a Beckman spectrophotometer, model D.U. 
Paper chromatography of porphyrins This was carried out 
as described in Section 5. 
Isolation and determination of porphobilinogen 
Urine and tissues Porphobilinogen was determined as 
described in Section 5. It was assumed that 1 mg. of porpho- 
bilinogen is equivalent to 130 Vahiquist (1939) units ( Westall, 
1952). 
Faeces To a weighed amount of faeces in a centrifuge 
tube, sufficient water was added to give a thin paste. Clarific- 
ation was effected by adding 10% (w /v) lead acetate in 3% (w /v) 
acetic acid, in a volume one -tenth of that of the diluted faeces, 
mixing and then centrifuging. The supernatant was decanted and 
excess Pb2+ was precipitated with a solution containing NaH2PO4 
(123 g. /l.) and K2HPO4 (138 g. /1.). The mixture was centrifuged 
and the supernatate analysed for porphobilinogen as described for 
urine. 
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Plasma Protein was precipitated by adding 0.33 vol. of 
20íL /w /v) trichloroacetic acid to centrifuged plasma as obtained 
post -mortem. The mixture was then centrifuged and the supernatant 
tested for porphobilinogen. In the living rat 0.1 ml. of blood 
from the tail was sucked into a 0.1 ml. pipette, previously rinsed 
with heparin. The blood was discharged into 1.5 ml. of 5$ (w /v) 
trichloroacetic acid contained in a centrifuge tube. This was 
thoroughly shaken, centrifuged and the supernatant tested for por- 
phobilinogen. The observation that porphobilinogen does not enter 
erythrocytes (Section 6) was confirmed in the present study. The 
blood haematocrit for the rat was taken to be 40 (Wintrobe, 1951) 
and plasma porphobilinogen was calculated on this basis. 
Paper chromatography This was done as described by 
Westall (1952) and Cookson and Rimington (1953). 
RESULTS 
Intravenous injection of porphobilinogen 
Excretion pattern of porphobilinogen and porphyrins Rats 
Nos. 1 and 2 were given intravenous injections of 9.04 and 9.4 mg., 
respectively, of porphobilinogen after a preliminary period of 8 
and 7 days, respectively, during which daily faecal and urinary 
porphyrins were determined. These determinations were continued 
during the succeeding 8 days. Porphobilinogen was rapidly excreted 
in the urine of both rats. It appeared in the urine within 10 
min. of injection and was detectable until 8 hours later. In rat 
No. 1 specimens of urine were collected every 2 hours during the 
12 hour period after injection. The results of porphobilinogen, 
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uroporphyrin and coproporphyrin determinations on these specimens 
are illustrated in Fig. 1. This shows that nearly half of the total 
porphobilinogen excreted in the urine (6.07 mg.) was passed in the 
first 2 hours after injection, while the excretion of the small 
quantities of uroporphyrin (4.59/4g.) and coproporphyrin (6.85/4g.) 
was more protracted. A smaller yield of porphobilinogen was 
obtained in the urine of rat No. 2, viz. 2.85 mg., of which 2.6 
mg. were excreted in the first 3 hours after injection. This rat 
excreted a total of 4.95 /4g. of uroporphyrin and 6.O/.g. of copro- 
porphyrin in the 24 hours following injection. 
Paper chromatography of these porphyrins showed that they 
behaved as uroporphyrin III and coproporphyrin III, respectively. 
The porphobilinogen excreted in the urine was indistinguishable 
from crystalline porphobilinogen by paper chromatography, using 
butanol- acetic acid (Wes tall, 1952) . Furthermore, the lactam 
derivatives (Cookson and Rimington, 1953) of the porphobilinogen 
excreted in the urine and of crystalline porphobilinogen, behaved 
identically on a paper chromatogram. 
Table 1 summarizes the mean daily faecal coproporphyrin 
and protoporphyrin values before and after administration of 
porphobilinogen in rats Nos. 1 and 2. These figures are similar 
in each rat. Paper chromatography of these porphyrins both 
before and after porphobilinogen administration demonstrated that 
some dicarboxylic porphyrin (similar in properties to protoporphy- 
rin) as well as coproporphyrin had been extracted by 0.1N -HC1 and 
thus the coproporphyrin determinations in Table I are too high. 





































































































































































































































































































































































































































































































































jig. / 2hrs. 
1.0 
RAT 1. d' 214g. 
9.04 





















Fig. 1. Urinary excretion of porphobilinogen and 
porphyrins after the intravenous injection of 
porphobilinogen in rat No. 1. 
coproporphyrin (as judged by fluorescence on paper chromatograms) 
was extracted by 0.1N -HC1 in each case. It was therefore 
considered that no significant change had occurred in faecal por- 
phyrins as a result of porphobilinogen administration. 
Neither rat showed any abnormal symptoms during the 8 -day 
period following the porphobilinogen injection. Haemoglobin . 
contents, red cell numbers and reticulocyte counts were determined 
in both rats, before and at the end of the experiment and one day 
before and one day after the injection. No significant changes 
in these haematological values were observed. 
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Rats killed within 30 min. Porphobilinogen. (2.2, 2.0 
and 2.1A. mg.) was injected by vein into rats Nos . 4 -6 and these 
were killed after 30, 30 and 10 min., respectively. The porpho- 
bilinogen contents of the tissues of these rats are summarized in 
Table 2. The urine, plasma and kidneys always contained porpho- 
bilinogen, while liver, spleen, brain, bone marrow and Earderian 
glands gave consistently negative results. Subcutaneous fat and 
lungs contained porphobilinogen, while skeletal and cardiac muscles 
(thcroughly washed free of blood) of rat No. 6 contained porpho-- 
bilinogen. The plasma porphobilinogen level of rat No. 6 was 
approximately 4 times that of rats Nos. 4 and 5 (killed at 30 min.) . 
Small amounts of porphobilinogen were found in the gut contents. 
Subcutaneous injection of porphobilinogen 
Rats killed within 30 min. after sin ll e injection. 
Porphobilinogen (2.0 and 2.62 mg.) was injected into rats Nos. 7 
and 8, respectively, and the animals were killed 30 min. after the 
injection. The pattern of urinary and tissue porphobilinogen 
(Table 2) was similar to that found after intravenous injection. 
The plasma porphobilinogen level was higher than that found in 
rats Nos. 4 and 5. 
Rats killed 20.25 hr. after half -hourly injections, 
maintained for 20 hr. In experimental porphyria in rats induced 
by allylisopropylacetamide, porphobilinogen is consistently found 
in the liver in high concentration, also in the kidney and urine, 
and sometimes in the plasma. This hepatic porphobilinogen could 
have been formed in the liver or at an extrahepatic site, e.g. the 












































































































































































































































































































































































































































































































































































































































































































The very rapid excretion of porphobilinogen in the urine and the 
absence of porphobilinogen from the liver in the above experiments, 
when the plasma still contained porphobilinogen, made such an extra - 
hepatic site unlikely. However, it was still possible that the 
liver might take up porphobilinogen from an extrahepatic site if 
porphobilinogen were present in the plasma for any length of time. 
To determine the approximate length of the pericd during which 
significant plasma levels are maintained in experimental porphyria, 
rat No. 12 was given allylisopropylacetamide by gastric intubation. 
Within 20 hours this rat had excreted porphobilinogen in the urine. 
It was killed and porphobilinogen was found in the liver and kidney 
(Table 2). 
In order to mimic the effects of continuous production of 
porphobilinogen by a possible extrahepatic site throughout this 
period, 1 mg. of porphobilinogen was injected subcutaneously into 
rat Io. 9 every 30 min. for 20 hours. The initial two doses were 
given together at the beginning of the experiment. . Urinary 
excretion of porphobilinogen was determined hourly and urinary 
uroporphyrin and coproporphyrin, as well as plasma porphobilinogen 
were determined every 2 hours (Fig. 2). The rat was killed 15 min. 
after the final injection and tissues were analysed for porphobil- 
inogen and porphyrins (Tables 2 and 3). The liver did not 
contain porphobilinogen, while the gut contents showed a significant 
amount of porphobilinogen, presumably from passage through the bile 
ducts. During the 20 hour period of the experiment the rat showed 
no pathological symptoms. 
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Fig. 2. Effects of repeated subcutaneous injections 
of porphobilinogen for 20 hr. on urinary por- 
phobilinogen and porphyrin excretion and on 
plasma porphobilinogen. For experimental 
details see text. 
Table 3. Porphyrin determinations (µg./ g. or µg. /ml.) in tissues of rats which had been given porphobilinogen 
Uroporphyrin was not found in any of the tissues of these rats. 
Liver Kidney 
Rat Copro- Proto- Copro- Proto - 
no. porphyrin porphyrin porphyrin porphyrin 
Blood 







































of this experiment the hourly urinary excretion levels of porpho- 
bilinogen were remarkably constant - a mean of 1530 ± 151,4g. 
(S.D.) /hr. The mean plasma porphobilinogen level during this 
period was 31 ± 7.4 k g. (S.D.) /ml. Thus the renal clearance for 
porphobilinogen in this rat was O.82 ml. /min. or 0.55 ml. /min. /100 g. 
of body weight. This figure is in good agreement with inulin 
clearance found in the rat (Smith, 1951) and would therefore 
suggest that porphobilinogen is filtered by the glomeruli and not 
reabsorbed to a significant extent. 
Table 3 summarizes the liver, kidney, and blood porphyrin 
determinations of rats Nos. 4, 6, 7 and 9, which had been given 
porphobilinogen parenterally. There is no significant elevation 
of the porphyrin levels. 
Enteral administration of pómilobilinogen 
Excretion pattern of porphobilinogen and porphyries 
A study similar to that described for rats Nos. 1 and 2, was carried 
out in rat No. 3. After a preliminary period of 6 days, 3.68 mg. 
of porphobilinogen were given by gastric intubation. Daily 
urinary and faecal porphobilinogen and porphyrin contents were 
determined during the base -line period and in the 7 days following 
porphobilinogen administration (Table 1). There was no signifi- 
cant change in the porphyrin levels in the urine or faeces. No 
porphobilinogen appeared in the urine of this rat (cf. rats Nos. 
10 and 11, below), but 45% of the porphobilinogen administered was 
recovered in the faeces. Traces of porphobilinogen were present 
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Fig. 3. Urinary excretion of porphobilinogen 
after intragastric intubation of 3.4 mg. 
of porphobilinogen. 
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Rat killed after 7.5 hr. Rat No. 10 was given 3.4 mg. 
of porphobilinogen by gastric intubation. Urinary porphobilinogen 
determinations were done every 30 min. (Fig. 3). Porphobilinogen 
was detected in the urine within the second half-hour and was 
excreted in small amounts until 6 hours after its administration. 
Maximum excretion in the urine occurred between 2 and 2.5 hours. 
Between 6 and 7.5 hours, when the rat was killed, no porphobilinogen 
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was detected in the urine. After death 2.12 mg. of porphobilin- 
ogen was recovered from the intestinal contents. It was notable 
that in spite of this large quantity of porphobilinogen in the gut, 
it was not excreted in the urine in the last 1.5 hr. and this 
wou1c: suggest that porphobilinogen is only absorbed in the upper 
part of the rat intestine. Porphobilinogen was not found in the 
other tissues (Table 2). 
Rat killed after 2 hr. Rat No. 11 was given 4.85 mg. of 
porphobilinogen by gastric intubation and killed 2 hours later in 
order to see whether porphobilinogen could be detected in the liver 
during a phase of maximal absorption of porphobilinogen from the 
gut (see above). Urinary porphobilinogen determinations, as in 
rat No. 10, showed the excretion of 11.3, 30 and 46,«g. of porpho- 
bilinogen in the second, third and fourth half -hour periods, 
respectively, after administration. The rat was then killed and 
1.75 mg. of porphobilinogen were recovered from the intestinal 
contents. The plasma contained 2.1? -g. of porphobilinogen/ml., 
whilst 0.104 mg. of porphobilinogen was recovered from gut tissues 
after they had been thoroughly washed with normal saline. Porpho- 
bilinogen was not present in liver, kidney, muscle, fat, Harderian 
gland or brain (Table 2). No porphyrins were detectable in the 
liver. 
In vitro incubation of porphobilinogen with gastro-intestinal 
contents of a rat 
This experiment was carried out to investigate further the 
absence of conversion of porphobilinogen into porphyrins in the 
gut, which was demonstrated in rat No. 3. A rat was killed and 
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its gastro -intestinal contents were mixed with sterile normal saline 
to give a total vol. of 23 ml. 4.5 ml. of this were pipetted into 
each of four 50 ml. conical flasks. Flasks Nos. 1 and 2 were 
immersed in boiling water for 5 minutes and 1 mg. of porphobilino- 
gen in 0.56 ml. of sterile normal saline was added to flasks Nos. 
2 and 4. The pH of each of the contents of these flasks was about 
6.6. The flasks were then plugged with cotton wool and incubated 
for 4 hours with shaking at 90 -100 oscillations /min. at 37 °. 
The contents were then analysed for porphobilinogen and porphyrins 
(Table 4) . 
The results show that a 59 and 52% recovery of porphobil- 
inogen was achieved from flasks Nos. 2 and 4, but there was no 
significant change in the porphyrin content in any flask, with the 
exception of a small quantity of uroporphyrin (0.71 ,kg) found in 
flask No. 2. 
Table 4. Incubation of porphobilinogen with gastro - intestinal contents of a rat 
An equal volume of a mixture of gastro -intestinal contents in sterile 0.9% (w /v) NaCI was added to each of flasks 










































The results show that most of the porphobilinogen admin- 
istered parenterally is excreted in the urine and that this excre- 
tion is rapid; small amounts, ?_ _ , are recovered in the faeces. 
Given, however, by the enteral route, it is mainly excreted 
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unchanged in the faeces, although small amounts, (in the case of 
rat No. 10, one-twentieth of the porphobilinogen given) may be 
excreted in the urine. The excretion behaviour of the naturally 
occurring porphyrins (uroporphyrin, coproporphyrin and proto- 
porphyrin), after enteral and parenteral administration to exper- 
imental animals, has been studied previously. Fischer (1916) and 
Gunther (1922) found that uroporphyrin given parenterally to mice 
and rabbits, respectively, is mainly excreted in the urine, while 
Fischer (1915) found that uroporphyrin, when taken by himself by 
mouth, was passed unchanged in the stool. On the other hand, 
coproporphyrin III, given orally or parenterally to rats, is not 
passed in the urine, but recovered in the stool (Hoffbauer, Watson 
and Schwartz, 1953). Protoporphyrin injected parenterally into 
dogs with a bile -renal fistula was not accounted for in the porphy- 
rins excreted thereafter, apart from traces of material resembling 
deuteroporphyrin (Watson, Pass and Schwartz, 1941). The 
excretion of porphobilinogen thus resembles more that of uropor- 
phyrin than that of coproporphyrin or protoperphyrin. The mean 
percentage recovery of the porphobilinogen administered, 
parenterally or enterally, was 53 ± 14. This compares with the 
50 recovery of coproporphyrin III injected parenterally into 
rats by Hoffbauer et al. (1953) . 
The absence of abnormal symptoms in any of the rats used 
in the present work confirms the results of the pharmacological 
study of porphobilinogen in Section 4. It is of some interest that 
a small, though significant, rise of coproporphyrin III occurred 
in the urine of rats Nos. 1, 2 and 9, besides some excretion of 
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uroporphyrin III. This is in accordance with the demonstration 
by Falk et al. (1953) using a haemolysed chicken erythrocyte 
system, that porphobilinogen is a precursor of uroporphyrin, 
coproporphyrin and protoporphyrin. 
The site of the excessive porphobilinogen formation in 
acute porphyria is of importance. Prunty (1945) showed that por- 
phobilinogen is found in high concentration in the liver at autopsy 
of these cases, and this observation has been repeatedly confirmed. 
Thus Schmid, Schwartz and Watson (1954) include this disease in 
their ' porphyria hepatica' group. Porphobilinogen is also found 
in the kidney and urine and sometimes in the bile and plasma, but 
not in other tissues. In experimental animals drugged with . 
sedormid or allylisopropylacetamide, these same tissues also contain 
porphobilinogen and in the same relative concentrations. In fact 
Schmid and Schwartz (1952) refer to the experimental porphyria 
produced by sedormid as belonging to the 'hepatic type'. This 
suggested but did not prove, that in acute porphyria and in 
experimental porphyria of animals, porphobilinogen is formed in 
the liver. It did not exclude the possibility that porphobilin- 
ogen is formed at an extrahepatic site, e.g. the bone marrow, and 
is transported by the blood stream to the liver. The present 
experiments indicate that porphobilinogen is mainly excreted by 
glomerular filtration in the rat. Further, they show that por- 
phobilinogen is not found in the liver after enteral or parenteral 
administration. The plasma porphobilinogen levels in these 
experiments were high, higher than those found in an attack of 
acute porphyria. In rat No. 9 this plasma level was maintained 
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for 20 hours, a period which had been found sufficient to induce 
an experimental porphyria by means of allylisopropylacetamide, 
with accumulation of porphobilinogen in the liver in rat No. 12, 
(Fig. 4) . These facts would suggest that extrahepatic porphobil- 
inogen formation in experimental porphyria in the rat is improbable. 
It is also of interest that there was no significant increase of 
either coproporphyrin or protoporphyrin in the livers of rats 
given porphobilinogen. In the livers of animals with experi- 
mental porphyria such an increase is present. 
7B. RENAL CLEARANCE OF ENDOGENOUS PORPHOBILINOG: N IN MAN 
There is some evidence that the mechanism of porphobilin- 
ogen excretion in the rat may be relevant to human acute porphyria. 
In this disease, the high porphobilinogen concentrations in the 
urine and the persistently low concentrations in the plasma, even 
at the height of an attack, suggest a rapid excretion of that 
substance. Furthermore, a sharp rise of porphobilinogen excretion 
in the urine often accompanies and may even precede the onset of 
clinical symptoms of porphyria, which would also suggest rapid 
elimination. Finally, acute porphyria urine, which is freshly 
passed and has not lain in the bladder for long, contains mainly 
porphobilinogen with only traces of coproporphyrin and uroporphyrin. 
This is the same pattern of porphobilinogen and porphyrin excretion 
as is found in the urine of a rat, injected parenterally with 
porphobilinogen. Ä greater conversion of porphobilinogen into 






1mg. S.C. PORPHOBILINOGEN 
per 1/2 hour for 20 hours. 
KILLED 20.15 HOURS 
AIA 50mg. ORAL 
KILLED IN 20 HOURS 
Fig. 4. Porphobilinogen (i&g.) in tissues of rats 
9 and 12. Rat 9 received repeated subcutaneous 
(S.C.) injections of porphobilinogen. Rat 12 
was given a single oral dose of allyl- isopropyl- 
acetamide (A.I.A.). I\To porphobilinogen has 
accumulated in the liver of rat 9, despite 
maintained high blood -level, whereas the liver 
of rat 12 contains much porphobilinogen. 
eliminated in acute porphyria. The probability of such a rapid 
elimination would explain the absence of significant photosensitiv- 
ity in this disease, since this symptom is caused by an excessive 
amount of formed porphyrins in skin. These findings would suggest 
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that the renal excretion of porphobilinogen in the rat might be 
similar to that in human acute porphyria. For these reasons 
studies were carried out to determine the renal clearance of 
endogenous porphobilinogen in three cases of acute intermittent 
porphyria (two during an acute attack and one during a remission) 
and in one case of latent porphyria. The results suggest that in 
these patients endogenous porphobilinogen was in fact excreted by 
glomerular filtration with little or no tubular reabsorption. 
METHODS AND MATERIALS 
Clinical 
The Cases 
Case 1. (Mrs. I.B. aged 21. Case No. 39 in Appendix) . 
Height 155 cm., weight 43.6 kg. Acute intermittent porphyria. 
This was her first attack. She had had recurrent bouts of ab- 
dominal pain, transient hypertension, and tachycardia for 6 weeks. 
There was weakness of her arms and legs. The experiment was 
done during the acute phase on a day when she was co- operative and 
had little abdominal pain. She excreted 215 mg. of porphobilin- 
ogen in her urine on that day. 
Case 2. (Mrs. J.M. aged 23. Case No. 38 in Appendix). 
Height 162 cm., weight 55.5 kg. Acute intermittent porphyria. 
This was her first attack. She had had severe abdominal pain 
and vomiting for 3 weeks and had difficulty in passing urine. On 
the day of the experiment her symptoms had greatly improved and 
she excreted 52 mg. of porphobilinogen in her urine. 
Case 3. (Mr. C., aged 29). Height 193 cm., weight 74 kg. 
Latent porphyria. Situs inversus totalis. Bronchiectasis. 
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Traumatic epilepsy. He has never had symptoms suggesting acute 
intermittent porphyria, yet he excretes about 100 mg. of porpho- 
bilinogen in his urine each day. (Patient of Dr. Donald Hunter, 
London Hospital). 
Case 4. (Mr. L.7. aged 24. Case No. 14 in Appendix) . 
Height 175 cm., weight 65.5 kg. Acute intermittent porphyria in 
remission. Ayear before he had a very severe attack with quadriple- 
gia. He still had wasting of the small muscles of his hands. He 
excreted about 120 mg. of porphobilinogen in his urine daily. 
Two separate experiments were made in this case:(a) clearance of 
endogenous porphobilinogen, and (b) simultaneous clearance of 
endogenous porphobilinogen and of inulin. 
All the patients were recumbent in bed throughout each 
experiment, except Case 3, in whom the effect of postural change 
on the renal clearance of porphobilinogen, creatinine, and urea 
was investigated. 
Food and Fluids 
Each patient was given breakfast before the start of the 
experiment. Cases 1 and 4(a) in addition had a light lunch 
during the experiments. Cases 2, 3, and 4(b) fasted throughout 
the experiments. The patients were encouraged to drink water and 
orange -juice from an hour before till the end of the clearance 
periods. 
Collection of Urine and Plasma 
Urine was passed voluntarily by all the patients except 
Case 2, who had to be catheterised at the end of the clearance 
period. The minimum of urine passed in any single clearance period 
136 
was 230 ml. The mean of all such volumes was 544 ± 260 ml. 
The experiments in every case were made between 7 a.m. 
and 5 p.m. In Case 1 the urine excreted in 6 hours (from 
11 a.m. till 5 p.m.) was collected, and plasma specimens were 
taken at 1, 3 and 5 hours after the start of the experiment. 
Case 2 emptied her bladder at 7 a.m. and was catheterised 4i-hours 
later. Plasma specimens were taken at 1 and 3 hours after the 
start of the experiment. In cases 3 and 4(a) the patients had 
four and five consecutive 2 -hour clearance periods beginning at 
7 a.m. and 9 a.m. respectively. Plasma specimens were taken an 
hour after the start of each clearance period. In Case 4(b) the 
clearance of endogenous porphobilinogen was studied for 2 hours 
(from noon to 2 p.m.). An intravenous inulin drip had been set 
up at 11 a.m., and inulin clearance was determined for the period 
12.30 - 2.0 p.m. The inulin clearance recorded represents the 
average of three separate half -hourly inulin clearances recorded 
in this 12 hours. The minimum of urine passed during each half - 
hourly period was 194 ml., and the mean volume for the three 
periods was 240 
± 
35 ml. 
Urea and creatinine clearances were measured in addition 
to porphobilinogen clearances in certain cases (see table). 
Biochemical Determinations 
Porphobilinogen was determined in urine and plasma by 
methods described in Section 5. In every case 1.5 ml. of 20% (w /v) 
trichloracetic acid was added to 6 ml. of plasma. 
Weighed quantities of crystalline porphobilinogen were 
added to distilled water and normal human plasma, sufficient to 
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TABLE 5 
















































































In case 4(b) the endogenous porphobilinogen clearance and the 
(nnlin clearance were measured simultaneously. 
Ti, recllmbept, S, standing. 
give concentrations in the same range as that of the specimens of 
urine and plasma to be tested. The densities of these standard 
aqueous and plasma solutions when treated with Ehrlich's reagent 
were measured at 552 m/t on a 'Unicam' spectrophotometer (S.P.500), 
and calibration curves were drawn, the spectrophotonietric readings 
being plotted against known concentrations of porphobilinogen in 
water and plasma. 
The urine in each case was diluted 25 - 100 times with 
distilled water. It was therefore considered permissible to 
measure the porphobilinogen content of this very diluted urine by 
the calibration curve of the standard aqueous porphobilinogen 
solutions. The porphobilinogen contents of patients' plasma were 
likewise calculated from the calibration curve of the standard 
plasma -porphobilinogen solutions. 
The specimens of urine and plasma were examined for their 
porphobilinogen content within half an hour of collection; before 
the determination they were stored at 2 °C. 
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Urea was determined in blood by the method of Van Slyke 
and Cullen (Hawk et al. 1947). Urinary urea was determined by 
the hypobromite method (Harrison 1947). 
Creatinine The methods described by Hawk et al. (1947) 
were used for plasma and urinary creatinine. 
Inulin clearance The method used for this was essenti- 
ally that described by Higashi and Peters (1950). I must thank 
Dr. L. J. Ross for guidance and assistance in this procedure. 
Results 
The results of these experiments are summarised in the 
table. The mean plasma -porphobilinogen concentrations in Cases 
1, 2, 3, and 4(a) were 1.0 ± 0, 1.0 ± 0.1, 0.6 ± 0.1, and 1.3 ± 
0.2,ug. per ml. respectively. 
The mean endogenous porphobilinogen clearances of all the 
patients when recumbent, corrected in each case to 1.73 sq. m. of 
body - surface area, was 106 ± 28.4 ml. per min. 
Discussion 
The results suggest that, in these patients, endogenous 
porphobilinogen was filtered by the glomeruli and not excreted or 
reabsorbed by the tubules to any significant extent. Creatinine 
and inulin are known to be entirely excreted by glomerular 
filtration. In Cases 3 and 4(a) the simultaneous renal clearances 
of creatinine and endogenous porphobilinogen were similar. This 
similarity was less obvious in Case 1. The simultaneous renal 
N I must thank the department of Clinical Pathology, University 
College Hospital, London, for these determinations. 
139 
clearances of inulin and endogenous porphobilinogen in case 4(b) 
were similar. The mean of the corrected porphobilinogen clearance 
of all the patients when recumbent (106 ± 28.4 ml. per min.) 
compared favourably with the figure recorded by Smith (1951) for 
glomerular filtration -rates obtained in mixed groups of males and 
females (116 ± 28.1 ml. per min.). 
The results of the influence of posture on the renal 
clearance of creatinine, urea, and porphobilinogen in Case 3 
require comment. Brun et al. (1945) recorded that glomerular 
filtration, measured by inulin clearance, and renal plasma flow, 
measured by diodone clearance, became lower when the reclining 
posture was changed to the passive erect posture, and then rose 
to their former levels when the patient resumed the reclining 
posture. These changes took place within 15 - 30 minutes of the 
change of posture. White and Rolf (1948) and Epstein et al. 
(1951) confirmed this influence of posture on inulin clearance, 
and Ni and Rehberg (1931) and White and Rolf (1948) showed a 
similar effect on the renal clearance of creatinine. On the other 
hand, Viar et al. (1951) did not find any influence of posture on 
creatinine clearance. 
The renal clearance of endogenous porphobilinogen in Case 
3 was somewhat higher in the reclining position than in the erect 
position, and the simultaneous urea and creatinine clearances 
showed a similar effect. These observations do not clarify fully 
the role, if any, of the renal tubules in the excretion of endogen- 
ous porphobilinogen, since the clearance of urea, which is slightly 
reabsorbed by the tubules, and of diodone, which is excreted by the 
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tubules, are also influenced by changes of posture. However, the 
close correspondence between the changes in porphobilinogen and 
creatinine output suggest a closely related mechanism of excretion. 
It has been suggested that, in experimental porphyria 
in the rat, porphobilinogen is formed in the liver and not at an 
extrahepatic site. In acute porphyria in man porphobilinogen is 
found in the same tissues as in experimental porphyria in the rat - 
i.e. liver, kidney, and plasma. In addition the mechanism of the 
renal clearance of porphobilinogen in acute porphyria in man appears 
to be the same as in the rat. This suggests that the reasoning 
that porphobilinogen is formed in the liver in experimental porphy- 
ria in the rat is valid for acute porphyria in man. 
Porphobilinogen is a substance of low molecular weight 
(226) and is pharmacologically inactive; it can be easily and 
accurately measured in very small concentrations in urine and 
plasma. After its injection into rats a maximal recovery of 79i 
was obtained, of which 75% was found in the urine, while the 
slight increase of urinary porphyrins reflected a 0.1% conversion 
of the injected porphobilinogen. Possibly this substance or one 
closely allied to it might provide a suitable tool for the deter- 
mination of the glomerular filtration -rate. 
The fact that some patients with latent porphyria and 
acute porphyria in remission may excrete large quantities of por- 
phobilinogen in the urine while they have a determinable plasma- 
porphobilinogen level should be remembered when an attempt is being 
made to assess the progress of a case of acute porphyria. It is 
also clear that clinical interpretations of changes in urinary 
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output cf porphobilinogen must take into account changes in renal 
function as well as changes in the production of porphobilinogen. 
For example, a decreased output of porphobilinogen can mean either 
that the patient is getting over his acute attack of porphyries or 
that his condition is worsening because of renal failure, with, 
of course, a lowered glomerular filtration -rate. Plasma- porpho- 
bilinogen levels and clearance determinations can be used to 
distinguish between these two possibilities. 
SUìíTlAßX 
1. Porphobilinogen has been administered parenterally and 
enterally to rats. After parenteral injection, porphobilinogen 
was rapidly and mainly excreted in the urine. Small amounts were 
excreted in the faeces. After enteral administration, only small 
amounts were slowly excreted in the urine. Most of it was passed 
unchanged in the faeces. The porphobilinogen excreted in urine 
was identical chromatographically with that administered. 
2. A calculation of renal clearance of porphobilinogen in 
the rat suggests that porphobilinogen is mainly excreted by 
glomerular filtration without significant reabsorption. 
3. A small but significant rise of coproporphyrir III, as 
well as the excretion of some uroporphyrin III, was noted in rat 
urine after parenteral injection of porphobilinogen. There was 
no significant change in faecal porphyrin excretion after enteral 
or parenteral administration of porphobilinogen. 
4. Aerobic incubation in vitro at 37° of porphobilinogen 
with gastro -intestinal contents of a rat showed no evidence of 
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conversion of porphobilinogen into porphyrins. 
5. Forphobilinogen was net found in the liver when rats were 
killed shortly after its enteral or parenteral administration, nor 
was it found in the liver of a rat after subcutaneous injections 
of porphobilinogen every half -hour for 2G hours, during which time 
a high plasma porphobilinogen concentration was maintained. 
These findings suggest that the porphobilinogen found in the liver 
of a rat with experimental porphyria is in fact formed there and 
is not transported by the blood stream to the liver from an extra - 
hepatic site. 
6. The relevance of these results, obtained in the rat, to 
human acute porphyria, is discussed. 
7. Renal clearance has been studied in three cases of acute 
porphyria and in one case of latent porphyria. 
8. The results suggest that endogenous porphobilinogen is 
excreted in man by glomerulsr filtration without appreciable 
tubular reabsorption. The significance of this finding is 
discussed. 
8 
PATHOGENESIS AND ORIGIN OF CLINICAL MANIFESTATIONS 
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8. l'iiTT-] Can SIS AND OltiIGIId OF CLINICti.L TviZrIFISTATIOTdS 
Since t3: o early descriptions of acute porphyria, there has 
been speculaticr on its pathogenesis and the mechanism of the 
causation of symptoms. Harley (1890) considered that there was 
an auto -intoxication due to faulty oxidation of a urinary pigment. 
In his discussion on sulphonal- induced porphyria, Stokvis (1895) 
postulated that the drug caused haemorrhages into the mucous 
membranes of the alimentary canal and that the blood pigment, so 
released, was converted to porphyrins. On the other hand, Oswald 
(1895) suggested that sulphonal affected the adrenals, which at 
that time were thought to be concerned with the degradation of 
haemoglobin. This effect, he believed, led to such an accumulation 
of the decomposition products of haemoglobin, which he considered 
to be porphyrins, as to seriously affect the nervous system and 
cause death. Later, Barker and Estes (1912), on the basis of a 
post -mortem examination, postulated that gastro- intestinal 
dilatation was the primary condition which caused a toxaemia. 
Snapper (1922) performed 2 autopsies on cases of acute porphyria 
and found tuberculosis of the retroperitoneal lymph glands in one 
and an infected hydronephrosis in the other. He then suggested 
that the colic and paralysis were caused primarily by a chronic 
poisoning of the retroperitoneal nerve plexuses. Garrod (1923) 
considered that patients with congenital porphyria lack an enzyme 
which is responsible for one of the stages in the conversion of 
blood pigment into bile pigment. Several authors claimed that 
porphyrins may influence isolated strips of animal intestine or 
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uterus (Gunther 1922, Supniewski 1927, Reitlinger and Klee, 1928, 
Simici, 1938, and Vannotti 1951). These pharmacological studies 
seemed convincing proof (Carrie, 1936) that the substances, 
causative of symptoms in the human disease, were the porphyrins. 
Berg (1945) suggested that the porphyrins produced a block in 
neuromuscular transmission. Waldenstrbm however (1937, 1939) cast 
doubt on the view that symptoms were caused by porphyrins but 
stressed the importance of vasospasm. He also suggested that 
certain pyridine derivatives, possibly formed from the excessive 
pyrroles, affected the nervous system. Lowry et al. (1950) 
suspected that porphobilinogen or some closely related substance 
was the cause of the clinical manifestations, while Denny -Brown 
and Sciarra (1945) considered that the pathological changes in the 
nervous system might be caused by an intermittent ischaemia, 
probably due to a circulating vasoconstrictor substance. 
The work reported in Section 4 suggested that purified 
porphyrins and porphobilinogen are pharmacologically inactive and 
also rendered unlikely the suggestion that a circulating vaso- 
constrictor substance exists in this disease. This interpretation 
was strengthened by the production of an experimental porphyria 
in animals by the non -hypnotic substance allyl- isopropylacetamide 
(Section 6). In this condition the animals excreted large amounts 
of porphobilinogen, but yet showed no clinical similarity to human 
acute porphyria, apart from constipation and loss of weight. 
Furthermore, porphobilinogen, not porphyrins, is the main excretion 
product in acute porphyria. Freshly voided urine contains little 
formed porphyrins. This may explain the absence of gross photo- 
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sensitivity of skin in acute porphyria, since photosensitivity is 
found in other types of porphyria in which formed porphyrins are 
excreted. The darkening of the skin noted in several cases of 
the present series may be caused by the simultaneous excretion of 
-aminolaevulic acid (Granick and Schrieck, 1955), which has some 
slight photosensitising action (Scott, 1955; Jarrett et al. 1956). 
The views on the origin of the clinical manifestations 
have therefore been contradictory, but there has been an increas- 
ing agreement that the liver is the seat of the abnormal porphyrin 
metabolism. Thus Garrod (1900), Neubauer (1900) and Mason, 
Courville and Ziskind (1933) supported this view and in 1945, Prunty 
found porphobilinogen in the liver of a case of acute porphyria. 
This was confirmed by Gray (1950) and Schmid et al. (1954). The 
latter classified acute porphyria as being of the hepatic type 
(Section 1). The work of the author suggested that the porpho- 
bilinogen found in the liver is made there and is not transported 
from an extrahepatic site (Section 7). 
In 1956, Gibson and Goldberg confirmed the importance of 
primary demyelination in this disease. The general distribution 
of this pathological change throughout the nervous system (Table 
4 Appendix) suggests that the clinical features may be explained 
entirely on a neurogenic basis. 
The neurological clinical manifestations are clearly 
related to the neuropathological findings. Thus the demyelination 
of peripheral nerves, from post -mortem or biopsy tissues, explains 
the limb paralysis. The lesions in the phrenic nerve in Case 32 
are related to the respiratory paralysis which occurred in that 
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patient. In Case 24 ataxia and nystagmus occurred and foci of 
demyelination were found in the white matter of the cerebellum. 
Some mental changes were observed in Cases 2, 24, 32 and 
43 and in each of these perivascular foci of demyelination were 
found in the cerebral white matter. It is also possible that an 
underlying mental instability was brought out by an attack (anther, 
1922). Spillane (1947) noted that when cerebral demyelination 
occurs in subacute combined degeneration, it is usually found in 
patients who have had psychotic manifestations. 
Gastro- intestinal symptoms consist primarily of pain, 
constipation, vomiting and diarrhoea. Intestinal spasms alternat- 
ing with atonia and dilatation, varying in location, but predomin- 
antly in the upper tract, have occasionally been observed at 
laparotomy of these patients. They have also been demonstrated 
both by intragastric balloon (Berg, 1945) and by radiography 
(Berlin and Cotton, 1950; Calvy and Dundon, 1952). Such effects 
may have been caused by patchy demyelination of the preganglionic 
motor fibres that innervate the viscera. These fibres have their 
cell stations in the spinal cord and medulla. Retrograde 
degenerative changes were found in these nuclei. Demyelination 
of the Vagus nerves (Cases 2 and 32) and of fibres of the sympath- 
etic chain (Case 32) were also noted. The demyelinating lesions 
in these nerves were disseminated patchily and this may have 
resulted in an irregular motor innervation of the bowel, which could 
cause the symptoms described above. 
Berlin and Cotton (1950) have put forward a similar neuro- 
genic hypothesis for the gastro -intestinal features of this disease. 
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They point out the similarity of the effects of porphyria and 
vagotomy upon gastro -intestinal motility and consider that the 
greater involvement of para -sympathetic innervation in porphyria 
may be responsible for dilatation and atony as the predominant 
functional disturbance. Watson (1954) reported marked relief of 
abdominal pain in 1 case after bilateral splanchnicectomy. 
Non- abdominal pain in the limbs and elsewhere may be due 
to sensory -fibre damage in the peripheral nerves. The changes in 
the posterior spinal root ganglia in the cases of this series were 
generally slight and inconstant, but such changes have been des- 
cribed by Bostroem (1920), Mason, Courville and Ziskind (1933) and 
by Denny -Brown and Sciarra (1945). 
Hypertension and Tachycardia The sino- aortic regulation 
of blood pressure and pulse rate is an important buffer mechanism. 
Pulsatile expansion of the carotid sinus and aorta stimulates the 
passage of impulses along the afferent pathways of the medullated 
carotid sinus and aortic nerves which join the glossopharyngeal 
and vagus nerves respectively. They end in the reticular sub- 
stance and the nucleus of the tractus solitarius. From the 
adjacent dorsal nucleus of the vagus nerve, inhibitory impulses 
are distributed to neighbouring vasomotor centres and also to the 
hypothalamic circulatory centres (Kezdi 1954). 
It is clear that interruption at any point in this pathway 
may block the buffer mechanism and give rise to hypertension and 
tachycardia. Changes in the vagus nerves, nucleus solitarius, 
the dorsal vagal nucleus and reticular substance have been observed 
in Cases 2, 32 and 43 (Table 4 Appendix). Kezdi (1954) has 
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investigated this buffer mechanism in a case of acute porphyria by 
observing the effect of stimulation (digital pressure) or block 
(procaine) of the carotid sinus region on blood pressure and pulse 
rate. He noted an absence of response in active phases of the 
disease and postulated a disruption of the mechanism and a neuro- 
genic cause for hypertension and tachycardia. 
Thus it is possible to explain all the main clinical 
features on a neurological basis. In view of the pharmacological, 
pathological and experimental evidence, such an explanation would 
seem more rational than the others which have been reviewed. It 
is suggested therefore that in acute porphyria there is a funda- 
mental disturbance of pyrrole pigment metabolism which has its 
site in the liver. Associated with this there may be a related 
disturbance in the metabolism of the nervous system, of which 
demyelination is the pathological expression. The exact nature 
of this association is not clear. The recent elucidation of the 
porphyrin -like structure of Vitamin B12 (Bonnet et al. 1955) may 
have some relevance, particularly when it is realized that 
demyelination of the nervous system may take place in pernicious 
anaemia (Spillane, 1947). This hypothesis is illustrated in 
Fig. 1. A substance X has been postulated, of which porpho- 
bilinogen is a precursor and which is essential for the nutrition 
of the myelin of the nervous system. A metabolic "block" to the 
formation of this substance in the liver would lead to an 
excessive production of p orphobilinogen and Q -aminolaevulic acid 
and also to demyelination of the nervous system. It is possible 
that a genetically -determined deficiency in a specific enzyme, 
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Figs 1. Section 8 
A substance X has been postulated of which 
porphobilinogen is a precursor and which is 
essential for the nutrition of myelin. A 
metabolic block to the formation of this 
substance in the liver would lead to an 
excessive production of porphobilinogen and 
also to demyelination of the nervous system. 
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variable in the expression of its severity, might explain the 
"block ". The intermittent nature of the disease might be related 
to the effect of other factors, e.g. endocrine factors, infection, 
barbiturates etc., on this abnormally sensitive pathway. In 
experimental porphyria in animals neither paralysis nor demyelin- 
ation of nervous tissue was found, although much porphobilinogen 
accumulated in the liver. This suggests that the fundamental 
biochemical lesions in human acute porphyria and experimental 
porphyria are not identical. 
The role of the barbiturates in this hypothesis requires 
particular mention. They appear to be associated with the onset 
or the aggravation of the neurological phase of the disease and 
they may precipitate an attack. Barbiturates have their hypnotic 
action by inhibiting the oxidative mechanisms of brain tissue and 
some of them, at least, influence pyrrole pigment metabolism in 
animals. Barbiturates may obtain their adverse effect in acute 
porphyria not only by inhibition of the formation of substance X 
but also by a direct depression of the oxidation of brain tissue. 
The varied clinical features of acute porphyria, as well 
as its pathological chemistry, could be explained on the basis of 




Abbreviations and Notes: 
P.Z. Pulse Rate. 
B.P. Blood Pressure. 
Hb. Haemoglobin concentration. 
R.B.C. Red blood cell count. 
W.E.C. White blood cell count. 
E.S.R. Erythrocyte sedimentation rate. 
C.S.F. Cerebrospinal fluid. 
The year (in brackets) and age given at the beginning of 
each case history, refer to the year in which symptoms commenced 
and the age of the patient in that year. 
The methods for the determination of porphyrins and 
porphobilinogen in urine and tissues have been described in 
Section 5. It should be noted that the characteristic excretion 
product in acute porphyria urine is porphobilinogen. The urinary 
uroporphyrin concentrations, recorded in some of these cases, were . 
estimated after heating the urine for 20 minutes with a pH 4.2 
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Mrs. E.H. Age 24 years (1953) Filler in fireworks factory 
Case No.1 
Five days after the birth of her first child, in December 
1952, this woman had an attack of severe colicky abdominal pain 
lasting a few hours. The child died one month later from 
bronchopneumonia. In I,Iay 1953 she had an attack of severe 
abdominal pain, diarrhoea and vomiting, with aching pains in her 
limbs and a feeling of weakness. This lasted for 3 days. She 
was well until 27/10/53 when she developed a chill and with this 
she had colicky abdominal pain, diarrhoea and vomiting; she was 
sleepless and nervous. She was admitted to Livingstone Hospital 
on 5/11/53 when phenobarbitone gr. 2 t.d.s. and sodium amytal 
gr. 3 was given daily for the next 5 days. During this period 
she developed weakness of arms and legs and numbness of forearms 
and hands. On 10/11/53 she was transferred to Joyce Green 
Hospital, Dartford, Kent, where red urine was noted for the first 
time. On examination she was afebrile. P.R. 110- 120 /minute. 
B.P. 
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. There was marked loss of power in all muscle groups, 
especially proximals, hypo-algesia and hypo- aesthesia from 
fingers to middle of upper arms and from toes to middle of thighs, 
bilateral facial nerve weakness, difficulty in swallowing and 
coughing. W.B.C. 24,000 /cmm. Hb. 13 G%. C.S.F. normal. 
Serum electrolytes showed low serum sodium and chlorides and 
slightly raised blood urea (Table 1). Liver function tests 
(Table 2). Urine porphobilinogen + ++ She became incontinent 
of urine and faeces, was semi -conscious and had Cheyne -Stokes 
respiration. Died 11/11/53. P.N. (Dr. N.P. Orchard). Early 
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bronchopneumonia of lower lobes. Recti abdominis showed area of 
degeneration and foci of round cel].s. Marked degeneration of 
Purkinje cells of cerebellum. The anterior horn cells at all 
levels of the spinal cord showed degenerative changes. Chemical 
pathology of tissues (Table 3). 
Summary 3 attacks of increasing severity following birth of 
first child. In the final fatal attack she was given 
barbiturates and developed neurological manifestations. Note 
diarrhoea, not constipation, as accompaniment of abdominal pain. 
Mrs. L.B. Age 52 years (1953) Housewife Case No. 2 
This patient was admitted to Mile End Hospital, London, 
on 4/6/53 because of morning vomiting and general nervousness of 
6 weeks' duration. Examination on admission showed only hyper- 
tension (B.P. 250) and obesity. She was given phenobarbitone 
1-4.0 
gr. 2 b.d. on a few occasions. 12 days after admission 
(16/6/53) she began to complain of severe epigastric pain and 
vomiting. There was some tenderness in the epigastrium but no 
rigidity. The same day an intravenous pyelogram was carried 
out ("pyeloselectan" 20 ml.) and after this she felt much worse. 
Seconal gr. 6 was given in a B.P. sedation test and the same dose 
of this barbiturate was repeated next day. At this time she was 
noisy and was behaving strangely. She continued to have pains 
in the abdomen and also in the back and upper thighs. She 
became very constipated and was incontinent of urine at times. 
4sigrip a mill 
1_«- :.} :J;..7 
ifI! T 
Plate I. (Appendix). 
Gall stone of Case 2. 
This fluoresced markedly and contained 
coproporphyrin III and a trace of uro- 
porphyrin. 
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On 27/6/53 she passed dark red urine, containing porphobilinogen 
and uroporphyrin, determined later as the series III isomer type. 
Examination on that day showed absence of ankle and knee tendon 
reflexes and generalized loss of pin -prick sensation. She had 




and her P.R. rose from about 80 /minute to 100 /minute. 
She remained afebrile. W.B.C. 7,100 /cmm. E.S.R. 8mm /hour. 
Hb. 13 G%. Blood urea rose from 38 mg.% on admission to 92 mg.. 
Urine contained no protein. She became dyspnoeic with bubbling 
respirations and died on 30/6/53. 
P.M. showed left -sided heart failure. Pulmonary haemorrhagic 
oedema. The gall- bladder contained a large pigment stone, the 
shape of a walnut (see Plate 1) 3.2 x 2.5 cm., 12.2 g. in weight. 
Chemical analysis of the stone showed the following: Bilirubin 
15%", net weight; calcium 0.1% net weight; porphyrin 0.05'% net 
weight. The porphyrin content was almost entirely copro- 
porphyrin series III, although a trace of uroporphyrin was 
discovered by means of paper chromatography. The chemical 
pathology of post -mortem tissues is described in Table 3. 
Summary Solitary fatal attack occurring in a woman of 52 with 
marked hypertension, possibly essential hypertension. Two 
seconal sedation tests may have precipitated the onset of 
neurological symptoms. 
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Miss M.M. Age 25 years (1952) Bakery Assistant Case No. 3 
This patient was first admitted to Stobhill General 
Hospital, Glasgow, on 1/12/52 with a history of severe colicky 
abdominal pain and vomiting of 4 days' duration. The pain 
started in the epigastriam and moved to the right iliac fossa. 
She described it "as if someone was tearing my inside out". 
Examination showed tenderness in the right iliac fossa. The 
pain continued intermittently for 5 weeks and she discharged 
herself from hospital on 9/1/53 although she felt then that her 
(R) arm was becoming weaker. During this admission she received 
sodium amytal on at least one occasion. She was re- admitted on 
15/1/53 with abdominal pain and severe pain in her knees, hips 
and shoulders. There was marked weakness of her arms and legs 
and slurring of speech. Porphobilinogen and uroporphyrin 
(15 mg. /24 hours at maximum) were then found in the urine. She 
was given a course of A.C.T.H. from 26/1/53 to 12/2/53 (total of 
340 mg. A.C.T.H.). She improved during this period but it was 
difficult to assess the influence of A.C.T.H. since daily 
uroporphyrin determinations had shown a downward trend, even 
before A.C.T.H. was commenced. In the next few months there was 
a marked improvement in the power of her limbs and by 18/5/53 
they had almost recovered, apart from some persistence of wrist 
drop. During this time she had occasional pain in the scapular 
region and in the abdomen. On 30/7/53 she was discharged to a 
convalescent home where she continued to get better. 
She was repeatedly re- admitted to hospital for 2 -3 weeks 
each time from September to December 1953 because of abdominal 
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pain and vomiting. Finally on 12/7/54 she was re- admitted with 
abdominal pain, vomiting and slight weakness of her legs. She 
was found to be 72 months pregnant. She was given pethidine in 
large doses for her pain and gave birth precipitately to a live 
male infant on 15/7/54. Several hours later she had a generalized 
epileptic convulsion lasting 4 minutes. In the next 5 days she 
had 1 -4 fits each day. She developed a hypochloraemic alkalosis 
(Table 1) and her blood urea rose to 268 mg.; before death 
despite replacement therapy. She developed hypertension (B.P. 
135) 
for the first time since her illness. P.R. rose to 100/ 
minute. Urine contained protein. Mentally she was apathetic 
and withdrawn. She remained afebrile but died 27/7/54. 
P.M. showed basal consolidation of both lungs. Serum electro- 
lytes during final admission (see Table 1). Liver function 
tests (see Table 2). For chemical pathology of tissues see 
Table 3. 
Family History Her sister has porphobilinogen in her urine. 
The infant passed porphobilinogen in his urine for 2 days after 
birth. 
Summary A series of attacks lasting 20 months, the final fatal 
outcome occurring 10 days after the birth of a 72 months foetus. 
Epilepsy, hypertension followed the birth of the child. 
156 
Mr. R.G. Age 22 years (1944) Labourer Case No. 4 
He was first admitted to hospital, while in the R.A.F. 
in 1944, because of severe colicky abdominal pain and constip- 
ation. While in hospital he developed pains in the legs and 
paraesthesiae of feet and also became hallucinated, e.g. he said 
that there were birds in the bed and thousands of them in the 
ward. His legs, and later his arms, became weak but there was 
never any sensory loss. He was discharged from the R.A.F. and 
between 1945 and 1948 he had many attacks requiring 11 admissions 
to the Ayr County Hospital and 6 admissions to the Western 
Infirmary, Glasgow. In these hospitals the same kind of attack 
as above was recorded. In most attacks vomiting occurred. In 
the severest phase of abdominal colic his abdomen was noted to 
be rigid. Marked tenderness of thigh and calf muscles was found 
on several occasions and the knee tendon reflexes were transiently 
diminished. Mental confusion and hallucinations were repeatedly 
present. Skin infections were common and in one episode 
(September, 1948) a (R) lower lobe pneumonia occurred. The 
attacks usually lasted a few days to one month. There was 
always marked loss of weight during his attacks. His last major 
one was in September 1950. He was seen in 1952 when he stated 
that he still got mild attacks of abdominal discomfort lasting a 
few hours, every 3 -4 months. Afebrile during all attacks except 
119 when he had pneumonia. B.P. in severe attacks rose to and 
130 
pulse rate to 130 -150 /minute. E.C.G. normal. Hb. 15.5 G %. 
R.B.C. 5.46 million /emm. Reticulocyte count 2 %. W.B.C. 
5,400 /cmm. Liver function tests (see Table 2). 
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Treated with I.V. calcium gluconate, saline or glucose saline. 
Eucortone or DOCA and Vitamin B therapy had no apparent benefit. 
Summary A series of severe attacks with abdominal and neuro- 
psychiatric manifestations over a period of 6 years. 
Pirs. G.1í. Age 24 years (1955) Housewife Case No. 5 
This young woman was admitted to Grantham and Kesteven 
General Hospital on 29/3/55 because of weakness, constipation, 
vomiting and lower abdominal pain of 10 days' duration. The 
pain was usually a dull ache in the (R) iliac fossa, sometimes 
radiating to the (L) iliac fossa. She had lost some weight in 
the past few months and had been admitted to this hospital 4 
years previously with pain in the (R) iliac fossa. B.D. . 
100 
P.R. 99 -100 /minute. Temperature 99 °F. She was discharged 
after 1 week. 
She was re- admitted 6 weeks later, on 25/5/55, because 
of the recurrence of symptoms in the previous 3 weeks. There 
was tenderness on deep pressure low in the (R) iliac fossa. 
N.B.C. 19,000 /cmm. She was given sodium amytal on 2 occasions 
and later complained of numbness of her legs, abdomen and 
shoulders. There was diminished pain sensation on the skin of 
the abdomen and lower limbs. Started on cortisone 25 mg. /6 
hours with marked improvement. Discharged 28/7/55. Re- 
admitted 10/9/55 with recurrence of pain 5 days previously, as 
well as marked frontal headaches, associated with photophobia. 
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Given soneryl on night of admission and for 3 nights thereafter 
and started on cortisone, 25 mg. b.d. next day. 3 days after 
admission reddish urine was noted and a diagnosis of acute 
porphyria was made. She was given atropine, belladonna and 
pethidine. She was also given neostigmine 2 days before death. 
Her doctor felt that the atropine relieved her pain. She 
developed attacks of tachypnoea (40 /minute) on 9/9/55. W.B.C. 
45,300 /omm. There was some moist Ales in her chest. 2 days 
later marked muscle weakness and wasting was noted, particularly 
in the extensors of the wrist. The tendon reflexes of arms and 
legs were absent. There was a deterioration in her general 
condition on 22/9/55. She was breathing rapidly and was slightly 
cyanosed and later that day she died. 
The patient was "emotional" during her last admission 
and became disorientated prior to death. 
She was given cortisone 25 mg. q.ì.d. 13- 15/9/55. Her 
husband thought her symptoms became worse at the time of 
menstruation. She had delivered a normal child 2 years prior 
to her final illness. Urine:protein negative,micro. N.A.D. 
E.S.R. 8 mm /hour. lib. 105. Urine porphobilinogen + ++ 
Family History None of note. 
Summer á y 3 increasingly severe attacks within 6 months occurring 
in a young woman of 24 years. In the first attack gastro- 
intestinal symptoms only occurred; in the second paraesthesiae, 
and in the third and fatal attack paralysis occurred. The 
second and third attacks were associated with barbiturate 
administration. Normal pregnancy and delivery 2 years previously. 
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Erg J.S. Age 23 years (1954) Canteen Assistant Case No. 6 
This woman was admitted 22/9/54 to the General Infirmary, 
Salisbury, because of abdominal pain and vomiting. She had had 
amenorrhoea for 3 months prior to this and she had been given 
sulphonamides and butobarbitone as treatment for 1 week before 
admission. In hospital she was nervous and in pain. B.P. 
P.R. 76 /min. Temperature normal. Hb. 14 G %. W.B.C. 6,900/ 
cmm. E.S.R. 26 mm. /hour. (,{lestergren). Urine porphobilinogen 
120 mg. /litre. Urine: protein negative. The pain gradually 
settled and it was noted that she had a mass in her (R) fornix. 
A diagnosis of tuberculous endometritis was made on histological 
evidence and she was later treated with streptomycin and P.A.S. 
(para- amino-salicylic acid). She did not develop neurological 
manifestations and she had no further symptoms for 16 months 
after the attack, although she continued to excrete 26 mg. 
porphobilinogen /litre urine during remission. 
Previous History Appendicectomy at 16 years. At 21 years while 
in the Middle East she developed malaria and reported to her 
doctor that she could not feel her (L) leg. He could find no 
clinical abnormality and the limb soon returned to normal. 
Family History Not known. 
Summary A solitary attack associated with tuberculous 
endometritis in a young woman of 23 years. 
160 
Mr. W.J.S. 38 years (1950) Brewery Traveller Case No. 7 
Since 1950 he has had 4 attacks of abdominal pain, 
vomiting and neuropsychiatric symptoms, each attack following 
an alcoholic bout. 
1950 Nervous, irritable, numb feelings at back of head, hands 
and legs, anorexic, colicky abdominal painand vomiting. Passed 
red urine. On examination epigastric tenderness, sluggish 
reflexes. 
La 1953 He had a similar attack as well as lumbar pain 
radiating to shoulders, following an excess of gin drinking. 
On this occasion he complained of great muscle weakness in all 
his limbs, particularly in the upper limbs. P.R. 100 -120 /min. 
Tendon reflexes barely elicited. No sensory loss. C.S.F. 
normal. Hysterical throughout admission. Given seconal, 
sodium amytal and soneryl on various occasions throughout stay 
in hospital. Given aneuryn H01. and nicotinamide. 
Discharged July 1953. 
April l He had improved since his last admission to 
hospital but 3 weeks before this admission he had drunk a good 
deal. A similar attack occurred with the additional symptoms 
of thick speech, diplopia and diarrhoea as well as constipation. 
Examination showed absence of tendon reflexes except biceps; 
nystagmus in all directions. B.P. 
1Q0 
. Grade II retinopathy. 
C.S.F. normal. Urine gave a strong Ehrlich's aldehyde reaction. 
Childlike mental behaviour. Memory loss, disorientation. He 
became very much improved in 2 -3 weeks. During this period he 
was given seconal, membutal and veronal and at the time of his 
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discharge he continued to have seconal gr. 12 nocte. 
Treatment as before. 
November 1955 He remained well until 4 weeks before this 4th 
admission to hospital. He had again been drinking to excess 
and had started taking sodium amytal nightly, and noted that his 
urine had become red. Marked difficulty in walking. Unable to 
eat unaided. Limbs hypotonic. Tendon jerks absent. Coarse 
nystagmus. P.R. 100 -120 /min. Emotionally labile, hysterical 
behaviour. Porphobi inogen discovered in his urine and 
diagnosis of acute porphyria established. Treated with Vit. B 
therapy as before. Barbiturates discontinued. Gradual 
improvement after about 2 weeks. Muscular power improved. 
B.P. returned to normal, fundi normal and his mental condition 
greatly improved. 
On an examination in April 1956 he was completely normal 
apart from residual weakness of both wrists and small muscles of 
his hands. 
Liver function tests on his several admissicns showed some 
abnormalities, e.g. thymol turbidity 3 -4 units, cephalin 
flocculation + to + ++ (Table 2). W.B.C. usually about 6,000/ 
cnun. E.S.R. 5 mm. /hour. 
Family History Nil of note. 
Summary Four attacks of abdominal pain, vomiting and neuro- 
psychiatric symptoms of increasing severity associated with 
alcoholism and to some extent with barbiturate intake. 
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Mrs. P.I.A. 30 years (1953) Housewife Case No. 8 
This woman was admitted in December 1954 to Lincoln 
County hospital with periumbi Tical pain, recurrent vomiting and 
headaches of about 1 week's duration. She was constipated for 
180 
4 days before admission. B.P. . P.R. 130 /min. E.S.R. 
11 mm (Westergren) . Rb. 15.5 G%. N.B.C. 11,600 /cmni. 
Urine prophobilinogen 113 mg. /24 hours. Serum cholesterol 
322 mg. %. She was apathetic, drowsy and in pain for 1 -2 weeks 
but rapidly recovered. During the acute attack she had a 
series of epileptiform attacks without focal onset. B.P. 
returned tc 
90 
. Discharged 7.1.55. Treated with pethidine, 
atropine and morphia with beneficial results. Since then until 
May 1956 she has had no symptoms. 
Family History See Family 1 and cases 9 and 10. 
Summary Solitary attack with abdominal symptoms, hypertension 
and epilepsy. 
Mr. D.C. 26 years (1955) Driver Case No. 9 
Admitted to Lincoln County Hospital 4.1.55. because of 
severe abdominal pain, nausea, flatulance, vomiting and constipa- 
tion of 3 days' duration. The pain was dull and aching, mainly 
periumbi ical, but going through to both loins and back. No 
loss of weight or paraesthesiae. Slight tenderness over right 
rectus abdominis muscle and in both loins. B.P. "5 (normal in 
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protein. Haematological examination, normal except W.B.C. 12,600/ 
cmm. Liver function tests, normal (Table 2). Urine contained much 
porphobilinogen. No neurological signs. Skin was unusually pig- 
mented. Symptoms gradually settled in 8 days and he was 
discharged from hospital on 20.1.55. Treated with pethidine and 
atropine gr.., both of which helped him. He was well until 
100 
26.7.55. when he was admitted to hospital for a tendon and digital 
nerve repair operation following an arm injury. As an 
anaesthetic he was given I.V. thiopentone, gas and oxygen. Two 
days later he had severe periumbilical pain, vomiting, general 
malaise and constipation. There was some tingling in the (L) 
calf, and occasional difficulty in starting micturition but no 
neurological signs. This cleared up in a few days and he was 
discharged 2.8.55. He has been well since then. 
Family History See Family 1 and Cases 8 and 10. 
Summary One attack with abdominal pain and hypertension. A 
second attack followed an operation, for which I.V. thiopentone 
was given. 
Miss R.A. Age 11 years (1955) Schoolgirl Case No. 10 
She was seen in November, 1955, because of a family 
history of acute porphyria. She had been complaining at 
intervals of slight pains in the loins, for about 1 year. In 
October 1955 she had some subcostal pain - slight and quite 
transient. She had never had any really acute abdominal pain or 
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vomiting, headache or constipation. Menstruation had not 
commienced. Urine porphobilinogen 29 mg. /litre. Urine 3-h years 
previously contained no porphobilinogen. 
Family History See Family 1 and cases 8 and 9. 
Summary Transient loin and subcostal pain and porphobilinogen- 
uria in a child of 11 years. 
Nr. i?.F . A. Age 23 years (195h) Porter Case No. 11 
This man was first admitted to the North Middlesex 
Hospital, London, on 15/1/54 with central abdominal colicky pain, 
loss of appetite, nausea and vomiting cf 24 hours' duration. 
There was some tenderness in the lower abdomen particularly on 
the right but no guarding or rigidity and some rectal tenderness 
on pressure to the right anteriorly. B.P. . A laparotomy 
was performed and a normal appendix was removed. He continued 
tc have pain and also complained of weakness of his abdominal 
muscles and lower limbs and became nervous and irritable. He 
was treated with ultra- violet light and improved. In June 1954 
he developed nausea, anorexia, vomiting and complained of pains 
in his limbs. He was anxious and miserable. He was given 
phenobarbitone gr. 2 on 5 occasions while at home. On 15/6/54 
he was admitted to Claybury Hospital with general weakness and 
pains in his limb muscles. Temperature 100 °F. P.R. 95 -120/ 
minute. B.P. 
11 
. There was a peculiar pigmentation of the 
abdomen and flexures of his arms. He was given sodium amytal 
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gr. 3 on 12 occasions. For a short time he had sugar in the 
urine and a mild diabetic glucose tolerance curve. He became 
incontinent of urine and unruly, develcped nystagmus, analgesia 
of the (R) arm and leg, and diminished (R) knee and ankle tendon 
reflexes. There was fine tremor of all his muscles and his 
speech became slurred. His behaviour. became childlike. Urine 
(8/7/54) contained protein and granular casts. Blood urea 144 
mg. 
He was re- admitted to the North Middlesex Hospital on 
15/7/54. In view of the marked muscle weakness, including 
bilateral wrist -drop, and myasthenic appearance, he was given a 
course of prostigmine but this had no obvious effect. He made 
slow but steady improvement and became more co- operative. By 
3/8/54 he could walk unsupported and he insisted on taking his 
discharge. His urine contained large quantities of porpho- 
bilinogen. Hb. 13 Giá. R.B.C. 5 million /cmm. W.B.C. 
10,000 /cmm. 
Summary 2 attacks in a man of 23. In the first, with gastro-in- 
testinal symptoms, an appendicectomy was performed. At the 
onset of the second he Was given barbiturates and then developed 
severe neuropsychiatrie manifestations. Myasthenic appearance 
but no response to prostigmine. 
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Mrs. S.C. Age 28 years (1951) Housewife Case No. 12 
Between August, 1951, and March, 1953, this woman has had 
about 11 attacks of abdominal pain, vomiting, constipation, pains 
in the neck and thighs, often with loss of power of hands and 
arms and sometimes of legs and voice. These attacks came on 
several days before her menstrual period and would only alleviate 
1 -2 weeks after her period. Her longest remission was between 
May, 1952, and January, 1953, during which time she was on methyl 
testosterone. Her normal B.P. is 
lg5 
but with onset of 
abdominal pain there was usually a rise, e.g. 160 . Afebrile. 
120 
Mentally,she showed no abnormality apart from slight depression 
during phases of paralysis. There was no history of taking 
barbiturates. Since March 1953 she has made considerable pro- 
gross. There has been no further attack since then. The urine 
contained much porphobilinogen and uroporphyrin, during these 
attacks. The urinary uroporphyrin on 16/3/53 was 7.8 mg. /day. 
Further records - Hb. 13.1 g.%. N.B.C. 6,400/cmm. 
E.S.R. 16mm /hour (Westergren). Given courses of cortisone and 
A.C.T.H. without obvious benefit. 
Family History Her sister had a similar attack 4 years 
previously in the early months of her pregnancy. The urine was 
not tested. 
Summary Repeated attacks for 2 years with gastro -intestinal and 
neurological symptoms. No history of barbiturate intoxication. 
Attacks associated with onset of menses. Improvement with methyl 
testosterone administration. Cortisone therapy without benefit. 
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Miss J.M. Age 32 years (1953) Storekeeper Case No. 13 
This woman was admitted to the Southern General Hospital, 
Glasgow, on 11/3/53. 3 weeks before admission she developed 
pain and numbness with swelling on the (L) side of her face. 
3 days before her admission she suffered severe pain in the lower 
abdomen, vomited and was constipated. During the first 3 weeks 
of her stay in hospital she became weaker and wasted. She 
first complained of weakness of the (R) arm then also of the 
(L) arm and legs. Examination showed muscular wasting, around 
the shoulder joints, hips and thighs. There was absence of 
pin -prick sensation over the trunk and proximal portion of the 
limbs. Afebrile. B.P. 
115 -125 
70-80 throughout attack. P.R. 
120 /minute. There was slight tenderness in the abdomen, but no 
guarding. There was no mental abnormality. A course of 
cortisone was given to her from 3- 21/4/53. During this time 
she improved greatly and she was discharged on 7/5/53 in a fit 
state. Information from this patient on 4/8/54 states that 
she has kept very well, and has no abdominal pain or muscle 
weakness. 
Further records - the urine contained much porpho- 
bilinogen and porphyrins. Hb. 13 G%. R.B.C. 4.8 million/cmm. 
W.B.C. 6,80 0/cmm. There was no history of taking any drugs 
apart from occasional veganin before admission to hospital. 
Summary A neurological form of the disease with no history 
of barbiturate ingestion. Improvement associated with 
cortisone therapy. 
Plate 2(a). Appendix. 
Case No. 14. Wasting of hand muscles. 
Thenar muscles are obviously affected. 
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Mr. L.F. Age 24 years (1953) Post Office Technician Case No. 14 
This young man was admitted to Wanstead Hospital, London; 
in April 1953 because of colicky abdominal pain constantly present 
for 3 weeks. Shortly before the onset of the pain he had a 
boil. on (R) forearm, abscesses of (L) elbow and gum and a poisoned 
finger. His own doctor had given him 2 tablets of.. sòì.igin :eeach 
night for about 2 - 3 weeks before his admission to hospital 
in order to make him sleep. A diagnosis of acute porphyria 
was made since the urine contained much porphobilinogen. His 
symptoms subsided and he was discharged. He was re- admitted 
on 1/6/53 with marked weakness of upper and lower limbs, 
abdominal piir, vomiting and constipation. His legs and arms 
became paralysed with absence of all tendon reflexc', 
and pinprick sensation. This state continued for 
several months but he gradually improved and was able to walk and 
use his arms. He was discharged on 21/12/53. When seen on 
27/7/54 he still had some degree of wrist drop and foot drop and 
wasting of thenar, hypothenar and interossei muscles of both 
hands (Plates 2, a and b). In August 1954 he still had 
occasional cramps in his calf muscles and still felt that the 
skin of his legs was very sensitive. On 27/7/54 he excreted 
193 mg. porphobilinogen /litre of urine. There was no mental 
abnormality during his attack, although he admits that he felt 
like committing suicide when the pain was very severe. 
Further records -B.P.. P.R. 90 /minute. 
Hb. 16 G%. R.B.C. 5.5 million /cmm. Reticulocyte count 0.5 %. 
Urine - protein negative. 
Plate 2(b). Appendix. 
Case No. 14. Wasting of hand muscles. 
Interossei notably affected. 
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S_1umnar Multiple skin infections and barbiturate administration 
followed by gastro -intestinal symptoms. Severe neurological 
phase of the disease ensued later. Almost complete recovery of 
motor power within 1 year. 
Mrs. M.B. Age 56 years (1952) Housewife Case No. 15 
This woman was admitted to University College Hospital, 
London, on 6/7/52 with severe pain in the back and legs and 
tiredness and lassitude for 4 weeks. In the previous 2 -3 weeks 
her appetite had become poor and she was constipated. For 10 
days she had had attacks of mid -abdominal pain and vomiting and 
noted that her urine was dark. She had been taking pheno- 
barbitone gr. k b.d. for the past 12 -18 months and sodium amytal 
gr. 2 or 3 nightly for 10 days before admission. 
Examination showed that she was co- operative but rather 
drowsy and slow in response to questions. Temperature 98.4 °F. 
E.S.R. 5 mm /hour. P.R. 100 -120 /minute. B.P. . Apart 
from diminished pin -prick sensation and weakness in both legs, 
the examination of the nervous system was normal. The abdomen 
was flaccid and there was tenderness in the (R) hypochondrium 
and in both renal angles. The urine contained much porpho- 
bilinogen and 4.36 mg. uroporphyrin /day. The pain was relieved 
by pethidine and in a few days she became brighter and very co- 
operative. Her legs became stronger and her pulse rate fell to 
90 /minute. In 1 week's time her urinary uroporphyrin had fallen 
to 0.77 mg. /day. She was discharged on 19/7/52 and warned 
FAMILY 2. t0 t0 
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against taking barbiturates. 
She reported on 29/7/54, 2 years later, that she was 
feeling much better and had had no symptoms. Her urine then 
did not contain porphobilinogen. 
Further records - Hb. 14 0%. W.B.C. 8,600/cram. Blood 
urea 27 mg. %. Urine contained a trace of protein. Liver 
function tests (see Table 2) . Stool porphyrin - Coproporphyrin 
15Ofrg. /g. dry weight. Protoporphyrin 255pg. /g dry weight. 
Total blood porphyrin 27/ug. /100 ml. of blood (normal) . 
Family History Her eldest son had porphobilinogen in his urine. 
This was confirmed by paper chromatography in 1954. There was 
no porphobilinogen in his urine 2 years later. See Family 2. 
Sunman' Onset of an attack after prolonged ingestion of pheno- 
barbitone and sodium ámytal in a woman of 56 years. She had no 
porphobilinogen in her urine 2 and 4 years after her attack. 
Her son is a latent case. 
Mr. S.G.K. Age 59 years (1951) Foreman cleaner Case No. 16 
This man was admitted to Whittington Hospital, London, on 
10 /4/51. For 4 days he had complained of persistent colicky 
epigastric pain, vomiting and constipation. The day before his 
admission he had become incoherent and repetitious in his speech 
and could only see dimly. While he was being admitted to 
hospital he had a sudden epileptic fit, Jacksonian in type. 
This began with clonic movements of the (L) arm, then (L) leg 
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and finally both sides of the body. The clonic movements 
increased in violence for several minutes and he then settled 
into unconsciousness. Within 5 minutes he again became rest- 
less and violent and was given 0.3 g. pentothal I.V. He had 
been taking phenobarbitone and codeine every night for 2 years. 




W.B.C. 11,000 /cmrn. Hb. 18 G%. R.B.C. 
6 million /emm. The abdomen was soft and there was no tender- 
ness. There was no abnormality in the nervous system except 
extensor plantar responses immediately after the fit. C.S.F. 
normal. Serum electrolytes normal (Table 1). Liver function 
tests (Table 2) . Urine contained much porphobilinogen and 
16.4 mg. of uroporphyrin/day. 
He had no further epileptic fits and his vision returned 
to normal within 2 days. Within 1 week his abdominal pain had 
ceased and normal bowel motions had commenced. Mentally he was 
rather depressed. He was discharged from hospital on 25/4/51. 
He still felt very weak for the next 3 months and remained in 
bed. He reported that he slept badly and had difficulty in 
walking. After this he steadily improved. He reported on 
29/7/54 that he had been free from symptoms, apart from slight 
head pains, in the past 3 years. He had scrupulously avoided 
barbiturates. On 4/8/54 his urine contained 130 mg. 
porphobilinogenilitre and 2041ug. coproporphyrin /litre. 
Summary Onset of acute porphyria after 2 years of nightly 
phenobarbitone ingestion. Presented to hospital as a case of 
Jacksonian epilepsy. No further attack after 3 years but still 
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passes porphobilinogen in his urine. 
LT. D.H.U. Age 30 years (1950) Farm labourer Case No. 17 
This man was admitted to Bedford General Hospital on 
15/12/50. He had developed acute tonsillitis 2 weeks previously 
and with it he had abdominal pain, constipation and vomiting. 
Just before he was admitted he had a convulsive seizure. While 
sitting, his eyes had turned up, his limbs moved jerkily for 10 
minutes and there was slight frothing at the mouth. He remained 
in coma for 1 hour after this. He had been having epigastric 
pain intermittently for about 1 year. 
Examination on admission showed no abnormality in the 
nervous system. 
W.B.C. 21,000. 
B.P. 1f14 P.R. 100-110/minute. Afebrile. 
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E.S.R. gmm. /hour. He was put on phenobarbitone 
gr. t.d.s. and butobarbitone gr. 
admission he developed a bilateral 
limb and shoulder girdle muscles. 
lower motor neurone facial palsy. 
3 nocte p.r.n. 10 days after 
flaccid paralysis of the upper 
Later he developed a bilateral 
He improved after this until 
March 1951 when his voice became husky and he had a bovine cough. 
At this time, too, a bilateral flaccid paralysis and complete 
loss of superficial sensation in his lower limbs occurred. A 
lumbar puncture showed a normal C.S.F. He was transferred to 
the National Hospital, Queen Square, on 9/4/51 where it was noted 
that he had gross generalized involvement of motor power, 
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nerves, as well as extensive sensory impairment. An E.E.G. was 
normal. The urine was found to contain much porphobilinogen and 
51.15 mg. of uroporphyrin /day. He improved slightly and was 
discharged on 27/9/51 to Manfieîd Hospital. With physiotherapy 
his hand power improved, his legs were only little unproved. 
By September 1952 he had managed to walk a little with crutches. 
2 years later, September 1954, he was able to walk but he still 
felt his hands and legs somewhat weak. He had no abdominal pain. 
In 1956 he still had some flexion deformity of his fingers and 
had to wear an orthopoedic support in his shoes. 
Further records - Liver function tests (Table 2 ). 
Family-History Brother is Case 18. See Family 3. 
Summer Attack commencing with gastro-intestinal symptoms and 
an epileptic seizure. In hospital he received barbiturates and 
a very severe neurological involvement occurred. It is of 
interest that his brother who was never given barbiturates had a 
much less severe attack (Case No. 18). 
Mr. C.W. Age 30 years (1953) Farm labourer Case No. 18 
This man is a younger brother of D.H.W. (Case No. 17). 
In 1951 his urine contained porphobilinogen and 2.645 mg. /litre 
of uroporphyrin. His urine had been tested routinely, since his 
brother was an established case of acute porphyria. He had no 
symptoms, however, until 5 days before his admission to Bedford 
General Hospital in 13/4/53. He then complained of severe, 
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continuous,gnawing pain in the (L) lumbar region, passing down to 
the left iliac fossa, vomiting and slight diarrhoea. He was 
sleepless and passed dark urine. There was no history of 
barbiturate ingestion. 
Examination on admission showed that he was anxious. 
There was no abdominal guarding or rigidity but a deep tenderness 
about the umbilicus. There was nothing abnormal in the nervous 
system. B.P. . P.R. 100 /minute. Afebrile. Hb. 13 GIB. 
94 
R.B.C. 4.41 million/cmm. W.B.C. 10,000 /cmm. The urine contained 
much porphobilinogen and uroporphyrin but no protein. Pethidine 
was used successfully for the relief of pain. 
Within 7 days of his admission his pain had gone and he 
was discharged on 25/4/53. He was seen again on 18/7/53. He 
had had a slight backache associated with the passage of darker 
urine than normal but was otherwise well. He was well in July 
1956 but still excreted 92 mg. /litre porphobilinogen in his urine. 
Family History See Family 3. 
Summary Short, sharp attack with lumbar pain and diarrhoea. 
Note same age of onset as brother (Case No. 17). 
Mr. J.L.S. Age 37 years (1951) Engineer Case No. 19 
This mat was admitted to Whittington Hospital, London, on 
26/5/51 with the sudden onset of anterior central chest pain and 
shortness of breath of 1 day's duration. The pain lasted several 
hours and was relieved by an injection of morphia. Y.R. 100/ 
minute. Temperature 99- 100 °F. W.B.C. 5,000 / mm. Hb. 15.5 G. 
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Urine contained much porphobilinogen. There was recurrence of 
substernal pain and breathlessness the next day but he eventually 
settled down and was discharged on 6/6/51. For about 1 year 
before this admission he had been given a small white tablet 
b.d. which made him "dopey" and for 7 days before admission he 
had been given daily injections into his arm which also made him 
sleepy. These drugs have been ascertained as phenobarbitone and 
sodium amytal during the first 7 months of this period but it has 
not been possible to make sure what kind of drug was given there- 
after. There was a previous history since 1942 of abdominal 
pain coming on z hour after meals and sometimes eased by medicines. 
In 1945 he was discharged from the Army because of a 'duodenal 
ulcer' and in 194e he had an appendicectomy, at which a normal 
appendix was removed. 
After his discharge from hospital he continued to have 
severe pressing, upper abdominal pain, sometimes relieved by food. 
he was re- admitted in March 1953 when a partial gastrectomy was 
performed. The pathologist reported a simple ulcer of the lesser 
curvature of the stomach. 
He was last seen on 11/1/54 when he reported that he had 
had no abdominal pain since his operation. 
Further records - his urine on 21/1/53 contained porpho- 
bilinogen and 0.6 mg. /litre of uroporphyrin. 
Summary The association of porphobilinogenuria with a gastric 
ulcer. Onset of his "attack" unusual - anterior chest pain and 
breathlessness but no other cause for these symptoms could be 
found. Had taken sleeping tablets for 1 year prior to onset. 
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Mrs. B.S. .ge 23 years (1953) Housewife Case No. 20 
This patient was admitted to the royal Infirmary, 
Sheffield, in March 1953 with a history of abdominal pain, con- 
stipation and paraesthesia of her feet. This occurred at the 
time of her period, which was not suppressed. Examination 
showed generalised abdominal tenderness. There was no neurolog- 
ical abnormality. E.Y. 160 . Temperature 99- 100 °F. P.R. 
100- 110 /minute. W.B.C. 5- 10,000 /cmm. E.S.R. 6mm /hour 
(Westergren). Her symptoms settled in a few weeks and she was 
discharged 19/6/53. She was re- admitted 2 months later with a 
second, milder attack of abdominal pain. On this occasion her 
urine contained much porphobilinogen and 7.3 mg. /litre uro- 
porphyrin. 
She was seen in April 1954, when she had become pregnant 
and had had no further episodes of pain since her last normal 
period. She remained symptom -free during her pregnancy but had 
a return of abdominal pain after delivery for a short time. 
She was last seen in April 1956 and had had no further symptoms 
since then. 
Summary 2 mild attacks. Pregnancy without incident but 
exacerbation immediately after delivery. 
Mr. R.F. Age 43 years (1952) Motor mechanic Case No. 21 
This man had occasional abdominal pain with constipation 
from the age of 35. He was admitted to Birkenhead General 
Hospital aged 43 years in May, 1952, with a 4 day history of 
Plate 3(a) Appendix. 
Case No. 21. 
Plate 3(b) Appendix. 
Case No. 21. 
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colicky abdominal pain beginning in the (R) iliac fossa, anorexia, 
vomiting and slight difficulty in micturition. There was tender- 
ness and some rigidity in the (R) iliac fossa. A laparotomy was 
performed and a normal appendix was removed. Intravenous 
pentothal was given at operation. Barbiturates (type unknown) 
had been given by his own doctor at home between 1950-1952. He 
was re- admitted to hospital in June 1952, with general weakness 
and loss of weight. On this occasion he was given seconal and 
nembutal. He was re- admitted once again in July 1952, and on 
this occasion porphobilinogen was discovered in his urine. He 
was generally weak and there was wasting and tenderness in the 
muscles of the shoulder girdle, hips and face (Elates 3 a and b). 
There was slight impairment of superficial sensation over cervical' 
5 and 6 dermatomes, numbness of posterior aspect of thighs and 
tenderness and hyperalgesia of the scrotal area. He was 
constipated on admission, but had diarrhoea for several days 
after admission. There was loss of sensation in the bladder 
with difficulty in starting micturition and he had to be 
catheterised for some days. His condition deteriorated for 
several weeks following admission and he became mentally confused 
and irrational with lucid intervals. The muscular weakness 
progressed from proximal to distal muscles and he developed wrist 
drop with flexion at metacarpo-phalangeal joints with extension 
at interphalangeal joints (Plates 3 a and b). His speech became 
slurred, he had difficulty in swallowing; there was intercostal 
breathing and almost complete paralysis of his legs. Throughout 
this time he had intermittent attacks of severe colicky pains with 
FAMILY 4. 
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marked perspiration. After this regression his condition remained 
stationary for about 1 month and he then made steady progress. 
He was discharged in December, 1952, not completely recovered, but 
he gained strength at home. He was seen again in 1954. Although 
he still gets occasional cramplike pain in the lower abdomen and 
legs, he has returned to work and leads a normal life. His 
urine still becomes dark on standing. In August 1956 he had 
completely recovered, but continued to excrete porphobilinogen in 
the urine. 
Further records He was afebrile throughout his illness apart 
from one occasion when he had an upper respiratory infection. 
His pulse rate remained at 105- 120 /minute during his severe phase. 
E.P. 7p , but this was only taken when he was recovering. E.C.G., 
C.S.F. - normal. Eb. 13.6 G %, R.B.C. 5.2 million/Om. W.B.C. 
9, C0 %run. Urine contained no protein. 
Liver function tests (Table 2). Serum electrolytes 
(Table 1). 
Family History He has 2 sisters, both of whom excrete porpho- 
bilinogen in the urine. One of these (Mrs. D.K . , Case No. 22) 
has had symptoms. See Family 4. 
Summary A prolonged attack with quadriparalysis and cranial 
nerve involvement. Barbiturates, including seconal given. 
Complete recovery. 
179 
Mrs. D.K. Age 36 years (1949) Housewife Case No. 22 
This woman is a sister of Case No. 21. On routine 
examination in 1952, much porphobilinogen was found in her urine. 
In 1949, 2 weeks after the birth of twins, she developed an 
"acute tonsillitis ". Shortly after this she complained of ab- 
dominal pain, constipation, pains in the legs, blurring of vision 
and headaches. Admitted to hospital 3 -9 -49; noted to be dis- 
orientated and restless, tendon reflexes sluggish, C.S.F. normal, 
tachycardia, B.P. 100 . 
She gradually became raticnal, but still 
complained of generalised pains. One month after admission she 
wac discharged, although she complained of leg pains. The patient 
remembered that her urine became very dark during this illness. 
In 1950 she was admitted to hospital because of chest 
pains. Since then (until 1956) there have been no further 
symptoms, suggestive of acute porphyria. Before the birth of her 
twins, she had 2 other children in 1937 and 1944. 
Family History See Family 4 and Case No. 21. 
Summary One attack in a woman aged 36 years, commencing 2 weeks 
after the birth of twins. 
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Miss J.F. Age 17 years (1952) Schoolgirl Case No. 23 
This young girl died after an explosive first attack of 
acute porphyria. About 2 months before her death she became 
restless and sleepless at night. 8 days before her death she 
began to vomit and have frequent cramp -like abdominal pain, first 
on one side then on the other. There was constipation and some 
abdominal distension. She was given 2 tablets of soneryl (gr. l4) 
on 3 or 4 nights for her sleeplessness. Her mother noted that she 
passed dark urine, which stained her pyjamas brown. Four days 
before her death she developed retention of urine, paraesthesiae in 
the genital area and had difficulty in focusing her eyes. Her 
speech became nasal and slurred, she had difficulty in swIllowing 
and her legs became weak. Her breathing was rapid. She was 
admitted to the London Clinic where her general weakness increased. 
While there she was given phenobarbitone and soneryl. She was 
admitted on 5.9.52., 2 days before her death, to the National 
Hospital for Nervous Diseases, Queen Square, London. 
On examination there, she was anxious, restless, agitated 
and confused. Her pupils did not react to light. There was 
well -marked palatal weakness and fluid regurgitated through her 
nose. The power of her limbs and trunk muscles was diminished 
and the lower limb reflexes were absent. There was a doubtful 
(R) extensor plantar response. Her intercostal muscles were 
weak. There was a vague level, mid -thoracic, below which all 
forms of sensation were impaired. B.P. ig Pulse 120 /minute. 
Afebrile. Respiration 30 /minute. She was given hexamethonium 
30 mg. 3 hourly which brought her B.P. down to 
b0 
for a short 
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period after each injection. Two days after admission her 
breathing became irregular and jerky and despite artificial 
respiration with the Bragg -. ul apparatus she died on 10.9.52. 
Further records Urine - Porphobilinogen 248mg /litre. 
Uroperphyrin 96.8mg /litre. 
Paper chromatographic investigation of the urinary porphyrin 
showed it to be entirely uroporphyrin series III. Chemical 
pathology of P.M. liver - Table 3. 
Summary An explosive fatal attack in a girl of 17 years. Onset 
of restlessness and insomnia; severe neurological manifestations; 
barbiturates given on several occasions. 
Mr. N.C.B.W. Age 33 years (1953) Lorry driver Case No. 24 
This man was admitted to Whancliffe Hospital, Sheffield, 
with a history of pain in both shoulders (R) knee and sacral 
region of 1 week's duration. He also complained of constipation 
and numbness in the upper part of thighs and genitalia. In 
1944 he had similar pains and they had been diagnosed as being 
caused by rheumatic fever, but he remembered that he then passed 
red urine. On examination it was noted that he was hysterical, 
there was muscular inco- ordination of his limbs, diminished pain 
and light touch sensation in the 'bathing trunks' area and a 
nystagmus to the left. There was no abdominal tenderness. 
B.P. l7Ó Before he was diagnosed as a case of acute porphyria 
he was given seconal gr. 3 each night from 27.2.53. to 4.3.53. 
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He became generally weak, was unable to swallow and there was 
difficulty in coughing. He became incontinent, rambling and 
noisy and died on 8.3.53. 
Further records He remained afebrile throughout this period ex- 
cept during the day before his death when his temperature rcse 
to 100 °F. Pulse Rate 100- 120 /minute. Hb. 14.8 G. E.S.R. 
6mnì. /hour. W.B.C. 12,000 /enrol. Blood urea 48 mg%. Urine 
(7.3.53.) contained 19.6 mg /litre of porphobilinogen and 12 mg./ 
litre uroporphyrin, identified later as uroporphyrin series III. 
Post -mortem showed fatty degeneration of the liver, gross gastric 
petechial haemorrhages and pulmonary and cerebral congestion. 
Foci of demyelination were found in the white matter of the 
cerebellum. (See table 4). Chemical pathology of P.M. tissues - 
see table 3. 
There was no family history of note. His 2 children did 
not excrete porphobilinogen in their urines. 
Summary An explosive, fatal attack onset by articular pain. 
Death from general paresis 4 days' after administration of 
seconal. 
Missla.E. Age 21 years (1951) Whisky- bond worker. Case No. 25 
This patient was admitted to the Western Infirmary, Glasgow, 
19.1.51., with a history of lower abdominal pain, nausea and 
vomiting of 2 days' duration. The abdominal pain was constantly 
present, but more severe and colicky at times and she also had 
Plate 4. Appendix. 
Case No. 2 . At this time she 
oftenscrened, had visual 
hallucinations and threatened 
to commit suicide. 
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pains in the medial aspect of her thighs. Her mother had noted 
that she was thinner and less active since 2 months previously. 
On examination it was noted that she was anxious, crying and 
cyanosed. Temperature 102 °F., Pulse Rate 140 /minute and B.P. 
150 W.B.C. 8,200 /cum. There was slight abdominal tenderness, 
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but no rigidity. The urine was claret -coloured and contained 
much porphobilinogen. She menstruated 3 days after her 
admission, the abdominal pains lessened and the B.P. fell to 
115 
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One month after her admission (19.2.51) she commenced a 
prolonged attack lasting 6 weeks with almost constant abdominal 
pain, tachycardia and amenorrhoea with loss of weight. She 
often screamed, had visual hallucinations and threatened suicide 
(Plate 4). By 27.3.51. she became weak, hypotensive (B.F. 
54)' 
somewhat dehydrated and was still in considerable pain. She was 
given 850 ml. of normal saline by subcutaneous drip using 9 mg. 
hyaluronides and started on a course of A.C.T.H. 12.5 mg 6 H. 
intramuscularly (50 mg /day) lasting 1 week (Fig.l). Her general 
condition improved greatly within 1 -2 days. Her pain diminished, 
B.P. rose to 120 and she became somewhat euphoric. She then 
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proceeded to a remission lasting for 1 year. Her periods 
returned in July 1951, she put on weight, but mentally she was 
quieter and "different ". 
She was re- admitted to hospital on 26.1.52. and remained 
there for the next 4 months with an attack similar to her previous 
one. She was given nembutal gr. 12 in error, and this coincided 
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of A.C.T.H. and developed an erysipelas -like rash of her leg and 
a temperature of 103 °F. She was very weak at this stage, her 
serum chlorides were diminished (Table 1), and on 26.2.52., after 
a period of overbreathing (respirations 46 /minute), she developed 
a tetanic spasm of her hands which were in the position of main 
d'accoucheur. During this spasm her serum calcium was 9.0 mg, 
and CO2 combining power 67 vols%. She gradually improved after 
antibiotic therapy, but there was considerable generalised 
muscular weakness for some time. There were no abnormal neuro- 
logical signs apart from this muscular weakness and absent knee 
tendon reflexes. During this phase she had complained of 
abdominal pains and shooting pains in her legs, but these, too, 
diminished. She was discharged from hospital on 14.4..52., since 
when she has had no further attacks. She reported in August 
1954, that she was working on a farm and feeling very fit. 
Further records Liver function tests (Table 2) normal. 
Hb. 13 G %. R.B.C. 4.499 million /cmm. Reticulocytes 1%. Urine 
contained no protein. There was no relevant family history. 
Summary 2 severe attacks, one in 1951, the ether in 1952. 
Severe abdominal pain and psychotic changes occurred in both 
attacks. In the first attack administration of A.C.T.H. was 
associated with improvement. In the second attack she was 
given nembutal gr. 12 in error and developed generalised muscular 
weakness. She made a complete recovery. 
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Mrs. J.G. Age 19 years (1949) Housewife Case No. 26 
This girl was admitted to Whittington Hospital, London, 
28.12.49. because of severe generalised abdominal pain, vomiting 
and constipation. These symptoms had been coming on gradually 
for a few months, but had become much more severe just before 
admission. On 29.12.49. her appendix was removed. A few days 
later she complained of weakness of the back, arms and thighs. 
She was discharged on 7.1.50. While in this hospital, she had 
been given soneryl gr. 3 on two occasions. At horse she still 
felt unwell; she shivered, coughed and there was increasing 
weakness of her muscles. She was admitted to Coppetts Wood 
Hospital, London, as a case of poliomyelitis. 
On examination, it was noted that there was weakness of 
the face, limbs and trunk. Afebrile. Pulse rate 110 /minute. 
W.B.C. 12,000 /cmm. Hb. 12.6 Gig. R.B.C. 6.06 million /cmm. 
C.S.F. was normal. Urine was pink in colour and contained much 
porphobilinogen and 48 mg/litre of uroporphyrin (19.1.50); it 
also contained a trace of protein. She became much weaker. 
First her arms and then her legs became paralysed. There was no 
sensory loss. She was mentally clouded and could not speak. 
There was amenorrhoea and loss of 3 stones in weight. She 
gradually improved and after 3 months she was transferred to the 
Metropolitan Hospital, where she remained for 2 months. She put 
on weight, her periods returned and her legs and arms recovered 
their power. Since August 1950, she has been well although she 
continues to pass porphobilinogen in her urine. She had her 
first baby in June 1952, and there was no trouble during pregnancy. 
She reported in July 1954 that she was well, had had no abdominal 
pain and was 5 months pregnant. 
Family History Her 2 cousins are said to have died from a 
similar condition. 
Summary A very severe attack with marked neurological signs, 
commencing as a simple attack with gastro- intestinal symptoms 
during which barbiturates were given. 2 normal pregnancies 
since her complete recovery. 
Mrs. B.H. Age 23 years (1953) Hairdresser Case No. 27 
This young woman had been healthy until 4 days before her 
admission to the Western Infirmary, Glasgow, on 1.7.53., because 
of pain, nausea, vomiting and constipation. The pain started 
across the lumbar region and radiated anteriorly and downwards 
into both groins and thighs; it was constant though varying in 
severity. She had never been given barbiturates. B.P. 
Pulse rate 140 /minute. Afebrile. E.S.R. 6mm /hour (Westergren). 
W.B.C. 7,200/cmm. Hb. 14 R.B.C. 4.8 mill /cmra. Urine 
contained much p orphobilinogen and porphyrins. There were no 
abnormal neurological signs. The pain settled about 6 days after 
her admission and she was discharged shortly afterwards. She was 
well when seen 1 year later. 
Further records Liver function tests - Table 2. 
Summary Single short attack. 
Site of pain unusual. 
No paralysis or hypertension. 
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Mrs. M.S. Age 23 years (1953) Civil Servant & Housewife Case No. 28 
This young woman had been suffering from intermittent 
attacks of abdominal pain and vomiting lasting about 12 hours for 
3 months before her first admission to the North Middlesex 
hospital, London, 7.10.53. For one week before her admission 
she had severe,constant,epigastric pain and insomnia, for which 
she was given sodium amytal and phenobarbitone. One day before 
her admission she had a generalised epileptic attack and this was 
the presenting cause of her admission. Her husband had noted a 
slight personality change in her - she had become quieter, more 
subdued and annoyed by small things. She never had had fits 
previously nor was there epilepsy in the family. 
On admission she was given intramuscular phenobarbitone 
gr. 3 on 2 occasions and phenobarbitone gr. z t.d.s. by mouth. 
A series of generalised clonic convulsions followed during the 
next 2 days and ceased when barbiturates were terminated on the 
diagnosis of acute porphyria. She continued to have inter- 
mittent abdominal pain for a few weeks, but this gradually 
lessened and she was discharged on 30.10.53. Her B.P. had risen 
during her attack to lßó and fell to a basal level of . 
Pulse rate rose to 120 /minute. Afebrile. The urine contained 
much porphobilinogen and 9.33 mg /day of uroporphyrin. Hb. 
12 G;. Liver Function Tests - normal (Table 2). Urine had a 
trace of protein. 
She was re- admitted to hospital on 23.2.54. and again on 
25.6.54. for further attacks of abdominal pain, constipation and 
vomiting with hypertension. There were no convulsions on these 
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occasions. These attacks were associated with increases in por- 
phobilinogen output. On each occasion the pain settled and she 
was able to be discharged in 1 -2 weeks. 
All 3 attacks commenced at the time of her menstrual 
periods which were delayed by 5 -10 days. 
Family History Nothing of note except that her mother has migraine. 
Summary This woman was admitted to hospital because of epilepsy, 
for which barbiturates were given. Epileptic fits ceased when 
the barbiturates were discontinued. 
Mrs.2.F.A. Age 46 years (1951) Housewife Case No. 29 
This woman was admitted to the National Hospital, Queen 
Square, London, on 23.1.51. 6 weeks before her admission she 
developed a "herpetic`' rash on the upper sternum and (L) side of 
her neck. She slept badly at this time and was given sleeping 
tablets and injections. 1 week later she started to vomit and 
continued to do so for about 2 weeks. 4 weeks before her ad- 
mission she had a sudden acute abdominal pain in the region of 
the umbilicus. The pain lessened but was followed by a dull 
abdominal ache and pain across the middle of the chest. These 
pains lessened in the next few weeks. She also became nervous 
and melancholic and was afraid that she might commit suicide. 
She developed pains in the soles of her feet and was unable to put 
her weight on them. She was seen by a psychiatrist and was 
admitted to Shenley Mental Hospital. While there she became 
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wearer and her abdominal pain continued. She had temporary 
diplopia. It was noted that she had nystagmus, slurred speech, 
dysdiadokokinesia, and tremor of her tongue. She was then trans- 
ferred to the National Hospital, Queen Square, London, as a case 
of post- herpet is encephalitis. 
On examination at that hospital it was noted that she was 
co- operative, slow in action and speech and cried easily. There 
was a (R) ptosis, general muscular weakness and tenderness, and 
absent knee and ankle tendon reflexes. There was no sensory 
loss, except a possible hypoalgesia of cervical 3 -5 dermatomes 
on the (L) side. B.P. 
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. Pulse rate 120 /minute. Tempera- 
ture 101 °F on admission, but this settled to normal in 3 days. 
E.S.R. 19 mm /1 hour. Hb. 13 G . R.B.C. 4.42 million /cmrn. 
W.B.C. 4,100 /cram. The urine contained much porphobilinogen and 
porphyr ins and a trace of protein. 
Her condition gradually improved; the abdominal pain 
lessened and she became stronger. This improvement was marred 
by a thrombophlebitis but she was well enough to be discharged on 
7.3.51. Mentally she returned to normal. She herself states 
that she felt much more stable when she realised that her doctors 
had found some cause for her symptoms and did not attribute them 
to 'nerves'. 
She reported on 3.8.54. that she was very well. She had 
had no pain for over 3 years. Her urine on that date contained 
no porphobilinogen. In 1956 she had had no recurrence of her 
disease. 
Further records Liver function tests - Table 2. L.E.G. was 
'slightly abnormal' (p. 30 ). 
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Family History Her grandmother had an episode of paralysis. 
Her paternal uncle had depression and committed suicide. 
Sumrnau An attack following herpes zoster and the administration 
of "sleeping tablets". Neuropsychiatri e manifestations. 
Mrs. D.J. Age 19 years (1955) Housewife Case No. 30 
This patient was admitted to Maelor General Hospital, 
Wrexham, on 13/6/55, during the first month of her pregnancy, 
because of abdominal pain and vomiting of 48 hours duration. 
She was also constipated and complained of generalised trunk and 
limb pains. Before the diagnosis was suspected she was given 
nembutal gr. lz and this was repeated 4 times in the next 5 days. 
10 days after admission she complained of extreme generalised 
muscular tenderness and about 1 week later there was marked 
weakness of her arms and legs with wasting of limb muscles, 
impairment of pin -prick sensation over the front of her thighs 
and legs and absent upper limb and weak (R) knee tendon reflexes. 
Her B.P. on admission was 190 but rose to with the onset of 
limb weakness. There was marked retinal artery spasm. Her 
P.R. was usually about 110- 120 /ninute. She had one episode of 
pyrexia (101°F) which resolved in 3 days and this was possibly 
due to a mild urinary infection. During her attacks she was 
very miserable and unto -operative. Hb. 14.8 G°. W.B.C. 4,400/ 
cmm. Reticulocyte count 1.5%. She was treated with pethidine 
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prostigmine were given without benefit. 'Ansolysen' retard I.M. 
did control the hypertension but had no effect on pain. She 
developed intercostal muscle weakness but did not require an 
artificial respirator. There was difficulty in taking food and 
fluids and she had to be fed by intragastric drip from 12/7/55 to 
3/9/55. her condition gradually improved although she complained 
of pain in her back and lower abdomen. She gave birth 
spontaneously to a live 7 month old infant on 13/12/55. One 
hour after delivery her pulse rose to 160 /minute. She was trans- 
fused with blood but after less than z pint had been given she 
collapsed and died. The infant died 11 hours after birth. 
Urine porphobilinogen 127 mg /litre (24/6/S5), SO mg /litre 
(13/9/55). 
Lally-History Nil of note. See family 5. 
Summary A severe attack in a girl of 19 years commencing in the 
first month of pregnancy and terminating fatally a few hours 
after the premature birth of her child, who also died. Neuro- 
logical manifestations associated with barbiturate administration. 
Mr. E.E. Age 34 years (1949) Clerk Case No. 31 
In July 1949, this man was admitted to hospital because 
of a purulent (R) maxillary sinusitis, following a tooth 
extraction 1 month previously. he was also sleepless and con- 
stipated. I- e was given penicillin injections and also pheno- 
barbitone daily and discharged in 10 days. Towards the end of 
this period he had severe epigastric pain and flatulence and felt 
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very unwell. These symptoms continued while he was at home, but 
lessened and disappeared after 14 days. 
He was well until May 1953, when he complained of pain in 
the (R) temple for which he was given sodium amytal and pheno- 
barbitone gr. 2 daily for 5 days. He then developed considerable 
weakness of his legs, severe epigastric pain, violent vomiting 
and insomnia. he was admitted to Croydon General Hospital where 
porphobilinogen was found in his urine. He was depressed and 
lacrimose and later became somnolent and unco-operative. He had 
marked general weakness, especially of hands and legs. B.P. 
160 Pulse rate 90- 110 /minute. Temperature 93.4°F.- 100°F. 
100 
E.S.R. 6mm /1 hour. Blood urea 90 mg% urea clearance 46% of 
average normal. Urine - trace protein. 
He remained very weak for 3 weeks; 10 days after his 
admission he developed a (L) femoral vein thrombosis. His legs 
regained their power and he was discharged 17.7.53., 5 weeks after 
admission. His fingers still remained weak for the next 6 
months but improved rapidly after treatment with wax baths. 
When seen on 20.8.54. he was very well. There was no 
porphobilinogen in his urine. 
Family record The urines of his mother, father, son and 
daughter contained no porphobilinogen. 
Summary 2 attacks in 1949 and 1953; neurological symptoms in 
1953; a history of barbiturate administration in both 1949 and 
1953. 
Plate 5. Appendix. 
Case No. 32. 
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Miss À.W. xge 20 years (1952) Employed at home. Case No. 32 
This girl was quite well until 10 weeks before her death 
on 14.3.52. She first complained of lower abdominal pain, 
constipation, vomiting and dysuria. She was admitted to the 
Deaconess Hospital, Edinburgh, where extensor plantar responses 
were noted on examination and a mild urinary infection was treated 
with streptomycin. She was also given phenobarbitone gr. z 
t.d.s. for 3 weeks since she was difficult to control and very 
nervous. On one or two occasions she received sodium luminal 
when her pain was severe. She was discharged after 1 month, 
during which period she had lost 1 stone in weight. She then 
went on holiday to Glasgow, but while there she developed weakness 
of arms and legs. She became markedly hysterical and was 
admitted to Glasgow Royal Mental Hospital, where porphobilinogen 
in large amounts was found in the urine. She was transferred to 
the Western Infirmary, Glasgow, on 11.3.52. and died 3 days later. 
During this short period her muscular weakness had progressed to 
a complete flaccid quadriplegia with absence of tendon reflexes 
and plantar reflexes (Plate 5). Sensation was normal. There 
was nystagmus and difficulty in swallowing, micturition and 
breathing. She died in a Drinker Respirator. 
Further records (11- 14.3.52.) Pulse rate 110 -120 /minute. B.P. 
128 L.S.R. Wintrobe - 2mm/1 hour. W.B.C. 12,300 /cimn (Neutro- 
phil polymorphs 82 %. Lymphocytes 1010. Monocytes 8%) . 
Hb. 15.5 G%. R.B.C. 5.62 million /cmn. Volume of packed red 
cells 55,50,5070. Urine had trace of protein and large quantities 
of porphobilinogen. Serum sodium and potassium normal, 
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chlorides diminished (Table 1). Empirical liver function tests - 
normal (Table 2) . 
P.M. port (Dr. J.B. Gibson). This was not remarkable with the 
exception of the lungs and nervous system. In the lungs there 
were patches of collapse and haemorrhage, apparently due to 
respiratory embarrassment. The pathological findings in the ner- 
vous system are summarised in Table 4. 
Family History Nil except her brother had infantile paralysis. 
Summary A fatal first attack in a girl of 20 years. Pheno- 
barbitone and sodium amytal given. Quadriparalysis, respiratory 
paralysis, death. 
K.B. . Age 14 years (1953) Schoolba Case No. 33 
This boy had a fatal attack of acute porphyria in 1953 
lasting 7 weeks. For about 1 year before this he had occasional 
attacks of colicky abdominal pain about every 2 months and lasting 
1 day. 
On 18.7.53. he started to have abdominal pain once again 
and this continued for 5 days, when he had a generalised 
epileptiform convulsion lasting 5-10 minutes, with jerking of all 
limbs, tongue -biting, and incontinence. He was admitted to 
Peterborough Memorial Hospital (23.7.53), where phenobarbitone 
was given in large doses for 1 week to control his fits. While 
there he developed a flaccid quadriparalysis, papilloedema and a 
B.P. of 5 . On 21.8.53. he was transferred to the National 
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Hospital for Nervous Diseases, Queen Square, London. He was noted 
to be a wasted ill -looking boy who was drowsy but co- operative. 
There was slight neck stiffness and early papilloedema of the (L) 
fundus and irregular narrowing of the retinal arteries. All 
limb muscles were wasted and tender. He could not sit up unaided. 
The knee tendon reflexes were absent. There was a feeble (R) 
extensor plantar response and hypoalgesia over his shins. 
Afebrile. P.R. 106 /minute. B.P. 
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. He continued to have 
fits, became restless and noisy. He was put on hexamethonirm 
bromide 25 mg. 3 hourly for 36 hours, but this was only effective 
in reducing the B.P. for short periods. 
He became more restless and inaccessible with lucid 
intervals. On 3.9.53. he became dyspnoeic, had 3 small fits and 
died next morning in coma. 
Further records W.B.C. 6,8CO /crnm. Hb. 160 %. R.B.C. 
5.68 million /cmm. E.S.R. 3mm /1 hour. Liver function tests - 
Table (2). Serum electrolytes Table (1). The urine contained 
much porphobilinogen. C.S.F. - normal. E.E.G. abnormal (p.29 ). 
Family- History His married sister, age 25 years, developed 
abdominal pain and vomiting in October 1952, followed by fits and 
paralysis of both legs. She died after 5 weeks. The urine of 
this patient was not tested for porphobilinogen. His parents 
and 5 remaining brothers and sisters are well and have no 
porphobilinogen in their urines. 
Summary A fatal attack, lasting 7 weeks in a boy of 14 years 
with abdominal pain, epileptic fits, papilloedema, hypertension 
and gross paralysis of limbs and respiration. Intermittent 
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bouts of abdominal pain for 1 year before this. His sister 
died of a similar condition, also with fits 1 year previously. 
Barbiturates given to the boy before onset of paralysis. 
Miss J.D. Age 33 years (1951) ñairdresser Case No. 34 
This woman has had 6 attacks of abdominal pain and 
vomiting from 1951 tc 1953. In October, 1951, she had acute 
abdominal pain, constipation, vomiting and frequency of 
mic Lurition for which a laparotomy was performed in Cumberland 
Infirmary, Carlisle. No abnormality was found. The symptoms 
continued for 3 weeks after operation. On 28.2.52. she had 
another attack of severe abdominal pain and vomiting, and 
although excess porphyrins were then found in the urine, a 
second operation was done because of the fear of a possible 
intestinal obstruction. She continued to vomit after operation 
and burst her operation wound as a result of this. On 16.8.52. 
she was admitted to the western Infirmary, Glasgow, with a 
similar attack lasting 18 hours. There had also been some 
numbness and weakness of her legs. It was noted then that she 
was restless and anxious. Afebrile. B.P. 199 (ih a previous 
182 attack this had risen to 100 
). Pulse rate 110 -120 /minute. 
There was some generalised abdominal tenderness, but no rigidity. 
Her legs were weak, but there were no other abnormal neuro- 
logical signs. She was given morphia, pethidine and aspirin 
for her pain, which gradually settled down in a few weeks. 
She had a further similar attack in November 1952, for which 
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A.C.T.H. was given for 2 weeks without apparent influence on 
symptoms. There were 2 further attacks in April and May 1953. 
Since then, until August 1954, she has had mild attacks of 
abdominal pain only. All her previous attacks had been pre- 
menstrual and her physician had suppressed her periods with 
testosterone since April, 1953. 
Further records Basal B.P. 1-70 . Liver function tests - 
normal (Table 2). The urine contained much porphobilinogen. 
She had not taken barbiturates since 1951. 
Summary Recurrent attacks of abdominal pain, vomiting and con- 
stipation for 2 years in a woman of 33. No history of 
barbiturates. Numbness and weakness of legs on 1 occasion. 
Mrs. A.W. Age 21 years (1953) Housewife Case No. 35 
This woman began to have abdominal pain and nausea for 
2 weeks after a missed menstrual period. She was thought to be 
pregnant, possibly to have a tubal pregnancy, and was admitted to 
Stobhill General Hospital, Glasgow, on 18.10.53. Examination 
showed that there was loss of power in the muscles of her back 
B.P.l ó . Pulse rate and arms. There was no sensory loss. 
100 -130 /minute. Afebrile. The urine contained much porpho- 
bilinogen and 22mg /litre of uroporphyrin. 
Her abdominal pain persisted for several weeks in hospital, 
but this gradually lessened and her muscle power improved. 
Mentally she was truculent and of low intelligence. When she was 
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discharged she attended the antenatal clinic for several months 
and her pregnancy was confirmed. She continued to excrete large 
amounts cf porphobilinogen in her urine without symptoms. 
Before the end of her pregnancy she defaulted from the antenatal 
clinic and has not been able to be traced. 
There was no history of barbiturates. 
Summary A first attack occurring in very early pregnancy in a 
woman of 21 years. Abdominal pain and muscular paresis. 
Tachycardia but no hypertension. The attack settled and she 
continued her pregnancy. 
Miss I.M. Age 28 years (1950) Nurse Case No. 36 
This young woman was well until December, 1950, when she 
started to have intermittent attacks of lower abdominal pain, 
constipation, vomiting and pain in the lower legs and feet, with 
the passage of reddish urine. This went on for 1 year during 
which she was admitted on 2 occasions (2.8.51. and 10.12.51.) to 
Hackney Hospital, London. While there it was noted that her 
180 170 
B.P. was intermittently raised 11 - 170) but sometimes returning 
to normal (1g0) Pulse rate was 130 /minute during severe phases. 
She was given barbiturates on several occasions during her stay 
in hospital, e.g. phenobarbitone gr. 3 p.r.n., and nembutal gr. 3 
p.r.n. nocte. She was afebrile. She became very depressed, 
was considered to be hysterical and was admitted to a mental 
hospital 27.11.51. for a short time for electric convulsion 
FAMILY 6. 
Case 3 6. 
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treatment. ifter this she developed a quadriparesis, lateral 
nystagmus, slight (R) ptosis, diffuse loss of pin -prick sensation, 
incontinence, aphonia and dysphagia. 
In this critical state, she was admitted to the Metabolic 
Ward at University College Hospital, London, under Dr. Blake - 
Pritchard and Dr. C.E. Dent. B.P. 
-70. 
There was a persistent 
tachycardia (110 /min.). The urine contained much porpho- 
bilinogen and uroporphyrin (maximal value 66mg /day). She was 
treated with hexamethonium bromide 40 mg. 3 hourly, to keep the 
systolic B.P. at 120 and prophylactic chicramphenicol. She 
improved gradually over several weeks - her voice first, then 
swallowing, then her limbs. Her urinary uroporphyrin fell to 
5mg/day. She had repeated B. coli urinary infections which 
caused slight relapses in which the urinary uroporphyrin level 
rose tc 15mg/day. A course of cortisone was given for 1 week 
without much effect. She became severely emaciated and her 
calorie intake was reinforced by the addition of 70 ml. absolute 
alcohol to her diet. She was also given isonicotinic acid 
hydrazide and methyl androstenediol to improve her appetite and 
nutritional state. Her physical condition improved gradually 
during the next 12 months and she became able to walk and use her 
hands, but there was an insidious degeneration of her mental 
condition throughout 1953 and she was placed (August, 1954) in a 
mental home as a certified patient. She was hallucinated, 
delusional and unable to work. In 1955 she made a remarkable 
physical and mental recovery and is now (1956) normal apart from 
the excretion of porphobilinogen in the urine. This improvement 
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was associated with the administration of neostigmine. 
Family history Sister is a latent porphyria. See Family 6. 
Summary A very severe prolonged attack with marked neurological 
symptoms. Barbiturates were given before onset of paralyses. 
Gradual physical improvement but insidious mental deterioration. 
Patient was certified in a mental home, but is now completely 
recovered. 
Mrs. K.M. Age 23 years (1951) Housewife Case No. 37 
This woman was admitted to University College Hospital, 
London, as a surgical emergency in January, 1952, because of severe 
colicky abdominal pain, vomiting and constipation of 10 days' 
duration with the passage of dark urine. A similar less severe 
episode had occurred 1 year previously. On examination it was 
noted that her temperature was 100 °F. Pulse rate 100 -120 /minute. 
She had an acute tonsillitis and culture of a throat swab gave a 
growth of haemolytic streptococcus. Ier. urine contained much 
porphobilinogen and 28.28 mg /litre of uroporphyrin on the day 
after her admission. B.P. . Retinal artery constriction 
with small waves of spasm, was noted. Her condition settled after 
a course of penicillin and her urinary uroporphyrin was 0.87 mg/ 
litre 16 days later. 
She was re- admitted on 14.9.52. with a sore throat, 
constipation, headache and nausea, but no abdominal pain. She 
had an acute tonsillitis and her temperature was 103 °F. 
CASE 37 ACUTE PORPHYRIA K.M. 23yrs. 
Influence of Infection on Porphobilinogen excretion 
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Hb. 15 G. W.B.C. 9,100/cmm. There was no tachycardia or 
hypertension on this occasion. She was again treated with 
penicillin and her temperature rapidly fell and her condition 
improved. A tonsillectomy was performed on 29.9.52. There 
was no untoward reaction from this. The daily porphobilinogen 
levels (expressed as uroporphyrin) throughout this period are 
noted in Fig. 2. They show the rise of porphobilinogen 
associated with this infection and its fall when the infection 
was controlled. She has remained very well for the past 4 years. 
Her urine on 8.2.53. did not contain porphobilinogen. 
Family history See Family 7. 
Summary 2 attacks of acute porphyria, each associated with acute 
tonsillitis. Remission after tonsillectomy. 
Case No. 38 
Mrs. J.11. Age 23 (1954; Packer in cigarette factory & housewife 
This patient, a sister of Case No. 37, was well until. 
4.8.54. when she complained cf sharp, gripping, lower abdominal 
pain and pains in the lateral aspects of her thighs. There was 
vomiting associated with the pain. She had given birth to a 
baby girl 4 months previously. In view of this, she Was admitted 
to the obstetric wing of University College Hospital, London, as 
a possible case of postpartum salpingitis and treated with 
penicillin and sulphonamides. The pains diminished, but they 
returned with the onset of her period 4 days later, and it was then 
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became constipated throughout this period and also complained of 
backache. On 16.E.54. she was transferred to the Iiedical Unit, 
U.C.H., London. 
On examination it was noted that she still had severe 
abdominal pain. There was generalised abdominal tenderness, but 
no rigidity. She was mentally alert and intelligent. She had 
difficulty in passing urine and required to be catheterised for 
several days. There were no abnormal neurological signs. 
B.P. 
150 Pulse rate 80/90 /minute. Lfebrile. Her pain and 
vomiting settled after about 1 week. She developed a symptomless 
urinary infection which was treated successfully with streptomycin. 
On 13.10.55. she delivered a normal child after an 
uneventful pregnancy. 
Further records Plasma electrolytes (18.8.54) showed 
diminished chlorides (Table 1). Liver function tests (18.8.54) 
(Table 2). Hb. 15 G W.B.C. 6,800 /cm;l. E.S.R. 20mm /1 hour. 
Her urine throughout her stay in hospital contained 50 -100mg /day 
of p orphobilinogen. 
Ftmily history See family 7. 
Summary A first attack in a woman of 23, 4 months after the 
birth of her child. No neurological signs but retention of 
urine for several days. Normal pregnancy one year later. 
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Mrs. T.B. Age 21 years (1954) Housewife Case No. 39 
This young woman was admitted to Luton and Dunstable 
Hospital on 4.7.54. with a history of severe continuous abdominal 
pain, mainly in the epigastriurn, with vomiting, constipation and 
loss of weight of 2 weeks' duration. She had given birth to a 
child 2 weeks before the onset of symptoms. She also had some 
dysuria and frequency for which her doctor had given her 
suiphatriad. He also gave her codeine and butobarbitone. 
There was a previous history of abortion after a 6 months' 
pregnancy in March 1953. In June 1953 she had cramp -like 
epigastrio and leg pains. 
In Luton and Dunstable Hospital she appeared very ill 
and mentally disturbed. There was epigastric tenderness but no 
rigidity, paresis of legs and arias but no sensory loss. She 
was transferred to University College Hospital, London, on 
14.7.54. and it was noted that she was in considerable pain. 
Limb paresis was still present. Only the (L) knee and (R) arm 
tendon reflexes could be obtained. B.P. X20 . Pulse rate 
130 /minute. Urine contained 150 -200 mg. porphobilinogen daily. 
She was treated with pethidine for her pain. She was 
also given probanthine 15mg 4H for 7 days and tetra ethyl 
ammonium chloride 100má t.d.s., for 14 days. There was no 
dramatic improvement of symptoms from both of these drugs. On 
21.8.54. she developed a temperature of 101 °F. This was due to 
a (R) lower lobe pneumonia, caused by a penicillin- resistant 
staphylococcus pyogenes. This was successfully treated with 
aureomycin. The infection must have taken place after the onset 
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of her illness because her chest X -ray in Luton and Dunstable 
Hospital was normal. 
She gradually improved after the treatment of her pneumonia. 
Her abdominal pains lessened, the muscular power and tendon 
reflexes returned and the B.P. and pulse rate returned to normal. 
She was discharged on 22.8.54. 
Further records 4- 14.7.54. Hb. 11.8 G. R.B.C. 4 million/ 
cmm. W.B.C. 11,600 /c_mm. L.S.R. 17mm /1 hour. Liver function 
tests - normal (Table 2). C.S.F. normal. 
Family history Her father is Case No. 40. Her paternal uncle 
is Case No. 41. See family 8. 
Sumuary A moderately severe attack in a girl of 21, starting 
2 weeks after the birth of her child. Mild neurological signs. 
Butobarbitone given. Intercurrent pneumonia treated successfully. 
Mr. R.A. Age 29 years (1935) Shipyard holder Case No. 40 
This man is the father of Case No. 39. His urine was 
examined when his daughter was unwell and found to contain porpho- 
bilinogen. His past history is very suggestive of a prolonged 
attack of acute porphyria. He had always noted that his urine 
was amber coloured - 'the colour of whisky'. On 16.6.35. he 
had a sudden (L) subcostal, gnawing, intermittent pain with 
vomiting and constipation. These symptoms recurred for the next 
2 years, during which time he was admitted, on 2 occasions, to 
the Royal Infirmary, Greenock. Pulse rate 70-90 /minute. Afebrile. 
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Barium meal was negative. No abdominal rigidity. He remembers 
that his legs and arms became very weak and his wife relates how 
he became changed mentally. He would not recognise her. On 
one occasion he jumped over the stair railings and tried to set 
things on fire while he was in hospital. He remembers that he 
was getting injections and tablets which made him sleepy. 
Examination of the records shows that these injections were mainly 
morphia and atropine. He did however have alonal gr. 2 on 
25.6.35. and medinal gr. 7.5 on 26.6.35. The hospital authorities 
wished to have him certified, but his father took him home 
and he gradually recovered his strength and normal mental state. 
On 15.1.37. a laparotomy was carried out at Broadstone Hospital, 
Port Glasgow, because of his persistant abdominal pain and a 
retrocaecal, non - inflamed appendix was removed. His wife states 
that it was 1940 before he was quite normal mentally and till 
then she felt afraid to be alone with him in the house. 
He has been well from that time until 1954, except for 
a period of 5 weeks in hospital in 1948 when he had generalised 
oedema, which quickly settled. Examination in August, 1954, 
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showed no physical abnormality except a B.P. of II0 . Urine 
contained 72mg /litre porphobilinogen and 58,4g /litre copro- 
p orphyrin. 
Family history See family 8. 
Summary Acute porphyria with onset 19 years ago. Marked 
mental change with gradual recovery to normal. Still excretes 
p orphobilinogen in his urine. 
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Mr. J.A. Age 31 years (1933) Shipyard worker Case No. 41 
This man, a brother of Case No. 40, began to be troubled 
with recurrent attacks of abdominal pain in 1933, with constipa- 
tion. A laparotomy was done in November 1933, and his appendix 
was removed. At operation areas of spasticity of the large 
bowel were seen. The pain continued after operation. In 
January, 193;., he found that he could not extend his fingers 
properly, nor his (R) wrist. 1 month later he complained of 
pain in his chest, which persisted and was worse on exertion. 
He was admitted to the Victoria Infirmary, Glasgow, on 7.3.34. 
and was noted to be emaciated, pale, sad and depressed. Move- 
ments of arms were weak. Bilateral wrist drop was present. 
There was weakness of the legs, but there was no foot drop. 
Tendon reflexes of the limbs were absent. There was no sensory 
loss. His urine was noted to be dark amber in colour. He was 
discharged from this hospital on 6.7.34., "very much improved ".. 
His pain continued after his discharge. 
On 3.5.35. he was admitted to the Royal Infirmary, 
Greenock, with a complaint of severe abdominal pain. On 
examination he was found to be in a debilitated condition with 
bilateral wrist drop and a flaccid quadriparesis. B.P. ló5 
Pulse rate 80- 100 /minute. Afebrile. C.S.F. normal. On 
10.5.35. he developed a carbuncle of his back and sugar was found 
in his urine. He was given medinal 2 tablets on 8.5.35. His 
condition deteriorated rapidly and he died on 15.5.35. 
Lam¡ly_llistory See family 8. 
Summary The history here is very suggestive of acute porphyria, 
although the urine, noted to be dark, was not investigated for 
the presence of porphobilinogen. The subsequent family history ' 
which unfolded - proved acute porphyria in his brother and niece - 
makes such a diagnosis very likely. 
Mrs. L. W. lige 55 years (1952) Housewife Case No. 42 
This woman was admitted to the London Hospital in May, 
1954. In the previous 2 years she had bouts of diarrhoea coming 
on in the early morning, lasting 2 -3 days and occurring every 
2 to 3 weeks. She had passed mucus during these attacks, never 
blood. She had hypogastric pain during the attacks and sometimes 
she vomited. Between attacks she was constipated. Her last 
attack occurred 4 weeks before her admission to hospital. For 
the past 8 weeks she had noted that she had passed dark urine. 
Past History 18 years before, she had abdominal pain and vomit- 
ing. She was then admitted to the London Hospital_. A 
laparotomy was performed and a retrocaecal fibrosed appendix was 
removed. She has had headaches, sometimes with vomiting, in 
the past 15 years. In recent years she has felt very lethargic 
and has never wanted to go out of the house, particularly since 
her husband died 4 years ago. 
On examination it was noted that she was an obese middle - 
aged woman. There was no physical abnormality, except that the 
palate elevated to the (R) . B.P. lad . Pulse rate 65 -95/ 
minute. 
litre. 
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Chile in hospital she had a severe attack of constant 
generalised abdominal pain with persistent vomiting and constipa- 
tion, lasting one week. This was the most severe attack of 
abdominal pain that she had suffered. She was discharged from 
hospital 1 month after admission. Since then she still has 
recurrent attacks of diarrhoea and also has had severe headaches. 
Barbiturates have not been given to this patient for 
several years. 
Faniljistory See family 9. Her nephew, age 40 years, has 
porphobilinogen in his urine. He is very healthy. The specimens 
of the remaining relatives were negative for porphobilinogen. 
Summary A middle -aged woman with recurrent attacks of diarrhoea, 
vomiting and some abdominal_ pain. She passes porphobilinogen 
in her urine. Long history of migraine. Nephew is a latent 
case. 
Air. Age 18 years (1952) Case No. 43 
This young man was well until February, 1952, since when 
he had intermittent attacks of nausea, vomiting, constipation, 
abdominal and leg pains until his death in December 1953. He 
required to be admitted to the Royal Infirmary, Glasgow, on 5 
occasions throughout this 22 months' period. In some of these 
attacks he had transient hypertension (B.F. 170 
100 140 
190), tachy- 
cardia (100 -120 /minute) and mental disorientation. In his final 
attack he was re- admitted to hospital because of headache and pains 
CASE 43. ACUTE PORPHYRIA J.W. a 18yrs. 
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in his back and limbs. he later developed tremor and weakness 
of his arms and legs. This limb weakness progressively in- 
creased for 2 months until his death on 14.12.53. from broncho- 
pneumonia. He was given a prolonged course of cortisone and a 
short course of A.C.T.H. in his final illness, but these did not 
seem to improve him. I-Ie had never been given barbiturates. 
Further records HIP'. 14.6 - 15.4 G. Liver function tests - 
normal (Table 2) . E.S.R. 9mm /1 hour. (Westergran) . 
Throughout his illness he excreted much porphobilinogen in his 
urine. P.n. tissues - Chemical analysis - Table 3. 
Family History His sister is Case No. 44. See family 10. 
Summary Recurrent attacks for nearly 2 years, final fatal one 
with slow development of limb weakness. Barbiturates not given. 
hiss M.W. Age 15 years (1951) Case No. 44 
This girl is the sister of Case No. 43. Her mother 
stated that she had intermittent attacks of abdominal pain and 
vomiting since early childhood. In 1951 she was admitted to an 
infectious diseases hospital because of abdominal pain, diarrhoea 
and pain and stiffness in the legs. She was diagnosed there as 
a case of acute porphyria, but before the diagnosis was made she 
was given barbiturates. In May to June, 1952, and again in 
November, 1952, she was under the care of Professor L.J. Davis at 
the Glasgow Royal Infirmary, with similar symptoms. There was 
an intermittent low -grade pyrexia and tachycardia of 120 /minute. 
FAMILY 10. 
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W.B.C. 8- 10,000 /cmm. She was re- admitted on 4.2.53. with the 
same pattern of symptoms. The B.P. was 
120 
, the first occasion 
on which hypertension was noted. She was dehydrated and her 
abdomen was tender. Both her legs were weak and there was 
increase of muscle tone and a (L) extensor plantar response. 
Her legs were hyperaesthetic but otherwise there was no sensory 
abnormality. Her condition improved within a few days. As in 
other attacks, her initial diarrhoea gave place to constipation. 
After her discharge from hospital she remained well until 
28.6.54. when she was re- admitted with abdominal and muscular 
pain, vomiting and constipation of 2 days' duration. There was 
tenderness and weakness of her legs but no sensory changes. 
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B.P. She improved on symptomatic treatment during the 
following 10 days and was finally discharged on 3.8.54. She has 
remained well since then. The urine has contained large amounts 
of porphobilinogen during attacks. 
Family history See family 10. her maternal aunt died in 1938 
after a prolonged illness ending in mental disturbance. Her 
twin brother complained of intermittent abdominal and leg pain 
in 1955 and required to be admitted to hospital. Porphobilinogen 
was never detected in his urine and the porphyrin contents of 
several specimens were normal. It was considered that this was 
an hysterical simulation of acute porphyria. 
Summary Repeated attacks of acute porphyria for 3 years. 
Diarrhoea a recurrent feature. Minimal neurological signs. 
Barbiturates not given since 1951. 
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Mr. D.W. Age 20 years (1940) Leather manufacturer Case No. 45 
This man was admitted to University College Hospital, 
London, on 1.5.54. because of severe vomiting and prostration 
which occurred at the end of, and following a journey by sea from 
the U.S.A. He started to vomit while on board ship and continued 
to do so in the few days between his arrival in this country and 
his admission to hospital. He had ten dramamine on his boat 
journey, though the sea was calm. No barbiturates were taken. 
He had 4 such attacks of severe vomiting in the past. - in 1940, 
1946, 1949 and 1951, the first three associated with stormy air 
trips. In his first attack in 1940 he also had tingling of his 
extremities, weakness of his muscles and aphonia, but these 
symptoms passed off. in 24 hours. The attack in 1951 came on 
after an injection of pentothal. There has never been any 
abdominal pain. 
Past History He had asthma and flexural eczema as a child. He 
still gets asthmatic attacks. He had jaundice in 1945 in Sao 
Paulo, but this was not associated with vomiting. There is no 
skin photosensitivity. On examination it was noted that he was 
dehydrated and mentally clouded. Afebrile. Pulse rate 70-80/ 
minute. B.P. 
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Urine (3.5.54.) contained 41mg /litre of 
parphobilinogen and 7.58mg /litre of ether soluble porphyrin, later 
shown by paper chromatography to be Coproporphyrin III with some 
hexacarboxylic and /or heptacarboxylic porpl:yrir... There was 
only a faint trace of uroporphyrin. The urine also gave a 
moderately strong acetone reaction. The stool porphyrin 
determination was - coporporphyrin 15.42mg/g dry trt., proto- 
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phyrir_ and deuteroporphyrin 3.5mg /g dry wt. Paper chromato- 
graphic analysis of the coproporphyrin fraction showed the same 
pattern of porphyrins as in the urine. 
The patient was treated with 5; dextrose in normal saline 
and ' avomine' . He stopped vomiting and became very much better 
in a few days. He was discharged on 8.5.54. 
Further recorIL 21.5.54. Urine Porphobilinogen - faintly 
present (confirmed by paper chromatography) . Coproporphyrin 
1.57mg /litre. Stool Coproporphyrin 2.23rng /g. dry wt. Pro - 
toporphyrin and deuteroporphyrin 0.06mg /g dry wt. Blood 
(Plasma + erythrocytes) - Prctoporphyrin 32.8Ag /l00 nil. 
Coproporphyrin 1.330g/100 ml. 
Family history There is a family history cf asthma and skin 
allergy. One brother died from Leukaemia. There is no other 
history suggestive of acute porphyria. His son excreted normal 
quantities of porphyrin in urine and stool. 
Sunmary Recurrent attacks of severe vomiting and prostration 
associated with travel in the past 14 years. No abdominal pain, 
tachycardia or hypertension. In the 1 attack during which he 
was observed, he excreted porphobilinogen and much coproporphyrin 
iII in the urine. When the attack had subsided the porpho- 
bilinogen and coproporphyrin excretions in the urine had greatly 
decreased, although they were still abnormally high. 
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Mr. E.J.P. Age 25 years (1952) Physicist Case No. 46 
This man has been perfectly healthy apart from inter- 
mittent pain in the right iliac fcssa in the past 2 years (1952- 
1954). The pain comes on in the morning soon after rising from 
bed and is more often present when he is worried. It is not 
accompanied by vomiting, nor associated with eating food. In 
194e his appendix was removed because of bilious attacks. 
There is no skin photosensitivity. 
The fact that his porphyrin excretion was abnormal was 
first noted by Dr. F.W. Darby, who was, at the time, doing a series 
of normal human urinary coproporphyrin studies. The urinary 
coproporphyrin of this man was abnormally high. Clinical exam- 
ination revealed no other abnormality. 
Examination of his urine on July 1954 showed porpho- 
bilinogen ( confirmed qualitatively by paper chromatography) , 
coproporphyrin 1.524mg¡ litre. 
Stool Coproporphyrin 259.3g/g. dry weight. Protoporphyrin - 
trace only. Paper chromatography of these porphyrins showed the 
urinary porphyrin to consist of mainly coproporphyrin III, with 
some uroporphyrin and some hexacarboxylic porphyrin, while the 
stool porphyrin was entirely coproporphyrin III. 
Family history Of his relatives, only his mother had recurrent 
abdominal pain. His father had died from syringomyelia in 1951. 
Urine and stool specimens were obtained from his mother, maternal 
aunt and his own baby daughter. His mother's stool showed some 
increase in porphyrin excretion (coproporphyrin 163ug /g. dry 
weight). The remaining specimens were normal. 
Plate 6a. Appendix. 
Case No. 47. Residual pigmentation on 
cheeks and bridge of nose. 
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Sumrary A healthy young man, with only slight recurrent 
abdominal pain, excretes porphobilinogen in the urine and much 
coprcporphyrin III in the urine and stool. 
Miss S. 7. Age 28 years (1950) Machinist Case No. 47 
This young woman was admitted to the Western infirmary, 
Glasgow, on 25.1.52. because of constant colicky lower abdominal 
pain, vomiting, constipation and the passage of dark urine for 2 
days. There was also difficulty in micturition. 9 days before 
admission she developed a red rash on the bridge of her nose and 
on both cheeks for which she was given white tablets, probably 
sulphonamides. 
Past History In 1950 she was admitted tc the Royal Infirmary, 
Glasgow, because of pain in the right iliac fossa and the passage 
of dark urine. A laparotomy was performed and a normal appendix 
was removed. There was no history of photosensitivity. On 
examination in January, 1952, it was noted that she was very 
thin, weak and that her face was pigmented with oedema and 
vesiculation of her cheeks (plate 6a). Pulse rate 100 -120/ 
minute. Afebrile. B.P. 
120 -.on admission, but she later 
developed a diastolic hypertension (B.1-. 1iS) . Her arms and 
legs became weak, although she could always move them feebly. 
There was a selective weakness of the extensors of the wrist and 
fingers giving the 'tricorne' hand (plate 6b). There was no 
sensory loss or loss of muscular co- ordination, as far as this 
could be examined. At one period bilateral extensor plantar 
Plate 6b. Appendix. 
Case No. 47. 
The "tricorne" hand. 
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responses could be obtained and there were increased ankle and 
knee tendon reflexes present with ankle clonus. Her abdominal 
pain continued for several weeks, but latterly she complained of 
numbness of her abdomen and pains in the legs and scapular region. 
Her vomiting stopped about 4 weeks after her admission and she 
was given 0.5 n. saline orally and parenteral normal saline in 
order to raise her persistently lowered serum chloride. . The 
administration cf 100 mg. A.C.T.H. per day (15- 21.2.52.) brought 
about a prompt and sustained restoration of the normal level. 
During this period her voline of packed red cells fell from 51% 
(31.1. )2.) to 42 (16.2.52.). There was a gradual improvement 
in her condition after 6 weeks and she was eventually discharged 
on to a convalescent home. 
There were no psychological changes throughout her illness 
apart from some reasonable anxiety over her condition. 
Throughout her illness she had amenorrhoea which continued 
till May, 1952. She has reported regularly since then till 
September, 1954, and during all this time she has remained very 
well and has gained over 1 stone in weight. 
Further records Her urine throughout her illness contained much 
porphobilinogen. The maximum uroperphyrin concentration was 34mg/litre. 
Serum electrolytes (Table 1) - before and after Á.C.T.H. 
Liver function tests (Table 2). Plasma did not fluoresce. 




" Fundus Hypertonicusu, with spasm of the retinal arteries (Plate 7). 
The fundus became normal in appearance when her B.P. returned to 
normal. 
Plate 7. Appendix. 
Case No. 47. F`undus Hypertonicus. 
I wish to thank Mr. Donald, Ophthal- 
mology department Western Infirmary, 
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161 644 18.41 + + + 
H25.1..52. 340 ! 401 5S.5 0 0 
K10.8.54. 404 203 ¡ 484 0 0 
H phase of remission 
Summary The general history of this girl is characteristic of 
acute porphyria. The skin lesion in the beginning of the 1952 
attack is puzzling, since there was no photosensitivity either 
before or after this occasion. The urine and stool in remission contained 
increased amounts of porphyrins. 
Mist L.ìí. tige 15 years (1951) Schoolgirl Case No. 4.8 
This girl was well until 17.5.51. when she developed a 
sore throat. She was treated with penicillin and sulphonilamide. 
The next day she complained of pain in the lower abdomen and in 
both hips. The pain was constantly present and associated with 
nausea, vomiting and constipation. On 20.5.51. she had headache 
with epistaxes and was said to have had two "convulsions" with 
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stiffness of her body, but without loss of consciousness. 
She was admitted next day to the gestern Infirmary, Glasgow. 
The pain persisted for about 1 week and she was discharged shortly 
after this. B.P. 
130 
. Pulse rate 120 /minute. Afebrile. 
her urine contained much porphobilinogen. 
She was well until September, 1952, when she had a 'cold' 
a2d this was treated with aspirin powders. Shortly afterwards 
she complained of lower abdominal pain radiating down both thighs, 
and also pain in the lumbar region. There was no vomiting or 
constipation. She was re- admitted to the gestern Infirmary, 
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Glasgow, on 24.9.52. B.P. Pulse rate was high through- 
out this attack and maximally 160 /minute. There was a low grade 
pyrexia with a maximum of 101.2 °F. W.B.C. 7,200 /cum. Hb. 
12.5 G . Her pain continued for about 15 days after her 
admission to hospital. On 29.9.52. she had a sudden partial 
loss of vision, lasting a few hours. About 5 days later she 
became confused, hallucinated and hysterical and almost un- 
manageable for some time, but settled down in a few days. She 
became so homesick and unhappy that she was allowed to go home. 
She remained unwell and was given 300,000 units daily of 
distaquaine penicillin for 6 days, as well as phenobarbitone 
gr. 2 nightly. Her condition deteriorated throughout this 
period and she was then admitted to Ayrshire Central Hospital, 
where she died with respiratory paralysis, after having been 
placed in an artificial respirator for 10 days. 
Further records Becosyn 50 mg. t.d.s. and priscol 20 mg. t.d.s. 
given throughout second attack without apparent effect. There 
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is no family history of ncte. She had not menstruated up to the 
timo of her first admission. 
Summary 2 attacks, the second fatal, in a girl of 15 years. 
The respiratory paralysis before death was preceded by barbiturate 
administration. 
Mr. N.B. ge 36 years (1954) Minister Case No. 49 
This man was well until September 1954, when he developed 
a sore throat for which he was given sulphonamides. Shortly 
after this (3/10/54) ho complained of colicky epigastri c pain at 
first constant and later intermittent, lasting for 2 -3 weeks 
during which time he was also constipated. Nc cause for the 
pain could be found. He was seen by a psychiatrist because he 
was a difficult patient. He had no neurological features, apart 
from bilateral nystagmus. B.P. 
71001 
P.R. 95/minute. 
Temperature 97.2 °F. L.S.R. 17 mm /hour. Hb. 14.4 G¡. 
I.B.C. 4,400 /cmm. Intermittent proteinuria. He gradually 
recovered and had no further attack for 1 years. he was given 
barbiturates after the pain started but did not develop paralysis. 
Urine porphobilinogen 68 mg /litre. Coproporphyrin 317µg /litre. 
Family History His only child is an epileptic. There is no 
porphobilinogen in the urine of this child. 
Summary Solitary attack following a sore throat and sulphon- 
amides. Barbiturates given during an attack but paralysis did 
not develop. 
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Mrs. M.B. Age 22 years (1954) housewife Case Ido. 50 
This young woman developed migraine in February 1953 and 
was put on phenobarbitone gr.4- b.d. or t.d.s. Although this 
made her feel giddy, sickly and dazed, she continued to take 
the drug until May 1954. She became progressively more depressed 
and after a peculiar "stiff" turn in which she felt depressed 
and cried, she was sent to the Maudsley Hospital for treatment. 
An E . L . G. , performed there, was normal and she was put on 
sodium amytal nocte which was continued until 1st September, 
1954. In August 1954 she complained of vague, intermittent 
abdominal pain, lethargy and depression. She then went on 
holiday to the Isle of Wight. The pain got more severe, 
radiating from the loins down both sides to the lower abdomen. 
It was constantly present, though it varied in intensity, and was 
associated with vomiting. She was admitted to hospital. Since 
she also had albuminuria, a diagnosis of pyelitis was made and 
she was treated with phenobarbitone and sulphonamides. Five 
days later she developed twitching movements in the (R) side of 
the face and loss of consciousness and subsequently had 4 further 
epileptiform attacks. When she recovered from these she was 
confused and drowsy and was transferred to a mental hospital. 
She still had abdominal pain, vomiting, anore.:ia and complained 
of some numbness from the waist downwards. It was noted that 
she passed dark urine and a diagnosis of acute porphyria was 
established. She was then transferred to University College 
Hospital, London (22.9.54.). She was drowsy, apathetic and 
still complained of abdominal pain and numbness of lower limbs. 
I 1 
460 t0 
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B.P . l . P .R. 116 minute. There was weakness on straight leg 
raising and absent knee jerks. Slight pyuria and bacilluria 
(B. coli). Fundi normal. Urine porphobilinogen 7.7 mg /litre. 
Blood urea 27 mg.. Rb. 15 Cr;,. W.B.C. 7,400 /cmm. She had 
lost over 1 stone in weight since the onset of her illness and 
had to be persuaded to take an adequate diet. The abdominal 
pain continued and was now associated with diarrhoea. The pain 
gradually eased and her mental condition improved. She was 
discharged 11/10/54. Since June 1954(until 1956) she has been 
very well, entirely free of symptoms. 
Previous illnesses Nocturnal enuresis since childhood. She is 
liable to hay-fever in summer. 
Family hi stor 9 other members of family tested for porpho- 
bilinogen in urine and all found negative (see family No. 11). 
Summary Prolonged barbiturate administration for migraine 
followed by depression and later epilepsy and neurological 
symptoms. Porphobilinogen in urine. 
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TABLE 1 (Appendix) 
Serum or Plasma Electrolytes 
Case Date. Sodium Potassium Chloride Bicarbonate Urea 
No. (m. eq.l.) (m. eq.l) (m. eq.l .) (m. eq.l.) mg. 









10.11.53. 121 5.3 80 27.3 58 
(died 11.11.53) 
12. 7.54. 4.1 98 35.2 75 
16. 7.54. 3.1 78 39.6 99 
18. 7.54. 130 3.15 88 33 67 
24. 7.54. 148 4.5 90 40 268 
O.i ed 25.7.54) 
134 3.7 100 
29. 1.52. 130 4.85 101 
20. 2.52. 136 3.7 87 
21. 2.52. 139 4.7 93 
25.2.52. 135 4.5 91 
2'7. .52. 137 5.1 95 
3.3.52. 139 4.6 103 
5.3.52. 147 5.1 103 
12.3.52. 154 4.6 93 
21.8.53. 153 4.6 100 
.18.8.54. 142 4.55 88 25 




18.2.52. 142 3.84 93 
19.2.52. 152 4.1 94 
21.2.52. 143 3.58 99 
23.2.52. 246 3.84 99 
25.2.52. 139 4.23 95 
26.2.52. 146 6.66 100 
1.3.52. 142 5.38 96 
3.3.52. 145 4.23 100 
11.3.52. 139 4.48 96 
17.3.52. 139 4.36 104 
27.3.52. 135 5.38 96 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Plate 8. Appendix. 
Case No. 32. Right phrenic nerve undergoing 
demyelination, with phagocytosis of released 
lipoid. Free macrophages are seen in oedem- 
atous spaces beneath the endoneurium. 
Sudan IV X 120. 
I am indebted to Dr. James B. Gibson for his 
permission to include Plates 8, 9, and 10. 
Plate 10. Appendix. 
Case No. 43. Parietal white matter, 
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